id	sid	tid	token	lemma	pos
iajs-3480	1	1	97	97	NUM
iajs-3480	1	2	©	©	PROPN
iajs-3480	1	3	2022	2022	NUM
iajs-3480	1	4	the	the	DET
iajs-3480	1	5	author(s	author(s	NOUN
iajs-3480	1	6	)	)	PUNCT
iajs-3480	1	7	.	.	PUNCT
iajs-3480	2	1	published	publish	VERB
iajs-3480	2	2	by	by	ADP
iajs-3480	2	3	college	college	NOUN
iajs-3480	2	4	of	of	ADP
iajs-3480	2	5	education	education	NOUN
iajs-3480	2	6	for	for	ADP
iajs-3480	2	7	pure	pure	ADJ
iajs-3480	2	8	science	science	NOUN
iajs-3480	2	9	(	(	PUNCT
iajs-3480	2	10	ibn	ibn	PROPN
iajs-3480	2	11	al	al	PROPN
iajs-3480	2	12	-	-	PUNCT
iajs-3480	2	13	haitham	haitham	PROPN
iajs-3480	2	14	)	)	PUNCT
iajs-3480	2	15	,	,	PUNCT
iajs-3480	2	16	university	university	NOUN
iajs-3480	2	17	of	of	ADP
iajs-3480	2	18	baghdad	baghdad	PROPN
iajs-3480	2	19	.	.	PUNCT
iajs-3480	3	1	this	this	PRON
iajs-3480	3	2	is	be	AUX
iajs-3480	3	3	an	an	DET
iajs-3480	3	4	open	open	ADJ
iajs-3480	3	5	-	-	PUNCT
iajs-3480	3	6	access	access	NOUN
iajs-3480	3	7	article	article	NOUN
iajs-3480	3	8	distributed	distribute	VERB
iajs-3480	3	9	under	under	ADP
iajs-3480	3	10	the	the	DET
iajs-3480	3	11	terms	term	NOUN
iajs-3480	3	12	of	of	ADP
iajs-3480	3	13	the	the	DET
iajs-3480	3	14	creative	creative	ADJ
iajs-3480	3	15	commons	common	NOUN
iajs-3480	3	16	attribution	attribution	NOUN
iajs-3480	3	17	4.0	4.0	NUM
iajs-3480	3	18	international	international	ADJ
iajs-3480	3	19	license	license	NOUN
iajs-3480	3	20	.	.	PUNCT
iajs-3480	4	1	hepcidin	hepcidin	ADJ
iajs-3480	4	2	and	and	CCONJ
iajs-3480	4	3	crp	crp	PROPN
iajs-3480	4	4	levels	level	NOUN
iajs-3480	4	5	in	in	ADP
iajs-3480	4	6	a	a	DET
iajs-3480	4	7	sample	sample	NOUN
iajs-3480	4	8	of	of	ADP
iajs-3480	4	9	iraqi	iraqi	ADJ
iajs-3480	4	10	hypothyroid	hypothyroid	ADJ
iajs-3480	4	11	patients	patient	NOUN
iajs-3480	4	12	treated	treat	VERB
iajs-3480	4	13	with	with	ADP
iajs-3480	4	14	levothyroxine	levothyroxine	PROPN
iajs-3480	4	15	haider	haider	PROPN
iajs-3480	4	16	d.	d.	PROPN
iajs-3480	4	17	abdullah1	abdullah1	PROPN
iajs-3480	4	18	,	,	PUNCT
iajs-3480	4	19	*	*	PUNCT
iajs-3480	4	20	and	and	CCONJ
iajs-3480	4	21	suha	suha	PROPN
iajs-3480	4	22	abdul	abdul	PROPN
iajs-3480	4	23	-	-	PUNCT
iajs-3480	4	24	khaliq	khaliq	PROPN
iajs-3480	4	25	al	al	PROPN
iajs-3480	4	26	-	-	PUNCT
iajs-3480	4	27	jowari2	jowari2	PROPN
iajs-3480	5	1	1,2department	1,2department	NUM
iajs-3480	5	2	of	of	ADP
iajs-3480	5	3	biology	biology	NOUN
iajs-3480	5	4	,	,	PUNCT
iajs-3480	5	5	college	college	NOUN
iajs-3480	5	6	of	of	ADP
iajs-3480	5	7	science	science	NOUN
iajs-3480	5	8	,	,	PUNCT
iajs-3480	5	9	university	university	NOUN
iajs-3480	5	10	of	of	ADP
iajs-3480	5	11	baghdad	baghdad	PROPN
iajs-3480	5	12	,	,	PUNCT
iajs-3480	5	13	baghdad	baghdad	PROPN
iajs-3480	5	14	,	,	PUNCT
iajs-3480	5	15	iraq	iraq	PROPN
iajs-3480	5	16	.	.	PUNCT
iajs-3480	6	1	*	*	PUNCT
iajs-3480	6	2	corresponding	correspond	VERB
iajs-3480	6	3	author	author	NOUN
iajs-3480	6	4	.	.	PUNCT
iajs-3480	7	1	received	receive	VERB
iajs-3480	7	2	:	:	PUNCT
iajs-3480	7	3	10	10	NUM
iajs-3480	7	4	may	may	PROPN
iajs-3480	7	5	2023	2023	NUM
iajs-3480	7	6	accepted	accept	VERB
iajs-3480	7	7	:	:	PUNCT
iajs-3480	7	8	4	4	NUM
iajs-3480	7	9	july	july	PROPN
iajs-3480	7	10	2023	2023	NUM
iajs-3480	7	11	published	publish	VERB
iajs-3480	7	12	:	:	PUNCT
iajs-3480	7	13	20	20	NUM
iajs-3480	7	14	october	october	NOUN
iajs-3480	7	15	2024	2024	NUM
iajs-3480	7	16	doi.org/10.30526/37.4.3480	doi.org/10.30526/37.4.3480	NOUN
iajs-3480	7	17	abstract	abstract	ADJ
iajs-3480	7	18	study	study	NOUN
iajs-3480	7	19	of	of	ADP
iajs-3480	7	20	hypothyroidism	hypothyroidism	NOUN
iajs-3480	7	21	and	and	CCONJ
iajs-3480	7	22	its	its	PRON
iajs-3480	7	23	relationship	relationship	NOUN
iajs-3480	7	24	to	to	ADP
iajs-3480	7	25	the	the	DET
iajs-3480	7	26	levels	level	NOUN
iajs-3480	7	27	of	of	ADP
iajs-3480	7	28	the	the	DET
iajs-3480	7	29	hormone	hormone	NOUN
iajs-3480	7	30	hepcidin	hepcidin	ADJ
iajs-3480	7	31	and	and	CCONJ
iajs-3480	7	32	creactive	creactive	ADJ
iajs-3480	7	33	protein	protein	NOUN
iajs-3480	7	34	in	in	ADP
iajs-3480	7	35	people	people	NOUN
iajs-3480	7	36	treated	treat	VERB
iajs-3480	7	37	with	with	ADP
iajs-3480	7	38	levothyroxine	levothyroxine	NOUN
iajs-3480	7	39	.	.	PUNCT
iajs-3480	8	1	this	this	DET
iajs-3480	8	2	study	study	NOUN
iajs-3480	8	3	was	be	AUX
iajs-3480	8	4	carried	carry	VERB
iajs-3480	8	5	out	out	ADP
iajs-3480	8	6	between	between	ADP
iajs-3480	8	7	november	november	PROPN
iajs-3480	8	8	2022	2022	NUM
iajs-3480	8	9	and	and	CCONJ
iajs-3480	8	10	march	march	PROPN
iajs-3480	8	11	2023	2023	NUM
iajs-3480	8	12	.	.	PUNCT
iajs-3480	9	1	the	the	DET
iajs-3480	9	2	study	study	NOUN
iajs-3480	9	3	had	have	VERB
iajs-3480	9	4	a	a	DET
iajs-3480	9	5	total	total	NOUN
iajs-3480	9	6	of	of	ADP
iajs-3480	9	7	90	90	NUM
iajs-3480	9	8	male	male	ADJ
iajs-3480	9	9	and	and	CCONJ
iajs-3480	9	10	female	female	ADJ
iajs-3480	9	11	participants	participant	NOUN
iajs-3480	9	12	with	with	ADP
iajs-3480	9	13	an	an	DET
iajs-3480	9	14	average	average	ADJ
iajs-3480	9	15	age	age	NOUN
iajs-3480	9	16	of	of	ADP
iajs-3480	9	17	25	25	NUM
iajs-3480	9	18	to	to	PART
iajs-3480	9	19	50	50	NUM
iajs-3480	9	20	years	year	NOUN
iajs-3480	9	21	old	old	ADJ
iajs-3480	9	22	.	.	PUNCT
iajs-3480	10	1	all	all	DET
iajs-3480	10	2	samples	sample	NOUN
iajs-3480	10	3	were	be	AUX
iajs-3480	10	4	obtained	obtain	VERB
iajs-3480	10	5	from	from	ADP
iajs-3480	10	6	both	both	DET
iajs-3480	10	7	hospitals	hospital	NOUN
iajs-3480	10	8	in	in	ADP
iajs-3480	10	9	baghdad	baghdad	PROPN
iajs-3480	10	10	and	and	CCONJ
iajs-3480	10	11	the	the	DET
iajs-3480	10	12	medical	medical	ADJ
iajs-3480	10	13	lab	lab	NOUN
iajs-3480	10	14	.	.	PUNCT
iajs-3480	11	1	the	the	DET
iajs-3480	11	2	diagnosis	diagnosis	NOUN
iajs-3480	11	3	of	of	ADP
iajs-3480	11	4	hypothyroidism	hypothyroidism	NOUN
iajs-3480	11	5	based	base	VERB
iajs-3480	11	6	on	on	ADP
iajs-3480	11	7	symptoms	symptom	NOUN
iajs-3480	11	8	and	and	CCONJ
iajs-3480	11	9	the	the	DET
iajs-3480	11	10	hypothyroidism	hypothyroidism	NOUN
iajs-3480	11	11	control	control	PROPN
iajs-3480	11	12	test	test	NOUN
iajs-3480	11	13	score	score	NOUN
iajs-3480	11	14	led	lead	VERB
iajs-3480	11	15	to	to	ADP
iajs-3480	11	16	the	the	DET
iajs-3480	11	17	collection	collection	NOUN
iajs-3480	11	18	of	of	ADP
iajs-3480	11	19	30	30	NUM
iajs-3480	11	20	samples	sample	NOUN
iajs-3480	11	21	from	from	ADP
iajs-3480	11	22	healthy	healthy	ADJ
iajs-3480	11	23	individuals	individual	NOUN
iajs-3480	11	24	,	,	PUNCT
iajs-3480	11	25	30	30	NUM
iajs-3480	11	26	from	from	ADP
iajs-3480	11	27	those	those	PRON
iajs-3480	11	28	with	with	ADP
iajs-3480	11	29	untreated	untreated	ADJ
iajs-3480	11	30	hypothyroidism	hypothyroidism	NOUN
iajs-3480	11	31	,	,	PUNCT
iajs-3480	11	32	and	and	CCONJ
iajs-3480	11	33	30	30	NUM
iajs-3480	11	34	additional	additional	ADJ
iajs-3480	11	35	samples	sample	NOUN
iajs-3480	11	36	.	.	PUNCT
iajs-3480	12	1	from	from	ADP
iajs-3480	12	2	people	people	NOUN
iajs-3480	12	3	with	with	ADP
iajs-3480	12	4	hypothyroidism	hypothyroidism	NOUN
iajs-3480	12	5	who	who	PRON
iajs-3480	12	6	were	be	AUX
iajs-3480	12	7	treated	treat	VERB
iajs-3480	12	8	with	with	ADP
iajs-3480	12	9	levothyroxine	levothyroxine	NOUN
iajs-3480	12	10	,	,	PUNCT
iajs-3480	12	11	where	where	SCONJ
iajs-3480	12	12	the	the	DET
iajs-3480	12	13	necessary	necessary	ADJ
iajs-3480	12	14	tests	test	NOUN
iajs-3480	12	15	were	be	AUX
iajs-3480	12	16	conducted	conduct	VERB
iajs-3480	12	17	for	for	ADP
iajs-3480	12	18	the	the	DET
iajs-3480	12	19	three	three	NUM
iajs-3480	12	20	groups	group	NOUN
iajs-3480	12	21	,	,	PUNCT
iajs-3480	12	22	blood	blood	NOUN
iajs-3480	12	23	samples	sample	NOUN
iajs-3480	12	24	were	be	AUX
iajs-3480	12	25	collected	collect	VERB
iajs-3480	12	26	in	in	ADP
iajs-3480	12	27	a	a	DET
iajs-3480	12	28	gel	gel	NOUN
iajs-3480	12	29	tube	tube	NOUN
iajs-3480	12	30	,	,	PUNCT
iajs-3480	12	31	and	and	CCONJ
iajs-3480	12	32	serum	serum	NOUN
iajs-3480	12	33	was	be	AUX
iajs-3480	12	34	separated	separate	VERB
iajs-3480	12	35	for	for	ADP
iajs-3480	12	36	use	use	NOUN
iajs-3480	12	37	in	in	ADP
iajs-3480	12	38	their	their	PRON
iajs-3480	12	39	respective	respective	ADJ
iajs-3480	12	40	measurements	measurement	NOUN
iajs-3480	12	41	of	of	ADP
iajs-3480	12	42	(	(	PUNCT
iajs-3480	12	43	tsh	tsh	PROPN
iajs-3480	12	44	,	,	PUNCT
iajs-3480	12	45	t3	t3	PROPN
iajs-3480	12	46	,	,	PUNCT
iajs-3480	12	47	t4	t4	PROPN
iajs-3480	12	48	,	,	PUNCT
iajs-3480	12	49	crp	crp	PROPN
iajs-3480	12	50	,	,	PUNCT
iajs-3480	12	51	and	and	CCONJ
iajs-3480	12	52	hepcidin	hepcidin	NOUN
iajs-3480	12	53	)	)	PUNCT
iajs-3480	12	54	.	.	PUNCT
iajs-3480	13	1	according	accord	VERB
iajs-3480	13	2	to	to	ADP
iajs-3480	13	3	the	the	DET
iajs-3480	13	4	results	result	NOUN
iajs-3480	13	5	,	,	PUNCT
iajs-3480	13	6	there	there	PRON
iajs-3480	13	7	were	be	VERB
iajs-3480	13	8	no	no	DET
iajs-3480	13	9	significant	significant	ADJ
iajs-3480	13	10	differences	difference	NOUN
iajs-3480	13	11	in	in	ADP
iajs-3480	13	12	the	the	DET
iajs-3480	13	13	mean	mean	ADJ
iajs-3480	13	14	patient	patient	NOUN
iajs-3480	13	15	’s	’s	PART
iajs-3480	13	16	age	age	NOUN
iajs-3480	13	17	(	(	PUNCT
iajs-3480	13	18	p=0.419	p=0.419	NOUN
iajs-3480	13	19	)	)	PUNCT
iajs-3480	13	20	or	or	CCONJ
iajs-3480	13	21	gender	gender	NOUN
iajs-3480	13	22	distribution	distribution	NOUN
iajs-3480	13	23	(	(	PUNCT
iajs-3480	13	24	p=0.638	p=0.638	NOUN
iajs-3480	13	25	)	)	PUNCT
iajs-3480	13	26	between	between	ADP
iajs-3480	13	27	the	the	DET
iajs-3480	13	28	three	three	NUM
iajs-3480	13	29	studied	studied	ADJ
iajs-3480	13	30	groups	group	NOUN
iajs-3480	13	31	.	.	PUNCT
iajs-3480	14	1	when	when	SCONJ
iajs-3480	14	2	thyroid	thyroid	NOUN
iajs-3480	14	3	function	function	NOUN
iajs-3480	14	4	tests	test	NOUN
iajs-3480	14	5	were	be	AUX
iajs-3480	14	6	done	do	VERB
iajs-3480	14	7	on	on	ADP
iajs-3480	14	8	the	the	DET
iajs-3480	14	9	groups	group	NOUN
iajs-3480	14	10	that	that	PRON
iajs-3480	14	11	were	be	AUX
iajs-3480	14	12	studied	study	VERB
iajs-3480	14	13	,	,	PUNCT
iajs-3480	14	14	the	the	DET
iajs-3480	14	15	hypothyroid	hypothyroid	ADJ
iajs-3480	14	16	patients	patient	NOUN
iajs-3480	14	17	had	have	VERB
iajs-3480	14	18	significantly	significantly	ADV
iajs-3480	14	19	lower	low	ADJ
iajs-3480	14	20	levels	level	NOUN
iajs-3480	14	21	of	of	ADP
iajs-3480	14	22	triiodothyronine	triiodothyronine	NOUN
iajs-3480	14	23	(	(	PUNCT
iajs-3480	14	24	t3	t3	PROPN
iajs-3480	14	25	)	)	PUNCT
iajs-3480	14	26	and	and	CCONJ
iajs-3480	14	27	thyroxine	thyroxine	NOUN
iajs-3480	14	28	(	(	PUNCT
iajs-3480	14	29	t4	t4	PROPN
iajs-3480	14	30	)	)	PUNCT
iajs-3480	14	31	and	and	CCONJ
iajs-3480	14	32	higher	high	ADJ
iajs-3480	14	33	levels	level	NOUN
iajs-3480	14	34	of	of	ADP
iajs-3480	14	35	thyroid	thyroid	NOUN
iajs-3480	14	36	-	-	PUNCT
iajs-3480	14	37	stimulating	stimulate	VERB
iajs-3480	14	38	hormone	hormone	NOUN
iajs-3480	14	39	(	(	PUNCT
iajs-3480	14	40	tsh	tsh	NOUN
iajs-3480	14	41	)	)	PUNCT
iajs-3480	14	42	before	before	ADP
iajs-3480	14	43	treating	treat	VERB
iajs-3480	14	44	them	they	PRON
iajs-3480	14	45	(	(	PUNCT
iajs-3480	14	46	p≤0.001	p≤0.001	NOUN
iajs-3480	14	47	)	)	PUNCT
iajs-3480	14	48	.	.	PUNCT
iajs-3480	15	1	and	and	CCONJ
iajs-3480	15	2	the	the	DET
iajs-3480	15	3	highest	high	ADJ
iajs-3480	15	4	serum	serum	NOUN
iajs-3480	15	5	hepcidin	hepcidin	PROPN
iajs-3480	15	6	and	and	CCONJ
iajs-3480	15	7	crp	crp	NOUN
iajs-3480	15	8	levels	level	NOUN
iajs-3480	15	9	(	(	PUNCT
iajs-3480	15	10	11.77±0.98	11.77±0.98	NUM
iajs-3480	15	11	and	and	CCONJ
iajs-3480	15	12	14.61±2.49	14.61±2.49	NUM
iajs-3480	15	13	respectively	respectively	ADV
iajs-3480	15	14	)	)	PUNCT
iajs-3480	15	15	were	be	AUX
iajs-3480	15	16	found	find	VERB
iajs-3480	15	17	in	in	ADP
iajs-3480	15	18	group	group	NOUN
iajs-3480	15	19	1	1	NUM
iajs-3480	15	20	patients	patient	NOUN
iajs-3480	15	21	.	.	PUNCT
iajs-3480	16	1	on	on	ADP
iajs-3480	16	2	the	the	DET
iajs-3480	16	3	contrary	contrary	NOUN
iajs-3480	16	4	,	,	PUNCT
iajs-3480	16	5	the	the	DET
iajs-3480	16	6	lowest	low	ADJ
iajs-3480	16	7	levels	level	NOUN
iajs-3480	16	8	(	(	PUNCT
iajs-3480	16	9	7.61±1.56	7.61±1.56	NOUN
iajs-3480	16	10	and	and	CCONJ
iajs-3480	16	11	3.19±0.29	3.19±0.29	NOUN
iajs-3480	16	12	,	,	PUNCT
iajs-3480	16	13	respectively	respectively	ADV
iajs-3480	16	14	)	)	PUNCT
iajs-3480	16	15	were	be	AUX
iajs-3480	16	16	present	present	ADJ
iajs-3480	16	17	in	in	ADP
iajs-3480	16	18	group	group	NOUN
iajs-3480	16	19	2	2	NUM
iajs-3480	16	20	patients	patient	NOUN
iajs-3480	16	21	.	.	PUNCT
iajs-3480	17	1	in	in	ADP
iajs-3480	17	2	healthy	healthy	ADJ
iajs-3480	17	3	subjects	subject	NOUN
iajs-3480	17	4	,	,	PUNCT
iajs-3480	17	5	the	the	DET
iajs-3480	17	6	hepcidin	hepcidin	ADJ
iajs-3480	17	7	and	and	CCONJ
iajs-3480	17	8	crp	crp	NOUN
iajs-3480	17	9	levels	level	NOUN
iajs-3480	17	10	were	be	AUX
iajs-3480	17	11	8.45±0.53	8.45±0.53	NUM
iajs-3480	17	12	and	and	CCONJ
iajs-3480	17	13	3.51±0.91	3.51±0.91	NOUN
iajs-3480	17	14	,	,	PUNCT
iajs-3480	17	15	respectively	respectively	ADV
iajs-3480	17	16	.	.	PUNCT
iajs-3480	18	1	accordingly	accordingly	ADV
iajs-3480	18	2	,	,	PUNCT
iajs-3480	18	3	there	there	PRON
iajs-3480	18	4	was	be	VERB
iajs-3480	18	5	a	a	DET
iajs-3480	18	6	significant	significant	ADJ
iajs-3480	18	7	difference	difference	NOUN
iajs-3480	18	8	in	in	ADP
iajs-3480	18	9	hepcidin	hepcidin	ADJ
iajs-3480	18	10	and	and	CCONJ
iajs-3480	18	11	crp	crp	NOUN
iajs-3480	18	12	levels	level	NOUN
iajs-3480	18	13	between	between	ADP
iajs-3480	18	14	the	the	DET
iajs-3480	18	15	three	three	NUM
iajs-3480	18	16	studied	studied	ADJ
iajs-3480	18	17	groups	group	NOUN
iajs-3480	18	18	,	,	PUNCT
iajs-3480	18	19	and	and	CCONJ
iajs-3480	18	20	the	the	DET
iajs-3480	18	21	results	result	NOUN
iajs-3480	18	22	showed	show	VERB
iajs-3480	18	23	a	a	DET
iajs-3480	18	24	decrease	decrease	NOUN
iajs-3480	18	25	in	in	ADP
iajs-3480	18	26	hepcidin	hepcidin	VERB
iajs-3480	18	27	and	and	CCONJ
iajs-3480	18	28	c	c	NOUN
iajs-3480	18	29	-	-	PUNCT
iajs-3480	18	30	reactive	reactive	ADJ
iajs-3480	18	31	protein	protein	NOUN
iajs-3480	18	32	after	after	ADP
iajs-3480	18	33	treatment	treatment	NOUN
iajs-3480	18	34	.	.	PUNCT
iajs-3480	19	1	keywords	keyword	NOUN
iajs-3480	19	2	:	:	PUNCT
iajs-3480	19	3	hypothyroidism	hypothyroidism	NOUN
iajs-3480	19	4	,	,	PUNCT
iajs-3480	19	5	hepcidin	hepcidin	PROPN
iajs-3480	19	6	,	,	PUNCT
iajs-3480	19	7	levothyroxine	levothyroxine	NOUN
iajs-3480	19	8	,	,	PUNCT
iajs-3480	19	9	c	c	NOUN
iajs-3480	19	10	-	-	PUNCT
iajs-3480	19	11	reactive	reactive	ADJ
iajs-3480	19	12	protein	protein	NOUN
iajs-3480	19	13	,	,	PUNCT
iajs-3480	19	14	thyroid	thyroid	NOUN
iajs-3480	19	15	-	-	PUNCT
iajs-3480	19	16	stimulating	stimulate	VERB
iajs-3480	19	17	hormone	hormone	NOUN
iajs-3480	19	18	,	,	PUNCT
iajs-3480	19	19	triiodothyronine	triiodothyronine	NOUN
iajs-3480	19	20	,	,	PUNCT
iajs-3480	19	21	thyroxine	thyroxine	NOUN
iajs-3480	19	22	.	.	PUNCT
iajs-3480	20	1	1	1	X
iajs-3480	20	2	.	.	X
iajs-3480	20	3	introduction	introduction	NOUN
iajs-3480	20	4	hypothyroidism	hypothyroidism	NOUN
iajs-3480	20	5	is	be	AUX
iajs-3480	20	6	a	a	DET
iajs-3480	20	7	common	common	ADJ
iajs-3480	20	8	condition	condition	NOUN
iajs-3480	20	9	where	where	SCONJ
iajs-3480	20	10	the	the	DET
iajs-3480	20	11	thyroid	thyroid	NOUN
iajs-3480	20	12	does	do	AUX
iajs-3480	20	13	n’t	not	PART
iajs-3480	20	14	create	create	VERB
iajs-3480	20	15	nor	nor	CCONJ
iajs-3480	20	16	release	release	VERB
iajs-3480	20	17	enough	enough	ADJ
iajs-3480	20	18	thyroid	thyroid	NOUN
iajs-3480	20	19	hormone	hormone	NOUN
iajs-3480	20	20	into	into	ADP
iajs-3480	20	21	the	the	DET
iajs-3480	20	22	bloodstream	bloodstream	NOUN
iajs-3480	20	23	.	.	PUNCT
iajs-3480	21	1	hypothyroidism	hypothyroidism	NOUN
iajs-3480	21	2	is	be	AUX
iajs-3480	21	3	defined	define	VERB
iajs-3480	21	4	as	as	ADP
iajs-3480	21	5	an	an	DET
iajs-3480	21	6	elevated	elevated	ADJ
iajs-3480	21	7	thyroidstimulating	thyroidstimulating	ADJ
iajs-3480	21	8	hormone	hormone	NOUN
iajs-3480	21	9	(	(	PUNCT
iajs-3480	21	10	tsh	tsh	NOUN
iajs-3480	21	11	)	)	PUNCT
iajs-3480	21	12	concentration	concentration	NOUN
iajs-3480	21	13	in	in	ADP
iajs-3480	21	14	combination	combination	NOUN
iajs-3480	21	15	with	with	ADP
iajs-3480	21	16	a	a	DET
iajs-3480	21	17	free	free	ADJ
iajs-3480	21	18	thyroxine	thyroxine	NOUN
iajs-3480	21	19	(	(	PUNCT
iajs-3480	21	20	ft4	ft4	PROPN
iajs-3480	21	21	)	)	PUNCT
iajs-3480	21	22	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3480	21	23	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3480	21	24	https://orcid.org/0000-0002-8037-9801	https://orcid.org/0000-0002-8037-9801	PROPN
iajs-3480	21	25	mailto:hda1997622@gmail.com	mailto:hda1997622@gmail.com	PROPN
iajs-3480	21	26	https://orcid.org/0000-0001-8364-7755	https://orcid.org/0000-0001-8364-7755	PROPN
iajs-3480	21	27	mailto:suha.aljwari@sc.uobaghdad.edu.iq	mailto:suha.aljwari@sc.uobaghdad.edu.iq	PROPN
iajs-3480	21	28	ihjpas	ihjpas	PROPN
iajs-3480	21	29	.	.	PUNCT
iajs-3480	22	1	2024	2024	NUM
iajs-3480	22	2	,	,	PUNCT
iajs-3480	22	3	37(4	37(4	NOUN
iajs-3480	22	4	)	)	PUNCT
iajs-3480	22	5	98	98	NUM
iajs-3480	22	6	concentration	concentration	NOUN
iajs-3480	22	7	below	below	ADP
iajs-3480	22	8	the	the	DET
iajs-3480	22	9	reference	reference	NOUN
iajs-3480	22	10	range	range	NOUN
iajs-3480	22	11	.	.	PUNCT
iajs-3480	23	1	this	this	PRON
iajs-3480	23	2	makes	make	VERB
iajs-3480	23	3	the	the	DET
iajs-3480	23	4	metabolism	metabolism	NOUN
iajs-3480	23	5	slow	slow	VERB
iajs-3480	23	6	down	down	ADP
iajs-3480	23	7	.	.	PUNCT
iajs-3480	24	1	also	also	ADV
iajs-3480	24	2	called	call	VERB
iajs-3480	24	3	underactive	underactive	ADJ
iajs-3480	24	4	thyroid	thyroid	NOUN
iajs-3480	24	5	,	,	PUNCT
iajs-3480	24	6	hypothyroidism	hypothyroidism	NOUN
iajs-3480	24	7	can	can	AUX
iajs-3480	24	8	make	make	VERB
iajs-3480	24	9	us	we	PRON
iajs-3480	24	10	feel	feel	VERB
iajs-3480	24	11	tired	tired	ADJ
iajs-3480	24	12	,	,	PUNCT
iajs-3480	24	13	gain	gain	VERB
iajs-3480	24	14	weight	weight	NOUN
iajs-3480	24	15	,	,	PUNCT
iajs-3480	24	16	and	and	CCONJ
iajs-3480	24	17	be	be	AUX
iajs-3480	24	18	unable	unable	ADJ
iajs-3480	24	19	to	to	PART
iajs-3480	24	20	tolerate	tolerate	VERB
iajs-3480	24	21	cold	cold	ADJ
iajs-3480	24	22	temperatures	temperature	NOUN
iajs-3480	24	23	.	.	PUNCT
iajs-3480	25	1	the	the	DET
iajs-3480	25	2	main	main	ADJ
iajs-3480	25	3	treatment	treatment	NOUN
iajs-3480	25	4	for	for	ADP
iajs-3480	25	5	hypothyroidism	hypothyroidism	NOUN
iajs-3480	25	6	is	be	AUX
iajs-3480	25	7	hormone	hormone	NOUN
iajs-3480	25	8	replacement	replacement	NOUN
iajs-3480	25	9	therapy	therapy	NOUN
iajs-3480	25	10	.	.	PUNCT
iajs-3480	26	1	levothyroxine	levothyroxine	PROPN
iajs-3480	26	2	(	(	PUNCT
iajs-3480	26	3	lt4	lt4	PROPN
iajs-3480	26	4	)	)	PUNCT
iajs-3480	26	5	is	be	AUX
iajs-3480	26	6	the	the	DET
iajs-3480	26	7	mainstay	mainstay	NOUN
iajs-3480	26	8	of	of	ADP
iajs-3480	26	9	treatment	treatment	NOUN
iajs-3480	26	10	and	and	CCONJ
iajs-3480	26	11	is	be	AUX
iajs-3480	26	12	one	one	NUM
iajs-3480	26	13	of	of	ADP
iajs-3480	26	14	the	the	DET
iajs-3480	26	15	most	most	ADV
iajs-3480	26	16	commonly	commonly	ADV
iajs-3480	26	17	prescribed	prescribe	VERB
iajs-3480	26	18	drugs	drug	NOUN
iajs-3480	26	19	worldwide	worldwide	ADV
iajs-3480	26	20	[	[	X
iajs-3480	26	21	1	1	NUM
iajs-3480	26	22	]	]	PUNCT
iajs-3480	26	23	.	.	PUNCT
iajs-3480	27	1	hypothyroidism	hypothyroidism	NOUN
iajs-3480	27	2	has	have	VERB
iajs-3480	27	3	several	several	ADJ
iajs-3480	27	4	causes	cause	NOUN
iajs-3480	27	5	.	.	PUNCT
iajs-3480	28	1	they	they	PRON
iajs-3480	28	2	include	include	VERB
iajs-3480	28	3	hashimoto	hashimoto	NOUN
iajs-3480	28	4	's	's	PART
iajs-3480	28	5	disease	disease	NOUN
iajs-3480	28	6	,	,	PUNCT
iajs-3480	28	7	an	an	DET
iajs-3480	28	8	autoimmune	autoimmune	ADJ
iajs-3480	28	9	disorder	disorder	NOUN
iajs-3480	28	10	where	where	SCONJ
iajs-3480	28	11	the	the	DET
iajs-3480	28	12	immune	immune	ADJ
iajs-3480	28	13	system	system	NOUN
iajs-3480	28	14	attacks	attack	VERB
iajs-3480	28	15	your	your	PRON
iajs-3480	28	16	thyroid	thyroid	NOUN
iajs-3480	28	17	.	.	PUNCT
iajs-3480	29	1	this	this	PRON
iajs-3480	29	2	is	be	AUX
iajs-3480	29	3	the	the	DET
iajs-3480	29	4	most	most	ADV
iajs-3480	29	5	common	common	ADJ
iajs-3480	29	6	cause	cause	NOUN
iajs-3480	29	7	.	.	PUNCT
iajs-3480	30	1	thyroiditis	thyroiditis	NOUN
iajs-3480	30	2	,	,	PUNCT
iajs-3480	30	3	inflammation	inflammation	NOUN
iajs-3480	30	4	of	of	ADP
iajs-3480	30	5	the	the	DET
iajs-3480	30	6	thyroid	thyroid	NOUN
iajs-3480	30	7	,	,	PUNCT
iajs-3480	30	8	congenital	congenital	ADJ
iajs-3480	30	9	hypothyroidism	hypothyroidism	NOUN
iajs-3480	30	10	refers	refer	VERB
iajs-3480	30	11	to	to	ADP
iajs-3480	30	12	hypothyroidism	hypothyroidism	NOUN
iajs-3480	30	13	that	that	PRON
iajs-3480	30	14	is	be	AUX
iajs-3480	30	15	present	present	ADJ
iajs-3480	30	16	from	from	ADP
iajs-3480	30	17	birth	birth	NOUN
iajs-3480	30	18	.	.	PUNCT
iajs-3480	31	1	a	a	DET
iajs-3480	31	2	surgical	surgical	ADJ
iajs-3480	31	3	procedure	procedure	NOUN
iajs-3480	31	4	may	may	AUX
iajs-3480	31	5	involve	involve	VERB
iajs-3480	31	6	the	the	DET
iajs-3480	31	7	removal	removal	NOUN
iajs-3480	31	8	of	of	ADP
iajs-3480	31	9	part	part	NOUN
iajs-3480	31	10	or	or	CCONJ
iajs-3480	31	11	all	all	PRON
iajs-3480	31	12	of	of	ADP
iajs-3480	31	13	the	the	DET
iajs-3480	31	14	thyroid	thyroid	NOUN
iajs-3480	31	15	.	.	PUNCT
iajs-3480	32	1	radiation	radiation	NOUN
iajs-3480	32	2	therapy	therapy	NOUN
iajs-3480	32	3	for	for	ADP
iajs-3480	32	4	the	the	DET
iajs-3480	32	5	thyroid	thyroid	NOUN
iajs-3480	32	6	with	with	ADP
iajs-3480	32	7	certain	certain	ADJ
iajs-3480	32	8	medicines	medicine	NOUN
iajs-3480	32	9	may	may	AUX
iajs-3480	32	10	cause	cause	VERB
iajs-3480	32	11	,	,	PUNCT
iajs-3480	32	12	in	in	ADP
iajs-3480	32	13	rare	rare	ADJ
iajs-3480	32	14	cases	case	NOUN
iajs-3480	32	15	,	,	PUNCT
iajs-3480	32	16	a	a	DET
iajs-3480	32	17	pituitary	pituitary	ADJ
iajs-3480	32	18	disease	disease	NOUN
iajs-3480	32	19	,	,	PUNCT
iajs-3480	32	20	or	or	CCONJ
iajs-3480	32	21	too	too	ADV
iajs-3480	32	22	much	much	ADJ
iajs-3480	32	23	or	or	CCONJ
iajs-3480	32	24	too	too	ADV
iajs-3480	32	25	little	little	ADJ
iajs-3480	32	26	iodine	iodine	NOUN
iajs-3480	32	27	in	in	ADP
iajs-3480	32	28	your	your	PRON
iajs-3480	32	29	diet	diet	NOUN
iajs-3480	33	1	[	[	X
iajs-3480	33	2	2	2	NUM
iajs-3480	33	3	]	]	PUNCT
iajs-3480	33	4	.	.	PUNCT
iajs-3480	34	1	hypothyroidism	hypothyroidism	NOUN
iajs-3480	34	2	can	can	AUX
iajs-3480	34	3	be	be	AUX
iajs-3480	34	4	caused	cause	VERB
iajs-3480	34	5	by	by	ADP
iajs-3480	34	6	autoimmune	autoimmune	ADJ
iajs-3480	34	7	hashimoto	hashimoto	NOUN
iajs-3480	34	8	's	's	PART
iajs-3480	34	9	disease	disease	NOUN
iajs-3480	34	10	and	and	CCONJ
iajs-3480	34	11	subclinical	subclinical	ADJ
iajs-3480	34	12	hypothyroidism	hypothyroidism	NOUN
iajs-3480	34	13	.	.	PUNCT
iajs-3480	35	1	when	when	SCONJ
iajs-3480	35	2	the	the	DET
iajs-3480	35	3	thyroid	thyroid	NOUN
iajs-3480	35	4	gland	gland	NOUN
iajs-3480	35	5	experiences	experience	VERB
iajs-3480	35	6	inflammation	inflammation	NOUN
iajs-3480	35	7	,	,	PUNCT
iajs-3480	35	8	it	it	PRON
iajs-3480	35	9	triggers	trigger	VERB
iajs-3480	35	10	a	a	DET
iajs-3480	35	11	response	response	NOUN
iajs-3480	35	12	in	in	ADP
iajs-3480	35	13	interleukins	interleukin	NOUN
iajs-3480	35	14	.	.	PUNCT
iajs-3480	36	1	an	an	DET
iajs-3480	36	2	increase	increase	NOUN
iajs-3480	36	3	in	in	ADP
iajs-3480	36	4	il6	il6	PROPN
iajs-3480	36	5	leads	lead	VERB
iajs-3480	36	6	to	to	ADP
iajs-3480	36	7	a	a	DET
iajs-3480	36	8	rise	rise	NOUN
iajs-3480	36	9	in	in	ADP
iajs-3480	36	10	hepcidin	hepcidin	ADJ
iajs-3480	36	11	concentration	concentration	NOUN
iajs-3480	36	12	[	[	X
iajs-3480	36	13	3	3	NUM
iajs-3480	36	14	]	]	PUNCT
iajs-3480	36	15	,	,	PUNCT
iajs-3480	36	16	which	which	PRON
iajs-3480	36	17	in	in	ADP
iajs-3480	36	18	turn	turn	NOUN
iajs-3480	36	19	raises	raise	VERB
iajs-3480	36	20	the	the	DET
iajs-3480	36	21	hormone	hormone	NOUN
iajs-3480	36	22	hepcidin	hepcidin	VERB
iajs-3480	36	23	in	in	ADP
iajs-3480	36	24	the	the	DET
iajs-3480	36	25	body	body	NOUN
iajs-3480	36	26	.	.	PUNCT
iajs-3480	37	1	this	this	PRON
iajs-3480	37	2	,	,	PUNCT
iajs-3480	37	3	in	in	ADP
iajs-3480	37	4	turn	turn	NOUN
iajs-3480	37	5	,	,	PUNCT
iajs-3480	37	6	regulates	regulate	VERB
iajs-3480	37	7	the	the	DET
iajs-3480	37	8	body	body	NOUN
iajs-3480	37	9	's	's	PART
iajs-3480	37	10	iron	iron	NOUN
iajs-3480	37	11	levels	level	NOUN
iajs-3480	37	12	.	.	PUNCT
iajs-3480	38	1	additionally	additionally	ADV
iajs-3480	38	2	,	,	PUNCT
iajs-3480	38	3	a	a	DET
iajs-3480	38	4	rise	rise	NOUN
iajs-3480	38	5	in	in	ADP
iajs-3480	38	6	interleukin	interleukin	NOUN
iajs-3480	38	7	6	6	NUM
iajs-3480	38	8	also	also	ADV
iajs-3480	38	9	causes	cause	VERB
iajs-3480	38	10	a	a	DET
iajs-3480	38	11	rise	rise	NOUN
iajs-3480	38	12	in	in	ADP
iajs-3480	38	13	crp	crp	PROPN
iajs-3480	38	14	,	,	PUNCT
iajs-3480	38	15	which	which	PRON
iajs-3480	38	16	is	be	AUX
iajs-3480	38	17	considered	consider	VERB
iajs-3480	38	18	an	an	DET
iajs-3480	38	19	indicator	indicator	NOUN
iajs-3480	38	20	of	of	ADP
iajs-3480	38	21	increased	increase	VERB
iajs-3480	38	22	inflammation	inflammation	NOUN
iajs-3480	38	23	in	in	ADP
iajs-3480	38	24	the	the	DET
iajs-3480	38	25	body	body	NOUN
iajs-3480	38	26	[	[	X
iajs-3480	38	27	4	4	NUM
iajs-3480	38	28	]	]	PUNCT
iajs-3480	38	29	.	.	PUNCT
iajs-3480	39	1	studies	study	NOUN
iajs-3480	39	2	also	also	ADV
iajs-3480	39	3	show	show	VERB
iajs-3480	39	4	that	that	SCONJ
iajs-3480	39	5	there	there	PRON
iajs-3480	39	6	is	be	VERB
iajs-3480	39	7	a	a	DET
iajs-3480	39	8	correlation	correlation	NOUN
iajs-3480	39	9	between	between	ADP
iajs-3480	39	10	high	high	ADJ
iajs-3480	39	11	levels	level	NOUN
iajs-3480	39	12	of	of	ADP
iajs-3480	39	13	crp	crp	PROPN
iajs-3480	39	14	and	and	CCONJ
iajs-3480	39	15	people	people	NOUN
iajs-3480	39	16	with	with	ADP
iajs-3480	39	17	subclinical	subclinical	ADJ
iajs-3480	39	18	hypothyroidism	hypothyroidism	NOUN
iajs-3480	39	19	,	,	PUNCT
iajs-3480	39	20	as	as	SCONJ
iajs-3480	39	21	this	this	DET
iajs-3480	39	22	protein	protein	NOUN
iajs-3480	39	23	is	be	AUX
iajs-3480	39	24	elevated	elevate	VERB
iajs-3480	39	25	and	and	CCONJ
iajs-3480	39	26	stimulated	stimulate	VERB
iajs-3480	39	27	by	by	ADP
iajs-3480	39	28	interleukin	interleukin	NOUN
iajs-3480	39	29	6	6	NUM
iajs-3480	39	30	,	,	PUNCT
iajs-3480	39	31	which	which	PRON
iajs-3480	39	32	is	be	AUX
iajs-3480	39	33	considered	consider	VERB
iajs-3480	39	34	an	an	DET
iajs-3480	39	35	indicator	indicator	NOUN
iajs-3480	39	36	of	of	ADP
iajs-3480	39	37	inflammation	inflammation	NOUN
iajs-3480	39	38	in	in	ADP
iajs-3480	39	39	the	the	DET
iajs-3480	39	40	body	body	NOUN
iajs-3480	39	41	.	.	PUNCT
iajs-3480	40	1	the	the	DET
iajs-3480	40	2	hormone	hormone	NOUN
iajs-3480	40	3	hepcidin	hepcidin	NOUN
iajs-3480	40	4	,	,	PUNCT
iajs-3480	40	5	representing	represent	VERB
iajs-3480	40	6	an	an	DET
iajs-3480	40	7	inflammatory	inflammatory	ADJ
iajs-3480	40	8	response	response	NOUN
iajs-3480	40	9	,	,	PUNCT
iajs-3480	40	10	controls	control	VERB
iajs-3480	40	11	hypothyroidism	hypothyroidism	NOUN
iajs-3480	40	12	and	and	CCONJ
iajs-3480	40	13	iron	iron	NOUN
iajs-3480	40	14	levels	level	NOUN
iajs-3480	40	15	,	,	PUNCT
iajs-3480	40	16	leading	lead	VERB
iajs-3480	40	17	to	to	ADP
iajs-3480	40	18	elevated	elevate	VERB
iajs-3480	40	19	il-6	il-6	NOUN
iajs-3480	40	20	and	and	CCONJ
iajs-3480	40	21	crp	crp	NOUN
iajs-3480	41	1	[	[	X
iajs-3480	41	2	5	5	NUM
iajs-3480	41	3	]	]	PUNCT
iajs-3480	41	4	.	.	PUNCT
iajs-3480	42	1	patients	patient	NOUN
iajs-3480	42	2	with	with	ADP
iajs-3480	42	3	hypothyroidism	hypothyroidism	NOUN
iajs-3480	42	4	from	from	ADP
iajs-3480	42	5	hashimoto	hashimoto	NOUN
iajs-3480	42	6	's	's	PART
iajs-3480	42	7	disease	disease	NOUN
iajs-3480	42	8	demonstrated	demonstrate	VERB
iajs-3480	42	9	the	the	DET
iajs-3480	42	10	use	use	NOUN
iajs-3480	42	11	of	of	ADP
iajs-3480	42	12	levothyroxine	levothyroxine	NOUN
iajs-3480	42	13	as	as	ADP
iajs-3480	42	14	a	a	DET
iajs-3480	42	15	treatment	treatment	NOUN
iajs-3480	42	16	for	for	ADP
iajs-3480	42	17	hypothyroidism	hypothyroidism	NOUN
iajs-3480	42	18	,	,	PUNCT
iajs-3480	42	19	as	as	SCONJ
iajs-3480	42	20	it	it	PRON
iajs-3480	42	21	serves	serve	VERB
iajs-3480	42	22	as	as	ADP
iajs-3480	42	23	a	a	DET
iajs-3480	42	24	substitute	substitute	NOUN
iajs-3480	42	25	for	for	ADP
iajs-3480	42	26	thyroid	thyroid	NOUN
iajs-3480	42	27	hormone	hormone	NOUN
iajs-3480	42	28	,	,	PUNCT
iajs-3480	42	29	which	which	PRON
iajs-3480	42	30	is	be	AUX
iajs-3480	42	31	deficient	deficient	ADJ
iajs-3480	42	32	.	.	PUNCT
iajs-3480	43	1	the	the	DET
iajs-3480	43	2	treatment	treatment	NOUN
iajs-3480	43	3	showed	show	VERB
iajs-3480	43	4	a	a	DET
iajs-3480	43	5	decrease	decrease	NOUN
iajs-3480	43	6	in	in	ADP
iajs-3480	43	7	inflammatory	inflammatory	ADJ
iajs-3480	43	8	indicators	indicator	NOUN
iajs-3480	43	9	in	in	ADP
iajs-3480	43	10	the	the	DET
iajs-3480	43	11	body	body	NOUN
iajs-3480	43	12	,	,	PUNCT
iajs-3480	43	13	as	as	SCONJ
iajs-3480	43	14	levothyroxine	levothyroxine	NOUN
iajs-3480	43	15	treatment	treatment	NOUN
iajs-3480	43	16	is	be	AUX
iajs-3480	43	17	considered	consider	VERB
iajs-3480	43	18	an	an	DET
iajs-3480	43	19	anti	anti	ADJ
iajs-3480	43	20	-	-	ADJ
iajs-3480	43	21	inflammatory	inflammatory	ADJ
iajs-3480	43	22	in	in	ADP
iajs-3480	43	23	the	the	DET
iajs-3480	43	24	thyroid	thyroid	NOUN
iajs-3480	43	25	gland	gland	NOUN
iajs-3480	43	26	and	and	CCONJ
iajs-3480	43	27	thus	thus	ADV
iajs-3480	43	28	reduces	reduce	VERB
iajs-3480	43	29	signs	sign	NOUN
iajs-3480	43	30	of	of	ADP
iajs-3480	43	31	inflammation	inflammation	NOUN
iajs-3480	43	32	[	[	X
iajs-3480	43	33	6	6	NUM
iajs-3480	43	34	]	]	PUNCT
iajs-3480	43	35	.	.	PUNCT
iajs-3480	44	1	2	2	X
iajs-3480	44	2	.	.	X
iajs-3480	44	3	materials	material	NOUN
iajs-3480	44	4	and	and	CCONJ
iajs-3480	44	5	methods	method	NOUN
iajs-3480	44	6	2.1	2.1	NUM
iajs-3480	44	7	.	.	PUNCT
iajs-3480	45	1	study	study	NOUN
iajs-3480	45	2	design	design	NOUN
iajs-3480	45	3	,	,	PUNCT
iajs-3480	45	4	timing	timing	NOUN
iajs-3480	45	5	,	,	PUNCT
iajs-3480	45	6	and	and	CCONJ
iajs-3480	45	7	ethical	ethical	ADJ
iajs-3480	45	8	consideration	consideration	NOUN
iajs-3480	45	9	this	this	DET
iajs-3480	45	10	study	study	NOUN
iajs-3480	45	11	was	be	AUX
iajs-3480	45	12	conducted	conduct	VERB
iajs-3480	45	13	during	during	ADP
iajs-3480	45	14	the	the	DET
iajs-3480	45	15	period	period	NOUN
iajs-3480	45	16	from	from	ADP
iajs-3480	45	17	november	november	PROPN
iajs-3480	45	18	2022	2022	NUM
iajs-3480	45	19	to	to	ADP
iajs-3480	45	20	march	march	PROPN
iajs-3480	45	21	2023	2023	NUM
iajs-3480	45	22	.	.	PUNCT
iajs-3480	46	1	for	for	ADP
iajs-3480	46	2	each	each	DET
iajs-3480	46	3	patient	patient	NOUN
iajs-3480	46	4	participating	participate	VERB
iajs-3480	46	5	in	in	ADP
iajs-3480	46	6	the	the	DET
iajs-3480	46	7	study	study	NOUN
iajs-3480	46	8	,	,	PUNCT
iajs-3480	46	9	written	write	VERB
iajs-3480	46	10	informed	informed	ADJ
iajs-3480	46	11	consent	consent	NOUN
iajs-3480	46	12	was	be	AUX
iajs-3480	46	13	obtained	obtain	VERB
iajs-3480	46	14	.	.	PUNCT
iajs-3480	47	1	the	the	DET
iajs-3480	47	2	ethical	ethical	ADJ
iajs-3480	47	3	committees	committee	NOUN
iajs-3480	47	4	of	of	ADP
iajs-3480	47	5	the	the	DET
iajs-3480	47	6	department	department	NOUN
iajs-3480	47	7	of	of	ADP
iajs-3480	47	8	biology	biology	NOUN
iajs-3480	47	9	,	,	PUNCT
iajs-3480	47	10	college	college	NOUN
iajs-3480	47	11	of	of	ADP
iajs-3480	47	12	science	science	NOUN
iajs-3480	47	13	,	,	PUNCT
iajs-3480	47	14	university	university	PROPN
iajs-3480	47	15	of	of	ADP
iajs-3480	47	16	baghdad	baghdad	PROPN
iajs-3480	47	17	approved	approve	VERB
iajs-3480	47	18	the	the	DET
iajs-3480	47	19	study	study	NOUN
iajs-3480	47	20	.	.	PUNCT
iajs-3480	48	1	the	the	DET
iajs-3480	48	2	study	study	NOUN
iajs-3480	48	3	had	have	VERB
iajs-3480	48	4	a	a	DET
iajs-3480	48	5	total	total	NOUN
iajs-3480	48	6	of	of	ADP
iajs-3480	48	7	90	90	NUM
iajs-3480	48	8	male	male	ADJ
iajs-3480	48	9	and	and	CCONJ
iajs-3480	48	10	female	female	ADJ
iajs-3480	48	11	participants	participant	NOUN
iajs-3480	48	12	with	with	ADP
iajs-3480	48	13	an	an	DET
iajs-3480	48	14	average	average	ADJ
iajs-3480	48	15	age	age	NOUN
iajs-3480	48	16	of	of	ADP
iajs-3480	48	17	25	25	NUM
iajs-3480	48	18	to	to	PART
iajs-3480	48	19	50	50	NUM
iajs-3480	48	20	years	year	NOUN
iajs-3480	48	21	old	old	ADJ
iajs-3480	48	22	.	.	PUNCT
iajs-3480	49	1	all	all	DET
iajs-3480	49	2	samples	sample	NOUN
iajs-3480	49	3	were	be	AUX
iajs-3480	49	4	obtained	obtain	VERB
iajs-3480	49	5	from	from	ADP
iajs-3480	49	6	both	both	DET
iajs-3480	49	7	hospitals	hospital	NOUN
iajs-3480	49	8	in	in	ADP
iajs-3480	49	9	baghdad	baghdad	PROPN
iajs-3480	49	10	and	and	CCONJ
iajs-3480	49	11	the	the	DET
iajs-3480	49	12	medical	medical	ADJ
iajs-3480	49	13	lab	lab	NOUN
iajs-3480	49	14	.	.	PUNCT
iajs-3480	50	1	they	they	PRON
iajs-3480	50	2	were	be	AUX
iajs-3480	50	3	diagnosed	diagnose	VERB
iajs-3480	50	4	with	with	ADP
iajs-3480	50	5	hypothyroidism	hypothyroidism	NOUN
iajs-3480	50	6	according	accord	VERB
iajs-3480	50	7	to	to	ADP
iajs-3480	50	8	symptoms	symptom	NOUN
iajs-3480	50	9	and	and	CCONJ
iajs-3480	50	10	a	a	DET
iajs-3480	50	11	hypothyroidism	hypothyroidism	NOUN
iajs-3480	50	12	control	control	NOUN
iajs-3480	50	13	test	test	NOUN
iajs-3480	50	14	score	score	NOUN
iajs-3480	50	15	.	.	PUNCT
iajs-3480	51	1	the	the	DET
iajs-3480	51	2	patient	patient	ADJ
iajs-3480	51	3	questionnaire	questionnaire	NOUN
iajs-3480	51	4	in	in	ADP
iajs-3480	51	5	appendix	appendix	NOUN
iajs-3480	51	6	1	1	NUM
iajs-3480	51	7	directly	directly	ADV
iajs-3480	51	8	provided	provide	VERB
iajs-3480	51	9	the	the	DET
iajs-3480	51	10	clinical	clinical	ADJ
iajs-3480	51	11	information	information	NOUN
iajs-3480	51	12	.	.	PUNCT
iajs-3480	52	1	the	the	DET
iajs-3480	52	2	consultant	consultant	NOUN
iajs-3480	52	3	supervised	supervise	VERB
iajs-3480	52	4	the	the	DET
iajs-3480	52	5	process	process	NOUN
iajs-3480	52	6	and	and	CCONJ
iajs-3480	52	7	secured	secured	ADJ
iajs-3480	52	8	approval	approval	NOUN
iajs-3480	52	9	for	for	ADP
iajs-3480	52	10	both	both	CCONJ
iajs-3480	52	11	patient	patient	ADJ
iajs-3480	52	12	and	and	CCONJ
iajs-3480	52	13	control	control	NOUN
iajs-3480	52	14	sampling	sampling	NOUN
iajs-3480	52	15	.	.	PUNCT
iajs-3480	53	1	2.2	2.2	NUM
iajs-3480	53	2	.	.	PUNCT
iajs-3480	53	3	study	study	NOUN
iajs-3480	53	4	groups	group	NOUN
iajs-3480	53	5	the	the	DET
iajs-3480	53	6	study	study	NOUN
iajs-3480	53	7	groups	group	NOUN
iajs-3480	53	8	are	be	AUX
iajs-3480	53	9	as	as	SCONJ
iajs-3480	53	10	follows	follow	VERB
iajs-3480	53	11	:	:	PUNCT
iajs-3480	53	12	group	group	NOUN
iajs-3480	53	13	1	1	NUM
iajs-3480	53	14	:	:	SYM
iajs-3480	53	15	30	30	NUM
iajs-3480	53	16	patients	patient	NOUN
iajs-3480	53	17	(	(	PUNCT
iajs-3480	53	18	9	9	NUM
iajs-3480	53	19	males	male	NOUN
iajs-3480	53	20	and	and	CCONJ
iajs-3480	53	21	21	21	NUM
iajs-3480	53	22	females	female	NOUN
iajs-3480	53	23	)	)	PUNCT
iajs-3480	53	24	with	with	ADP
iajs-3480	53	25	hypothyroidism	hypothyroidism	NOUN
iajs-3480	53	26	with	with	ADP
iajs-3480	53	27	no	no	DET
iajs-3480	53	28	treatment	treatment	NOUN
iajs-3480	53	29	.	.	PUNCT
iajs-3480	54	1	group	group	NOUN
iajs-3480	54	2	2	2	NUM
iajs-3480	54	3	:	:	SYM
iajs-3480	54	4	30	30	NUM
iajs-3480	54	5	patients	patient	NOUN
iajs-3480	54	6	(	(	PUNCT
iajs-3480	54	7	9	9	NUM
iajs-3480	54	8	male	male	NOUN
iajs-3480	54	9	and	and	CCONJ
iajs-3480	54	10	21	21	NUM
iajs-3480	54	11	female	female	NOUN
iajs-3480	54	12	)	)	PUNCT
iajs-3480	54	13	diagnosed	diagnose	VERB
iajs-3480	54	14	with	with	ADP
iajs-3480	54	15	hypothyroidism	hypothyroidism	NOUN
iajs-3480	54	16	and	and	CCONJ
iajs-3480	54	17	treated	treat	VERB
iajs-3480	54	18	with	with	ADP
iajs-3480	54	19	levothyroxine	levothyroxine	NOUN
iajs-3480	54	20	for	for	ADP
iajs-3480	54	21	one	one	NUM
iajs-3480	54	22	year	year	NOUN
iajs-3480	54	23	or	or	CCONJ
iajs-3480	54	24	less	less	ADJ
iajs-3480	54	25	.	.	PUNCT
iajs-3480	55	1	group	group	NOUN
iajs-3480	55	2	3	3	NUM
iajs-3480	55	3	includes	include	VERB
iajs-3480	55	4	30	30	NUM
iajs-3480	55	5	healthy	healthy	ADJ
iajs-3480	55	6	euthyroid	euthyroid	NOUN
iajs-3480	55	7	individuals	individual	NOUN
iajs-3480	55	8	of	of	ADP
iajs-3480	55	9	both	both	DET
iajs-3480	55	10	sexes	sex	NOUN
iajs-3480	55	11	(	(	PUNCT
iajs-3480	55	12	12	12	NUM
iajs-3480	55	13	males	male	NOUN
iajs-3480	55	14	and	and	CCONJ
iajs-3480	55	15	13	13	NUM
iajs-3480	55	16	females	female	NOUN
iajs-3480	55	17	)	)	PUNCT
iajs-3480	55	18	.	.	PUNCT
iajs-3480	56	1	the	the	DET
iajs-3480	56	2	study	study	NOUN
iajs-3480	56	3	excluded	exclude	VERB
iajs-3480	56	4	patients	patient	NOUN
iajs-3480	56	5	who	who	PRON
iajs-3480	56	6	met	meet	VERB
iajs-3480	56	7	the	the	DET
iajs-3480	56	8	following	follow	VERB
iajs-3480	56	9	criteria	criterion	NOUN
iajs-3480	56	10	:	:	PUNCT
iajs-3480	56	11	patients	patient	NOUN
iajs-3480	56	12	with	with	ADP
iajs-3480	56	13	diabetic	diabetic	ADJ
iajs-3480	56	14	mellitus	mellitus	NOUN
iajs-3480	56	15	,	,	PUNCT
iajs-3480	56	16	hypertension	hypertension	NOUN
iajs-3480	56	17	,	,	PUNCT
iajs-3480	56	18	thalassemia	thalassemia	NOUN
iajs-3480	56	19	,	,	PUNCT
iajs-3480	56	20	kidney	kidney	NOUN
iajs-3480	56	21	and	and	CCONJ
iajs-3480	56	22	liver	liver	NOUN
iajs-3480	56	23	disease	disease	NOUN
iajs-3480	56	24	,	,	PUNCT
iajs-3480	56	25	and	and	CCONJ
iajs-3480	56	26	iron	iron	NOUN
iajs-3480	56	27	supplements	supplement	NOUN
iajs-3480	56	28	.	.	PUNCT
iajs-3480	57	1	2.3	2.3	NUM
iajs-3480	57	2	.	.	PUNCT
iajs-3480	58	1	blood	blood	NOUN
iajs-3480	58	2	sampling	sample	VERB
iajs-3480	58	3	ihjpas	ihjpa	NOUN
iajs-3480	58	4	.	.	PUNCT
iajs-3480	59	1	2024	2024	NUM
iajs-3480	59	2	,	,	PUNCT
iajs-3480	59	3	37(4	37(4	NOUN
iajs-3480	59	4	)	)	PUNCT
iajs-3480	59	5	99	99	NUM
iajs-3480	59	6	we	we	PRON
iajs-3480	59	7	aspirated	aspirate	VERB
iajs-3480	59	8	5–6	5–6	NOUN
iajs-3480	59	9	ml	ml	NOUN
iajs-3480	59	10	of	of	ADP
iajs-3480	59	11	peripheral	peripheral	ADJ
iajs-3480	59	12	whole	whole	ADJ
iajs-3480	59	13	blood	blood	NOUN
iajs-3480	59	14	from	from	ADP
iajs-3480	59	15	each	each	DET
iajs-3480	59	16	control	control	NOUN
iajs-3480	59	17	and	and	CCONJ
iajs-3480	59	18	patient	patient	ADJ
iajs-3480	59	19	group	group	NOUN
iajs-3480	59	20	using	use	VERB
iajs-3480	59	21	a	a	DET
iajs-3480	59	22	plastic	plastic	ADJ
iajs-3480	59	23	disposable	disposable	ADJ
iajs-3480	59	24	syringe	syringe	NOUN
iajs-3480	59	25	.	.	PUNCT
iajs-3480	60	1	we	we	PRON
iajs-3480	60	2	immediately	immediately	ADV
iajs-3480	60	3	dispensed	dispense	VERB
iajs-3480	60	4	this	this	DET
iajs-3480	60	5	blood	blood	NOUN
iajs-3480	60	6	:	:	PUNCT
iajs-3480	60	7	we	we	PRON
iajs-3480	60	8	transferred	transfer	VERB
iajs-3480	60	9	6	6	NUM
iajs-3480	60	10	ml	ml	NOUN
iajs-3480	60	11	of	of	ADP
iajs-3480	60	12	blood	blood	NOUN
iajs-3480	60	13	into	into	ADP
iajs-3480	60	14	a	a	DET
iajs-3480	60	15	gel	gel	NOUN
iajs-3480	60	16	tube	tube	NOUN
iajs-3480	60	17	,	,	PUNCT
iajs-3480	60	18	allowed	allow	VERB
iajs-3480	60	19	it	it	PRON
iajs-3480	60	20	to	to	PART
iajs-3480	60	21	clot	clot	VERB
iajs-3480	60	22	for	for	ADP
iajs-3480	60	23	10	10	NUM
iajs-3480	60	24	minutes	minute	NOUN
iajs-3480	60	25	at	at	ADP
iajs-3480	60	26	37	37	NUM
iajs-3480	60	27	°	°	SYM
iajs-3480	60	28	c	c	NOUN
iajs-3480	60	29	in	in	ADP
iajs-3480	60	30	water	water	NOUN
iajs-3480	60	31	bath	bath	NOUN
iajs-3480	60	32	,	,	PUNCT
iajs-3480	60	33	and	and	CCONJ
iajs-3480	60	34	centrifuged	centrifuge	VERB
iajs-3480	60	35	it	it	PRON
iajs-3480	60	36	at	at	ADP
iajs-3480	60	37	3000	3000	NUM
iajs-3480	60	38	rpm	rpm	NOUN
iajs-3480	60	39	for	for	ADP
iajs-3480	60	40	10	10	NUM
iajs-3480	60	41	minutes	minute	NOUN
iajs-3480	60	42	.	.	PUNCT
iajs-3480	61	1	after	after	ADP
iajs-3480	61	2	obtaining	obtain	VERB
iajs-3480	61	3	the	the	DET
iajs-3480	61	4	clear	clear	ADJ
iajs-3480	61	5	serum	serum	NOUN
iajs-3480	61	6	,	,	PUNCT
iajs-3480	61	7	we	we	PRON
iajs-3480	61	8	stored	store	VERB
iajs-3480	61	9	it	it	PRON
iajs-3480	61	10	at	at	ADP
iajs-3480	61	11	-20	-20	PROPN
iajs-3480	61	12	c	c	NOUN
iajs-3480	61	13	until	until	SCONJ
iajs-3480	61	14	we	we	PRON
iajs-3480	61	15	used	use	VERB
iajs-3480	61	16	it	it	PRON
iajs-3480	61	17	for	for	ADP
iajs-3480	61	18	hormonal	hormonal	ADJ
iajs-3480	61	19	and	and	CCONJ
iajs-3480	61	20	immunological	immunological	ADJ
iajs-3480	61	21	parameter	parameter	NOUN
iajs-3480	61	22	assays	assay	NOUN
iajs-3480	61	23	.	.	PUNCT
iajs-3480	62	1	we	we	PRON
iajs-3480	62	2	discarded	discard	VERB
iajs-3480	62	3	the	the	DET
iajs-3480	62	4	hemolyzed	hemolyze	VERB
iajs-3480	62	5	samples	sample	NOUN
iajs-3480	62	6	(	(	PUNCT
iajs-3480	62	7	bernadette	bernadette	PROPN
iajs-3480	62	8	and	and	CCONJ
iajs-3480	62	9	dianne	dianne	PROPN
iajs-3480	62	10	,	,	PUNCT
iajs-3480	62	11	bernadette	bernadette	PROPN
iajs-3480	62	12	mazurek	mazurek	PROPN
iajs-3480	62	13	melnyk	melnyk	ADV
iajs-3480	62	14	and	and	CCONJ
iajs-3480	62	15	dianne	dianne	PROPN
iajs-3480	62	16	morrison	morrison	PROPN
iajs-3480	62	17	-	-	PUNCT
iajs-3480	62	18	beedy	beedy	PROPN
iajs-3480	62	19	,	,	PUNCT
iajs-3480	62	20	2012	2012	NUM
iajs-3480	62	21	)	)	PUNCT
iajs-3480	62	22	.	.	PUNCT
iajs-3480	63	1	2.4	2.4	NUM
iajs-3480	63	2	.	.	PUNCT
iajs-3480	63	3	methods	method	NOUN
iajs-3480	63	4	the	the	DET
iajs-3480	63	5	hormones	hormone	NOUN
iajs-3480	63	6	triiodothyronine	triiodothyronine	VERB
iajs-3480	63	7	(	(	PUNCT
iajs-3480	63	8	t3	t3	PROPN
iajs-3480	63	9	)	)	PUNCT
iajs-3480	63	10	,	,	PUNCT
iajs-3480	63	11	thyroxine	thyroxine	NOUN
iajs-3480	63	12	(	(	PUNCT
iajs-3480	63	13	t4	t4	PROPN
iajs-3480	63	14	)	)	PUNCT
iajs-3480	63	15	,	,	PUNCT
iajs-3480	63	16	and	and	CCONJ
iajs-3480	63	17	thyroid	thyroid	VERB
iajs-3480	63	18	stimulating	stimulate	VERB
iajs-3480	63	19	hormone	hormone	NOUN
iajs-3480	63	20	(	(	PUNCT
iajs-3480	63	21	tsh	tsh	NOUN
iajs-3480	63	22	)	)	PUNCT
iajs-3480	63	23	were	be	AUX
iajs-3480	63	24	tested	test	VERB
iajs-3480	63	25	using	use	VERB
iajs-3480	63	26	immunoassays	immunoassay	NOUN
iajs-3480	63	27	to	to	PART
iajs-3480	63	28	measure	measure	VERB
iajs-3480	63	29	the	the	DET
iajs-3480	63	30	amount	amount	NOUN
iajs-3480	63	31	of	of	ADP
iajs-3480	63	32	tft	tft	NOUN
iajs-3480	63	33	in	in	ADP
iajs-3480	63	34	human	human	ADJ
iajs-3480	63	35	serum	serum	NOUN
iajs-3480	63	36	and	and	CCONJ
iajs-3480	63	37	plasma	plasma	NOUN
iajs-3480	63	38	.	.	PUNCT
iajs-3480	64	1	elecsys	elecsys	PROPN
iajs-3480	64	2	and	and	CCONJ
iajs-3480	64	3	cobas	cobas	PROPN
iajs-3480	64	4	e	e	PROPN
iajs-3480	64	5	immunoassay	immunoassay	PROPN
iajs-3480	64	6	analyzers	analyzer	NOUN
iajs-3480	64	7	are	be	AUX
iajs-3480	64	8	the	the	DET
iajs-3480	64	9	intended	intend	VERB
iajs-3480	64	10	platforms	platform	NOUN
iajs-3480	64	11	for	for	ADP
iajs-3480	64	12	the	the	DET
iajs-3480	64	13	electrochemiluminescence	electrochemiluminescence	NOUN
iajs-3480	64	14	immunoassay	immunoassay	NOUN
iajs-3480	64	15	"	"	PUNCT
iajs-3480	64	16	eclia	eclia	PROPN
iajs-3480	64	17	"	"	PUNCT
iajs-3480	64	18	.	.	PUNCT
iajs-3480	65	1	we	we	PRON
iajs-3480	65	2	made	make	VERB
iajs-3480	65	3	the	the	DET
iajs-3480	65	4	assay	assay	NOUN
iajs-3480	65	5	using	use	VERB
iajs-3480	65	6	an	an	DET
iajs-3480	65	7	automated	automate	VERB
iajs-3480	65	8	instrument	instrument	NOUN
iajs-3480	65	9	(	(	PUNCT
iajs-3480	65	10	cobase	cobase	NOUN
iajs-3480	65	11	e411	e411	PROPN
iajs-3480	65	12	)	)	PUNCT
iajs-3480	65	13	and	and	CCONJ
iajs-3480	65	14	a	a	DET
iajs-3480	65	15	tft	tft	ADJ
iajs-3480	65	16	kit	kit	NOUN
iajs-3480	65	17	from	from	ADP
iajs-3480	65	18	cobase	cobase	PROPN
iajs-3480	65	19	,	,	PUNCT
iajs-3480	65	20	germany	germany	PROPN
iajs-3480	65	21	.	.	PUNCT
iajs-3480	66	1	therefore	therefore	ADV
iajs-3480	66	2	,	,	PUNCT
iajs-3480	66	3	this	this	DET
iajs-3480	66	4	instrument	instrument	NOUN
iajs-3480	66	5	automatically	automatically	ADV
iajs-3480	66	6	controls	control	VERB
iajs-3480	66	7	the	the	DET
iajs-3480	66	8	assay	assay	NOUN
iajs-3480	66	9	temperature	temperature	NOUN
iajs-3480	66	10	and	and	CCONJ
iajs-3480	66	11	steps	step	NOUN
iajs-3480	66	12	.	.	PUNCT
iajs-3480	67	1	normal	normal	ADJ
iajs-3480	67	2	ranges	range	NOUN
iajs-3480	67	3	:	:	PUNCT
iajs-3480	67	4	for	for	ADP
iajs-3480	67	5	t3	t3	PROPN
iajs-3480	67	6	0.8	0.8	NUM
iajs-3480	67	7	-	-	SYM
iajs-3480	67	8	2.0	2.0	NUM
iajs-3480	67	9	(	(	PUNCT
iajs-3480	67	10	ng	ng	PROPN
iajs-3480	67	11	/	/	SYM
iajs-3480	67	12	ml	ml	PROPN
iajs-3480	67	13	)	)	PUNCT
iajs-3480	67	14	,	,	PUNCT
iajs-3480	67	15	normal	normal	ADJ
iajs-3480	67	16	ranges	range	VERB
iajs-3480	67	17	for	for	ADP
iajs-3480	67	18	tsh	tsh	NOUN
iajs-3480	67	19	0.270	0.270	NUM
iajs-3480	67	20	-	-	SYM
iajs-3480	67	21	4.2	4.2	NUM
iajs-3480	67	22	(	(	PUNCT
iajs-3480	67	23	μiu	μiu	PROPN
iajs-3480	67	24	/	/	SYM
iajs-3480	67	25	ml	ml	NOUN
iajs-3480	67	26	)	)	PUNCT
iajs-3480	67	27	,	,	PUNCT
iajs-3480	67	28	normal	normal	ADJ
iajs-3480	67	29	ranges	range	NOUN
iajs-3480	67	30	for	for	ADP
iajs-3480	67	31	t4	t4	PROPN
iajs-3480	67	32	5.1	5.1	NUM
iajs-3480	67	33	-	-	SYM
iajs-3480	67	34	14.1	14.1	NUM
iajs-3480	67	35	(	(	PUNCT
iajs-3480	67	36	μg	μg	PROPN
iajs-3480	67	37	/	/	SYM
iajs-3480	67	38	dl	dl	PROPN
iajs-3480	67	39	)	)	PUNCT
iajs-3480	67	40	.	.	PUNCT
iajs-3480	68	1	determination	determination	NOUN
iajs-3480	68	2	of	of	ADP
iajs-3480	68	3	crp	crp	PROPN
iajs-3480	68	4	an	an	DET
iajs-3480	68	5	in	in	ADP
iajs-3480	68	6	vitro	vitro	X
iajs-3480	68	7	test	test	NOUN
iajs-3480	68	8	quantitatively	quantitatively	ADV
iajs-3480	68	9	determines	determine	VERB
iajs-3480	68	10	the	the	DET
iajs-3480	68	11	crp	crp	PROPN
iajs-3480	68	12	concentration	concentration	NOUN
iajs-3480	68	13	in	in	ADP
iajs-3480	68	14	serum	serum	NOUN
iajs-3480	68	15	using	use	VERB
iajs-3480	68	16	photometric	photometric	NOUN
iajs-3480	68	17	systems	system	NOUN
iajs-3480	68	18	and	and	CCONJ
iajs-3480	68	19	the	the	DET
iajs-3480	68	20	bs-430	bs-430	PROPN
iajs-3480	68	21	chemistry	chemistry	NOUN
iajs-3480	68	22	analyzer	analyzer	NOUN
iajs-3480	68	23	mindray	mindray	NOUN
iajs-3480	68	24	automated	automate	VERB
iajs-3480	68	25	kit	kit	NOUN
iajs-3480	68	26	from	from	ADP
iajs-3480	68	27	mindary	mindary	ADJ
iajs-3480	68	28	,	,	PUNCT
iajs-3480	68	29	china	china	PROPN
iajs-3480	68	30	.	.	PUNCT
iajs-3480	69	1	normal	normal	ADJ
iajs-3480	69	2	ranges	range	NOUN
iajs-3480	69	3	for	for	ADP
iajs-3480	69	4	crp	crp	PROPN
iajs-3480	69	5	are	be	AUX
iajs-3480	69	6	0–5	0–5	NOUN
iajs-3480	69	7	(	(	PUNCT
iajs-3480	69	8	pg	pg	NOUN
iajs-3480	69	9	/	/	SYM
iajs-3480	69	10	ml	ml	VERB
iajs-3480	69	11	)	)	PUNCT
iajs-3480	69	12	.	.	PUNCT
iajs-3480	70	1	determination	determination	NOUN
iajs-3480	70	2	of	of	ADP
iajs-3480	70	3	hepcidin	hepcidin	VERB
iajs-3480	70	4	by	by	ADP
iajs-3480	70	5	using	use	VERB
iajs-3480	70	6	the	the	DET
iajs-3480	70	7	elisa	elisa	NOUN
iajs-3480	70	8	technique	technique	NOUN
iajs-3480	70	9	,	,	PUNCT
iajs-3480	70	10	according	accord	VERB
iajs-3480	70	11	to	to	ADP
iajs-3480	70	12	the	the	DET
iajs-3480	70	13	manufacturer	manufacturer	NOUN
iajs-3480	70	14	's	's	PART
iajs-3480	70	15	instructions	instruction	NOUN
iajs-3480	70	16	for	for	ADP
iajs-3480	70	17	the	the	DET
iajs-3480	70	18	abbexa	abbexa	PROPN
iajs-3480	70	19	kit	kit	PROPN
iajs-3480	70	20	,	,	PUNCT
iajs-3480	70	21	united	united	ADJ
iajs-3480	70	22	kingdom	kingdom	PROPN
iajs-3480	70	23	.	.	PUNCT
iajs-3480	71	1	this	this	DET
iajs-3480	71	2	elisa	elisa	PROPN
iajs-3480	71	3	kit	kit	NOUN
iajs-3480	71	4	uses	use	VERB
iajs-3480	71	5	the	the	DET
iajs-3480	71	6	sandwich	sandwich	NOUN
iajs-3480	71	7	-	-	PUNCT
iajs-3480	71	8	elisa	elisa	PROPN
iajs-3480	71	9	principle	principle	NOUN
iajs-3480	71	10	.	.	PUNCT
iajs-3480	72	1	normal	normal	ADJ
iajs-3480	72	2	ranges	range	NOUN
iajs-3480	72	3	for	for	ADP
iajs-3480	72	4	hepcidin	hepcidin	VERB
iajs-3480	72	5	are	be	AUX
iajs-3480	72	6	6.5–11.3	6.5–11.3	NUM
iajs-3480	72	7	pg	pg	NOUN
iajs-3480	72	8	/	/	SYM
iajs-3480	72	9	ml	ml	NOUN
iajs-3480	72	10	.	.	NOUN
iajs-3480	73	1	3	3	X
iajs-3480	73	2	.	.	NOUN
iajs-3480	73	3	results	result	NOUN
iajs-3480	73	4	and	and	CCONJ
iajs-3480	73	5	discussion	discussion	NOUN
iajs-3480	73	6	3.1	3.1	NUM
iajs-3480	73	7	.	.	PUNCT
iajs-3480	74	1	classification	classification	NOUN
iajs-3480	74	2	of	of	ADP
iajs-3480	74	3	the	the	DET
iajs-3480	74	4	studied	study	VERB
iajs-3480	74	5	groups	group	NOUN
iajs-3480	74	6	the	the	DET
iajs-3480	74	7	present	present	ADJ
iajs-3480	74	8	study	study	NOUN
iajs-3480	74	9	enrolled	enrol	VERB
iajs-3480	74	10	90	90	NUM
iajs-3480	74	11	people	people	NOUN
iajs-3480	74	12	,	,	PUNCT
iajs-3480	74	13	selected	select	VERB
iajs-3480	74	14	the	the	DET
iajs-3480	74	15	subjects	subject	NOUN
iajs-3480	74	16	,	,	PUNCT
iajs-3480	74	17	and	and	CCONJ
iajs-3480	74	18	divided	divide	VERB
iajs-3480	74	19	them	they	PRON
iajs-3480	74	20	into	into	ADP
iajs-3480	74	21	three	three	NUM
iajs-3480	74	22	groups	group	NOUN
iajs-3480	74	23	.	.	PUNCT
iajs-3480	75	1	the	the	DET
iajs-3480	75	2	first	first	ADJ
iajs-3480	75	3	group	group	NOUN
iajs-3480	75	4	(	(	PUNCT
iajs-3480	75	5	group	group	NOUN
iajs-3480	75	6	1	1	NUM
iajs-3480	75	7	)	)	PUNCT
iajs-3480	75	8	included	include	VERB
iajs-3480	75	9	30	30	NUM
iajs-3480	75	10	patients	patient	NOUN
iajs-3480	75	11	with	with	ADP
iajs-3480	75	12	a	a	DET
iajs-3480	75	13	history	history	NOUN
iajs-3480	75	14	of	of	ADP
iajs-3480	75	15	newly	newly	ADV
iajs-3480	75	16	diagnosed	diagnose	VERB
iajs-3480	75	17	hypothyroidism	hypothyroidism	NOUN
iajs-3480	75	18	;	;	PUNCT
iajs-3480	75	19	the	the	DET
iajs-3480	75	20	second	second	ADJ
iajs-3480	75	21	group	group	NOUN
iajs-3480	75	22	(	(	PUNCT
iajs-3480	75	23	group	group	NOUN
iajs-3480	75	24	2	2	NUM
iajs-3480	75	25	)	)	PUNCT
iajs-3480	75	26	involved	involve	VERB
iajs-3480	75	27	30	30	NUM
iajs-3480	75	28	hypothyroid	hypothyroid	ADJ
iajs-3480	75	29	patients	patient	NOUN
iajs-3480	75	30	on	on	ADP
iajs-3480	75	31	thyroxin	thyroxin	NOUN
iajs-3480	75	32	treatment	treatment	NOUN
iajs-3480	75	33	.	.	PUNCT
iajs-3480	76	1	these	these	DET
iajs-3480	76	2	two	two	NUM
iajs-3480	76	3	groups	group	NOUN
iajs-3480	76	4	of	of	ADP
iajs-3480	76	5	patients	patient	NOUN
iajs-3480	76	6	were	be	AUX
iajs-3480	76	7	compared	compare	VERB
iajs-3480	76	8	with	with	ADP
iajs-3480	76	9	30	30	NUM
iajs-3480	76	10	healthy	healthy	ADJ
iajs-3480	76	11	controls	control	NOUN
iajs-3480	76	12	(	(	PUNCT
iajs-3480	76	13	group	group	NOUN
iajs-3480	76	14	3	3	NUM
iajs-3480	76	15	)	)	PUNCT
iajs-3480	76	16	(	(	PUNCT
iajs-3480	76	17	figure	figure	NOUN
iajs-3480	76	18	1	1	NUM
iajs-3480	76	19	)	)	PUNCT
iajs-3480	76	20	.	.	PUNCT
iajs-3480	77	1	figure	figure	NOUN
iajs-3480	77	2	1	1	NUM
iajs-3480	77	3	.	.	PUNCT
iajs-3480	78	1	classification	classification	NOUN
iajs-3480	78	2	of	of	ADP
iajs-3480	78	3	the	the	DET
iajs-3480	78	4	studied	study	VERB
iajs-3480	78	5	groups	group	NOUN
iajs-3480	78	6	.	.	PUNCT
iajs-3480	79	1	3.2	3.2	NUM
iajs-3480	79	2	.	.	PUNCT
iajs-3480	79	3	comparison	comparison	NOUN
iajs-3480	79	4	of	of	ADP
iajs-3480	79	5	age	age	NOUN
iajs-3480	79	6	and	and	CCONJ
iajs-3480	79	7	gender	gender	NOUN
iajs-3480	79	8	between	between	ADP
iajs-3480	79	9	the	the	DET
iajs-3480	79	10	studied	study	VERB
iajs-3480	79	11	groups	group	NOUN
iajs-3480	79	12	the	the	DET
iajs-3480	79	13	mean	mean	ADJ
iajs-3480	79	14	patients	patient	NOUN
iajs-3480	79	15	’	'	PUNCT
iajs-3480	79	16	age	age	NOUN
iajs-3480	79	17	was	be	AUX
iajs-3480	79	18	expressed	express	VERB
iajs-3480	79	19	as	as	ADP
iajs-3480	79	20	mean	mean	NOUN
iajs-3480	79	21	±	±	NUM
iajs-3480	79	22	standard	standard	ADJ
iajs-3480	79	23	deviation	deviation	NOUN
iajs-3480	79	24	,	,	PUNCT
iajs-3480	79	25	and	and	CCONJ
iajs-3480	79	26	gender	gender	NOUN
iajs-3480	79	27	distributions	distribution	NOUN
iajs-3480	79	28	were	be	AUX
iajs-3480	79	29	expressed	express	VERB
iajs-3480	79	30	as	as	ADP
iajs-3480	79	31	frequency	frequency	NOUN
iajs-3480	79	32	and	and	CCONJ
iajs-3480	79	33	percentage	percentage	NOUN
iajs-3480	79	34	.	.	PUNCT
iajs-3480	80	1	according	accord	VERB
iajs-3480	80	2	to	to	ADP
iajs-3480	80	3	the	the	DET
iajs-3480	80	4	results	result	NOUN
iajs-3480	80	5	,	,	PUNCT
iajs-3480	80	6	there	there	PRON
iajs-3480	80	7	were	be	VERB
iajs-3480	80	8	no	no	DET
iajs-3480	80	9	significant	significant	ADJ
iajs-3480	80	10	differences	difference	NOUN
iajs-3480	80	11	in	in	ADP
iajs-3480	80	12	the	the	DET
iajs-3480	80	13	mean	mean	ADJ
iajs-3480	80	14	patient	patient	NOUN
iajs-3480	80	15	’s	’s	PART
iajs-3480	80	16	age	age	NOUN
iajs-3480	80	17	(	(	PUNCT
iajs-3480	80	18	p=0.419	p=0.419	NOUN
iajs-3480	80	19	)	)	PUNCT
iajs-3480	80	20	or	or	CCONJ
iajs-3480	80	21	gender	gender	NOUN
iajs-3480	80	22	distribution	distribution	NOUN
iajs-3480	80	23	(	(	PUNCT
iajs-3480	80	24	p=0.638	p=0.638	NOUN
iajs-3480	80	25	)	)	PUNCT
iajs-3480	80	26	between	between	ADP
iajs-3480	80	27	the	the	DET
iajs-3480	80	28	three	three	NUM
iajs-3480	80	29	studied	studied	ADJ
iajs-3480	80	30	groups	group	NOUN
iajs-3480	80	31	,	,	PUNCT
iajs-3480	80	32	as	as	SCONJ
iajs-3480	80	33	demonstrated	demonstrate	VERB
iajs-3480	80	34	in	in	ADP
iajs-3480	80	35	table	table	NOUN
iajs-3480	80	36	1	1	NUM
iajs-3480	80	37	and	and	CCONJ
iajs-3480	80	38	figure	figure	VERB
iajs-3480	80	39	2	2	NUM
iajs-3480	80	40	.	.	NOUN
iajs-3480	80	41	30	30	NUM
iajs-3480	80	42	33.3	33.3	NUM
iajs-3480	80	43	%	%	NOUN
iajs-3480	80	44	30	30	NUM
iajs-3480	80	45	33.3	33.3	NUM
iajs-3480	80	46	%	%	NOUN
iajs-3480	80	47	30	30	NUM
iajs-3480	80	48	33.3	33.3	NUM
iajs-3480	80	49	%	%	NOUN
iajs-3480	80	50	group	group	NOUN
iajs-3480	80	51	1	1	NUM
iajs-3480	80	52	:	:	PUNCT
iajs-3480	80	53	hypothroidism	hypothroidism	NOUN
iajs-3480	80	54	without	without	ADP
iajs-3480	80	55	treatment	treatment	NOUN
iajs-3480	80	56	group	group	NOUN
iajs-3480	80	57	2	2	NUM
iajs-3480	80	58	:	:	PUNCT
iajs-3480	80	59	hypothroidism	hypothroidism	NOUN
iajs-3480	80	60	with	with	ADP
iajs-3480	80	61	treatment	treatment	NOUN
iajs-3480	80	62	group	group	NOUN
iajs-3480	80	63	3	3	NUM
iajs-3480	80	64	:	:	PUNCT
iajs-3480	80	65	healthy	healthy	ADJ
iajs-3480	80	66	controls	control	NOUN
iajs-3480	80	67	ihjpas	ihjpa	NOUN
iajs-3480	80	68	.	.	PUNCT
iajs-3480	81	1	2024	2024	NUM
iajs-3480	81	2	,	,	PUNCT
iajs-3480	81	3	37(4	37(4	NOUN
iajs-3480	81	4	)	)	PUNCT
iajs-3480	81	5	100	100	NUM
iajs-3480	81	6	table	table	NOUN
iajs-3480	81	7	1	1	NUM
iajs-3480	81	8	.	.	PUNCT
iajs-3480	81	9	demographic	demographic	ADJ
iajs-3480	81	10	features	feature	NOUN
iajs-3480	81	11	of	of	ADP
iajs-3480	81	12	the	the	DET
iajs-3480	81	13	studied	study	VERB
iajs-3480	81	14	groups	group	NOUN
iajs-3480	81	15	.	.	PUNCT
iajs-3480	82	1	parameter	parameter	NOUN
iajs-3480	82	2	(	(	PUNCT
iajs-3480	82	3	mean	mean	PROPN
iajs-3480	82	4	±	±	NUM
iajs-3480	82	5	sd	sd	NOUN
iajs-3480	82	6	)	)	PUNCT
iajs-3480	82	7	hypothyroidism	hypothyroidism	NOUN
iajs-3480	82	8	without	without	ADP
iajs-3480	82	9	treatment	treatment	NOUN
iajs-3480	82	10	(	(	PUNCT
iajs-3480	82	11	group	group	NOUN
iajs-3480	82	12	1	1	NUM
iajs-3480	82	13	)	)	PUNCT
iajs-3480	82	14	hypothyroidism	hypothyroidism	NOUN
iajs-3480	82	15	with	with	ADP
iajs-3480	82	16	treatment	treatment	NOUN
iajs-3480	82	17	(	(	PUNCT
iajs-3480	82	18	group	group	NOUN
iajs-3480	82	19	2	2	NUM
iajs-3480	82	20	)	)	PUNCT
iajs-3480	82	21	healthy	healthy	ADJ
iajs-3480	82	22	controls	control	NOUN
iajs-3480	82	23	(	(	PUNCT
iajs-3480	82	24	group	group	NOUN
iajs-3480	82	25	3	3	NUM
iajs-3480	82	26	)	)	PUNCT
iajs-3480	82	27	p	p	NOUN
iajs-3480	82	28	value	value	NOUN
iajs-3480	82	29	age	age	NOUN
iajs-3480	82	30	(	(	PUNCT
iajs-3480	82	31	years	year	NOUN
iajs-3480	82	32	)	)	PUNCT
iajs-3480	82	33	39.40	39.40	NUM
iajs-3480	82	34	±	±	NUM
iajs-3480	82	35	8.50	8.50	NUM
iajs-3480	82	36	38.30	38.30	NUM
iajs-3480	82	37	±	±	NUM
iajs-3480	82	38	8.07	8.07	NUM
iajs-3480	82	39	36.67	36.67	NUM
iajs-3480	82	40	±	±	NUM
iajs-3480	82	41	7.49	7.49	NUM
iajs-3480	82	42	0.419	0.419	NUM
iajs-3480	82	43	f	f	PROPN
iajs-3480	82	44	ns	ns	ADJ
iajs-3480	82	45	gender	gender	NOUN
iajs-3480	82	46	male	male	ADJ
iajs-3480	82	47	female	female	ADJ
iajs-3480	82	48	9	9	NUM
iajs-3480	82	49	(	(	PUNCT
iajs-3480	82	50	30	30	NUM
iajs-3480	82	51	%	%	NOUN
iajs-3480	82	52	)	)	PUNCT
iajs-3480	82	53	21	21	NUM
iajs-3480	82	54	(	(	PUNCT
iajs-3480	82	55	70	70	NUM
iajs-3480	82	56	%	%	NOUN
iajs-3480	82	57	)	)	PUNCT
iajs-3480	82	58	9	9	NUM
iajs-3480	82	59	(	(	PUNCT
iajs-3480	82	60	30	30	NUM
iajs-3480	82	61	%	%	NOUN
iajs-3480	82	62	)	)	PUNCT
iajs-3480	82	63	21	21	NUM
iajs-3480	82	64	(	(	PUNCT
iajs-3480	82	65	70	70	NUM
iajs-3480	82	66	%	%	NOUN
iajs-3480	82	67	)	)	PUNCT
iajs-3480	82	68	12	12	NUM
iajs-3480	82	69	(	(	PUNCT
iajs-3480	82	70	40	40	NUM
iajs-3480	82	71	%	%	NOUN
iajs-3480	82	72	)	)	PUNCT
iajs-3480	82	73	18	18	NUM
iajs-3480	82	74	(	(	PUNCT
iajs-3480	82	75	60	60	NUM
iajs-3480	82	76	%	%	NOUN
iajs-3480	82	77	)	)	PUNCT
iajs-3480	82	78	0.638	0.638	NUM
iajs-3480	82	79	χ2	χ2	NOUN
iajs-3480	82	80	ns	ns	NUM
iajs-3480	82	81	sd	sd	PROPN
iajs-3480	82	82	:	:	PUNCT
iajs-3480	82	83	standard	standard	ADJ
iajs-3480	82	84	deviation	deviation	NOUN
iajs-3480	82	85	;	;	PUNCT
iajs-3480	82	86	ns	ns	NUM
iajs-3480	82	87	:	:	PUNCT
iajs-3480	82	88	not	not	PART
iajs-3480	82	89	significant	significant	ADJ
iajs-3480	82	90	(	(	PUNCT
iajs-3480	82	91	p	p	X
iajs-3480	82	92	>	>	X
iajs-3480	82	93	0.05	0.05	NUM
iajs-3480	82	94	)	)	PUNCT
iajs-3480	82	95	;	;	PUNCT
iajs-3480	82	96	f	f	PROPN
iajs-3480	82	97	:	:	PUNCT
iajs-3480	82	98	anova	anova	PROPN
iajs-3480	82	99	test	test	NOUN
iajs-3480	82	100	;	;	PUNCT
iajs-3480	82	101	χ2	χ2	PROPN
iajs-3480	82	102	:	:	PUNCT
iajs-3480	82	103	chi	chi	PROPN
iajs-3480	82	104	square	square	ADJ
iajs-3480	82	105	figure	figure	NOUN
iajs-3480	82	106	2	2	NUM
iajs-3480	82	107	.	.	PUNCT
iajs-3480	82	108	comparison	comparison	NOUN
iajs-3480	82	109	of	of	ADP
iajs-3480	82	110	demographic	demographic	ADJ
iajs-3480	82	111	features	feature	NOUN
iajs-3480	82	112	between	between	ADP
iajs-3480	82	113	the	the	DET
iajs-3480	82	114	studied	study	VERB
iajs-3480	82	115	groups	group	NOUN
iajs-3480	82	116	.	.	PUNCT
iajs-3480	83	1	there	there	PRON
iajs-3480	83	2	were	be	VERB
iajs-3480	83	3	no	no	DET
iajs-3480	83	4	clear	clear	ADJ
iajs-3480	83	5	differences	difference	NOUN
iajs-3480	83	6	in	in	ADP
iajs-3480	83	7	the	the	DET
iajs-3480	83	8	age	age	NOUN
iajs-3480	83	9	groups	group	NOUN
iajs-3480	83	10	,	,	PUNCT
iajs-3480	83	11	but	but	CCONJ
iajs-3480	83	12	there	there	PRON
iajs-3480	83	13	were	be	VERB
iajs-3480	83	14	differences	difference	NOUN
iajs-3480	83	15	in	in	ADP
iajs-3480	83	16	gender	gender	NOUN
iajs-3480	83	17	.	.	PUNCT
iajs-3480	84	1	according	accord	VERB
iajs-3480	84	2	to	to	ADP
iajs-3480	84	3	this	this	DET
iajs-3480	84	4	study	study	NOUN
iajs-3480	84	5	[	[	X
iajs-3480	84	6	7	7	NUM
iajs-3480	84	7	]	]	PUNCT
iajs-3480	84	8	,	,	PUNCT
iajs-3480	84	9	the	the	DET
iajs-3480	84	10	rate	rate	NOUN
iajs-3480	84	11	of	of	ADP
iajs-3480	84	12	hypothyroidism	hypothyroidism	NOUN
iajs-3480	84	13	is	be	AUX
iajs-3480	84	14	frequently	frequently	ADV
iajs-3480	84	15	higher	high	ADJ
iajs-3480	84	16	in	in	ADP
iajs-3480	84	17	females	female	NOUN
iajs-3480	84	18	than	than	ADP
iajs-3480	84	19	in	in	ADP
iajs-3480	84	20	males	male	NOUN
iajs-3480	84	21	.	.	PUNCT
iajs-3480	85	1	according	accord	VERB
iajs-3480	85	2	to	to	ADP
iajs-3480	85	3	a	a	DET
iajs-3480	85	4	study	study	NOUN
iajs-3480	85	5	conducted	conduct	VERB
iajs-3480	85	6	on	on	ADP
iajs-3480	85	7	a	a	DET
iajs-3480	85	8	group	group	NOUN
iajs-3480	85	9	of	of	ADP
iajs-3480	85	10	people	people	NOUN
iajs-3480	85	11	in	in	ADP
iajs-3480	85	12	europe	europe	PROPN
iajs-3480	85	13	,	,	PUNCT
iajs-3480	85	14	they	they	PRON
iajs-3480	85	15	were	be	AUX
iajs-3480	85	16	diagnosed	diagnose	VERB
iajs-3480	85	17	with	with	ADP
iajs-3480	85	18	hypothyroidism	hypothyroidism	NOUN
iajs-3480	85	19	.	.	PUNCT
iajs-3480	86	1	according	accord	VERB
iajs-3480	86	2	to	to	ADP
iajs-3480	86	3	the	the	DET
iajs-3480	86	4	sensitivity	sensitivity	NOUN
iajs-3480	86	5	analysis	analysis	NOUN
iajs-3480	86	6	,	,	PUNCT
iajs-3480	86	7	the	the	DET
iajs-3480	86	8	prevalence	prevalence	NOUN
iajs-3480	86	9	of	of	ADP
iajs-3480	86	10	hypothyroidism	hypothyroidism	NOUN
iajs-3480	86	11	tends	tend	VERB
iajs-3480	86	12	to	to	PART
iajs-3480	86	13	be	be	AUX
iajs-3480	86	14	higher	high	ADJ
iajs-3480	86	15	in	in	ADP
iajs-3480	86	16	female	female	ADJ
iajs-3480	86	17	patients	patient	NOUN
iajs-3480	86	18	[	[	X
iajs-3480	86	19	8	8	NUM
iajs-3480	86	20	]	]	PUNCT
iajs-3480	86	21	.	.	PUNCT
iajs-3480	87	1	hypothyroidism	hypothyroidism	NOUN
iajs-3480	87	2	,	,	PUNCT
iajs-3480	87	3	a	a	DET
iajs-3480	87	4	disorder	disorder	NOUN
iajs-3480	87	5	in	in	ADP
iajs-3480	87	6	the	the	DET
iajs-3480	87	7	thyroid	thyroid	NOUN
iajs-3480	87	8	gland	gland	NOUN
iajs-3480	87	9	that	that	PRON
iajs-3480	87	10	does	do	AUX
iajs-3480	87	11	not	not	PART
iajs-3480	87	12	make	make	VERB
iajs-3480	87	13	enough	enough	ADJ
iajs-3480	87	14	thyroid	thyroid	NOUN
iajs-3480	87	15	hormone	hormone	NOUN
iajs-3480	87	16	,	,	PUNCT
iajs-3480	87	17	is	be	AUX
iajs-3480	87	18	the	the	DET
iajs-3480	87	19	second	second	ADJ
iajs-3480	87	20	most	most	ADV
iajs-3480	87	21	common	common	ADJ
iajs-3480	87	22	endocrine	endocrine	ADJ
iajs-3480	87	23	disorder	disorder	NOUN
iajs-3480	87	24	in	in	ADP
iajs-3480	87	25	women	woman	NOUN
iajs-3480	87	26	[	[	X
iajs-3480	87	27	9	9	NUM
iajs-3480	87	28	]	]	PUNCT
iajs-3480	87	29	.	.	PUNCT
iajs-3480	88	1	3.3	3.3	NUM
iajs-3480	88	2	.	.	PUNCT
iajs-3480	89	1	comparison	comparison	NOUN
iajs-3480	89	2	of	of	ADP
iajs-3480	89	3	thyroid	thyroid	NOUN
iajs-3480	89	4	function	function	NOUN
iajs-3480	89	5	tests	test	NOUN
iajs-3480	89	6	between	between	ADP
iajs-3480	89	7	the	the	DET
iajs-3480	89	8	studied	study	VERB
iajs-3480	89	9	groups	group	NOUN
iajs-3480	89	10	the	the	DET
iajs-3480	89	11	comparison	comparison	NOUN
iajs-3480	89	12	of	of	ADP
iajs-3480	89	13	thyroid	thyroid	NOUN
iajs-3480	89	14	function	function	NOUN
iajs-3480	89	15	tests	test	NOUN
iajs-3480	89	16	between	between	ADP
iajs-3480	89	17	the	the	DET
iajs-3480	89	18	studied	study	VERB
iajs-3480	89	19	groups	group	NOUN
iajs-3480	89	20	is	be	AUX
iajs-3480	89	21	illustrated	illustrate	VERB
iajs-3480	89	22	in	in	ADP
iajs-3480	89	23	table	table	NOUN
iajs-3480	89	24	2	2	NUM
iajs-3480	89	25	and	and	CCONJ
iajs-3480	89	26	figure	figure	VERB
iajs-3480	89	27	3	3	NUM
iajs-3480	89	28	.	.	PUNCT
iajs-3480	90	1	according	accord	VERB
iajs-3480	90	2	to	to	ADP
iajs-3480	90	3	the	the	DET
iajs-3480	90	4	results	result	NOUN
iajs-3480	90	5	,	,	PUNCT
iajs-3480	90	6	there	there	PRON
iajs-3480	90	7	were	be	VERB
iajs-3480	90	8	significantly	significantly	ADV
iajs-3480	90	9	lower	low	ADJ
iajs-3480	90	10	t3	t3	PROPN
iajs-3480	90	11	and	and	CCONJ
iajs-3480	90	12	t4	t4	PROPN
iajs-3480	90	13	levels	level	NOUN
iajs-3480	90	14	and	and	CCONJ
iajs-3480	90	15	higher	high	ADJ
iajs-3480	90	16	tsh	tsh	NOUN
iajs-3480	90	17	levels	level	NOUN
iajs-3480	90	18	in	in	ADP
iajs-3480	90	19	hypothyroid	hypothyroid	ADJ
iajs-3480	90	20	patients	patient	NOUN
iajs-3480	90	21	before	before	ADP
iajs-3480	90	22	the	the	DET
iajs-3480	90	23	treatment	treatment	NOUN
iajs-3480	90	24	(	(	PUNCT
iajs-3480	90	25	p	p	X
iajs-3480	90	26	<	<	X
iajs-3480	90	27	0.001	0.001	NUM
iajs-3480	90	28	)	)	PUNCT
iajs-3480	90	29	.	.	PUNCT
iajs-3480	91	1	table	table	NOUN
iajs-3480	91	2	2	2	NUM
iajs-3480	91	3	.	.	PUNCT
iajs-3480	91	4	comparison	comparison	NOUN
iajs-3480	91	5	of	of	ADP
iajs-3480	91	6	thyroid	thyroid	NOUN
iajs-3480	91	7	function	function	NOUN
iajs-3480	91	8	tests	test	NOUN
iajs-3480	91	9	between	between	ADP
iajs-3480	91	10	the	the	DET
iajs-3480	91	11	studied	study	VERB
iajs-3480	91	12	groups	group	NOUN
iajs-3480	91	13	.	.	PUNCT
iajs-3480	92	1	thyroid	thyroid	NOUN
iajs-3480	92	2	function	function	NOUN
iajs-3480	92	3	tests	test	VERB
iajs-3480	92	4	hypothyroidism	hypothyroidism	NOUN
iajs-3480	92	5	without	without	ADP
iajs-3480	92	6	treatment	treatment	NOUN
iajs-3480	92	7	(	(	PUNCT
iajs-3480	92	8	group	group	NOUN
iajs-3480	92	9	1	1	NUM
iajs-3480	92	10	)	)	PUNCT
iajs-3480	92	11	hypothyroidism	hypothyroidism	NOUN
iajs-3480	92	12	with	with	ADP
iajs-3480	92	13	treatment	treatment	NOUN
iajs-3480	92	14	(	(	PUNCT
iajs-3480	92	15	group	group	NOUN
iajs-3480	92	16	2	2	NUM
iajs-3480	92	17	)	)	PUNCT
iajs-3480	92	18	healthy	healthy	ADJ
iajs-3480	92	19	controls	control	NOUN
iajs-3480	92	20	(	(	PUNCT
iajs-3480	92	21	group	group	NOUN
iajs-3480	92	22	3	3	NUM
iajs-3480	92	23	)	)	PUNCT
iajs-3480	92	24	p	p	NOUN
iajs-3480	92	25	value	value	NOUN
iajs-3480	92	26	0	0	NUM
iajs-3480	92	27	5	5	NUM
iajs-3480	92	28	10	10	NUM
iajs-3480	92	29	15	15	NUM
iajs-3480	92	30	20	20	NUM
iajs-3480	92	31	25	25	NUM
iajs-3480	92	32	30	30	NUM
iajs-3480	92	33	35	35	NUM
iajs-3480	92	34	40	40	NUM
iajs-3480	92	35	age	age	NOUN
iajs-3480	92	36	(	(	PUNCT
iajs-3480	92	37	years	year	NOUN
iajs-3480	92	38	)	)	PUNCT
iajs-3480	92	39	males	male	NOUN
iajs-3480	92	40	females	female	VERB
iajs-3480	92	41	39.4	39.4	NUM
iajs-3480	92	42	9	9	NUM
iajs-3480	92	43	21	21	NUM
iajs-3480	92	44	38.3	38.3	NUM
iajs-3480	92	45	9	9	NUM
iajs-3480	92	46	21	21	NUM
iajs-3480	92	47	36.67	36.67	NUM
iajs-3480	92	48	12	12	NUM
iajs-3480	92	49	18	18	NUM
iajs-3480	92	50	group	group	NOUN
iajs-3480	92	51	1	1	NUM
iajs-3480	92	52	group	group	NOUN
iajs-3480	92	53	2	2	NUM
iajs-3480	92	54	group	group	NOUN
iajs-3480	92	55	3	3	NUM
iajs-3480	92	56	p=0.419	p=0.419	X
iajs-3480	92	57	p=0.638	p=0.638	ADJ
iajs-3480	92	58	ihjpas	ihjpa	NOUN
iajs-3480	92	59	.	.	PUNCT
iajs-3480	93	1	2024	2024	NUM
iajs-3480	93	2	,	,	PUNCT
iajs-3480	93	3	37(4	37(4	PROPN
iajs-3480	93	4	)	)	PUNCT
iajs-3480	93	5	101	101	NUM
iajs-3480	93	6	t3	t3	NOUN
iajs-3480	93	7	(	(	PUNCT
iajs-3480	93	8	ng	ng	PROPN
iajs-3480	93	9	/	/	SYM
iajs-3480	93	10	ml	ml	PROPN
iajs-3480	93	11	)	)	PUNCT
iajs-3480	93	12	0.47	0.47	NUM
iajs-3480	93	13	±	±	NUM
iajs-3480	93	14	0.28	0.28	NUM
iajs-3480	93	15	1.35	1.35	NUM
iajs-3480	93	16	±	±	NUM
iajs-3480	93	17	0.35	0.35	NUM
iajs-3480	93	18	1.42	1.42	NUM
iajs-3480	93	19	±	±	NUM
iajs-3480	93	20	0.34	0.34	NUM
iajs-3480	93	21	<	<	X
iajs-3480	93	22	0.001f	0.001f	PROPN
iajs-3480	93	23	s	s	PART
iajs-3480	93	24	t4	t4	PROPN
iajs-3480	93	25	(	(	PUNCT
iajs-3480	93	26	µg	µg	PROPN
iajs-3480	93	27	/	/	SYM
iajs-3480	93	28	dl	dl	NOUN
iajs-3480	93	29	)	)	PUNCT
iajs-3480	93	30	3.16	3.16	NUM
iajs-3480	93	31	±	±	NUM
iajs-3480	93	32	1.64	1.64	NUM
iajs-3480	93	33	8.06	8.06	NUM
iajs-3480	93	34	±	±	NUM
iajs-3480	93	35	1.63	1.63	NUM
iajs-3480	93	36	8.71	8.71	NUM
iajs-3480	93	37	±	±	NUM
iajs-3480	93	38	2.07	2.07	NUM
iajs-3480	93	39	<	<	X
iajs-3480	93	40	0.001f	0.001f	NOUN
iajs-3480	93	41	s	s	PART
iajs-3480	93	42	tsh(µiu	tsh(µiu	NOUN
iajs-3480	93	43	/	/	SYM
iajs-3480	93	44	ml	ml	NOUN
iajs-3480	93	45	)	)	PUNCT
iajs-3480	93	46	19.72	19.72	NUM
iajs-3480	93	47	±	±	NUM
iajs-3480	93	48	3.52	3.52	NUM
iajs-3480	93	49	1.87	1.87	NUM
iajs-3480	93	50	±	±	NUM
iajs-3480	93	51	0.93	0.93	NUM
iajs-3480	93	52	1.85	1.85	NUM
iajs-3480	93	53	±	±	NUM
iajs-3480	93	54	0.88	0.88	NUM
iajs-3480	93	55	<	<	X
iajs-3480	93	56	0.001f	0.001f	PROPN
iajs-3480	93	57	s	s	PART
iajs-3480	93	58	t3	t3	NOUN
iajs-3480	93	59	:	:	PUNCT
iajs-3480	93	60	triiodothyronine	triiodothyronine	NOUN
iajs-3480	93	61	;	;	PUNCT
iajs-3480	93	62	t4	t4	PROPN
iajs-3480	93	63	:	:	PUNCT
iajs-3480	93	64	thyroxin	thyroxin	NOUN
iajs-3480	93	65	;	;	PUNCT
iajs-3480	93	66	tsh	tsh	ADJ
iajs-3480	93	67	:	:	PUNCT
iajs-3480	93	68	thyroid	thyroid	NOUN
iajs-3480	93	69	stimulating	stimulate	VERB
iajs-3480	93	70	hormone	hormone	NOUN
iajs-3480	93	71	;	;	PUNCT
iajs-3480	93	72	s	s	X
iajs-3480	93	73	:	:	PUNCT
iajs-3480	93	74	significant	significant	ADJ
iajs-3480	93	75	(	(	PUNCT
iajs-3480	93	76	p≤0.05	p≤0.05	NOUN
iajs-3480	93	77	)	)	PUNCT
iajs-3480	93	78	;	;	PUNCT
iajs-3480	94	1	f	f	X
iajs-3480	94	2	:	:	PUNCT
iajs-3480	94	3	anova	anova	PROPN
iajs-3480	94	4	figure	figure	VERB
iajs-3480	94	5	3	3	NUM
iajs-3480	94	6	.	.	NOUN
iajs-3480	94	7	comparison	comparison	NOUN
iajs-3480	94	8	of	of	ADP
iajs-3480	94	9	demographic	demographic	ADJ
iajs-3480	94	10	features	feature	NOUN
iajs-3480	94	11	between	between	ADP
iajs-3480	94	12	the	the	DET
iajs-3480	94	13	studied	study	VERB
iajs-3480	94	14	groups	group	NOUN
iajs-3480	94	15	.	.	PUNCT
iajs-3480	95	1	a	a	DET
iajs-3480	95	2	post	post	X
iajs-3480	95	3	hoc	hoc	X
iajs-3480	95	4	test	test	NOUN
iajs-3480	95	5	of	of	ADP
iajs-3480	95	6	anova	anova	PROPN
iajs-3480	95	7	showed	show	VERB
iajs-3480	95	8	significant	significant	ADJ
iajs-3480	95	9	differences	difference	NOUN
iajs-3480	95	10	between	between	ADP
iajs-3480	95	11	group	group	NOUN
iajs-3480	95	12	1	1	NUM
iajs-3480	95	13	patients	patient	NOUN
iajs-3480	95	14	and	and	CCONJ
iajs-3480	95	15	group	group	NOUN
iajs-3480	95	16	2	2	NUM
iajs-3480	95	17	and	and	CCONJ
iajs-3480	95	18	group	group	NOUN
iajs-3480	95	19	3	3	NUM
iajs-3480	95	20	patients	patient	NOUN
iajs-3480	95	21	(	(	PUNCT
iajs-3480	95	22	p	p	X
iajs-3480	95	23	<	<	X
iajs-3480	95	24	0.001	0.001	NUM
iajs-3480	95	25	)	)	PUNCT
iajs-3480	95	26	regarding	regard	VERB
iajs-3480	95	27	all	all	DET
iajs-3480	95	28	thyroid	thyroid	NOUN
iajs-3480	95	29	function	function	NOUN
iajs-3480	95	30	tests	test	NOUN
iajs-3480	95	31	;	;	PUNCT
iajs-3480	95	32	on	on	ADP
iajs-3480	95	33	the	the	DET
iajs-3480	95	34	contrary	contrary	NOUN
iajs-3480	95	35	,	,	PUNCT
iajs-3480	95	36	there	there	PRON
iajs-3480	95	37	were	be	VERB
iajs-3480	95	38	no	no	DET
iajs-3480	95	39	significant	significant	ADJ
iajs-3480	95	40	differences	difference	NOUN
iajs-3480	95	41	in	in	ADP
iajs-3480	95	42	t3	t3	PROPN
iajs-3480	95	43	,	,	PUNCT
iajs-3480	95	44	t4	t4	PROPN
iajs-3480	95	45	,	,	PUNCT
iajs-3480	95	46	and	and	CCONJ
iajs-3480	95	47	tsh	tsh	NOUN
iajs-3480	95	48	levels	level	NOUN
iajs-3480	95	49	between	between	ADP
iajs-3480	95	50	group	group	NOUN
iajs-3480	95	51	2	2	NUM
iajs-3480	95	52	and	and	CCONJ
iajs-3480	95	53	group	group	NOUN
iajs-3480	95	54	3	3	NUM
iajs-3480	95	55	patients	patient	NOUN
iajs-3480	95	56	,	,	PUNCT
iajs-3480	95	57	with	with	ADP
iajs-3480	95	58	p	p	NOUN
iajs-3480	95	59	values	value	NOUN
iajs-3480	95	60	equal	equal	ADJ
iajs-3480	95	61	to	to	ADP
iajs-3480	95	62	0.341	0.341	NUM
iajs-3480	95	63	,	,	PUNCT
iajs-3480	95	64	0.729	0.729	NUM
iajs-3480	95	65	,	,	PUNCT
iajs-3480	95	66	and	and	CCONJ
iajs-3480	95	67	0.1	0.1	NUM
iajs-3480	95	68	,	,	PUNCT
iajs-3480	95	69	as	as	SCONJ
iajs-3480	95	70	presented	present	VERB
iajs-3480	95	71	in	in	ADP
iajs-3480	95	72	table	table	NOUN
iajs-3480	95	73	3	3	NUM
iajs-3480	95	74	.	.	PUNCT
iajs-3480	95	75	table	table	NOUN
iajs-3480	95	76	3	3	NUM
iajs-3480	95	77	.	.	X
iajs-3480	95	78	post	post	VERB
iajs-3480	95	79	hoc	hoc	X
iajs-3480	95	80	test	test	NOUN
iajs-3480	95	81	of	of	ADP
iajs-3480	95	82	anova	anova	PROPN
iajs-3480	95	83	of	of	ADP
iajs-3480	95	84	thyroid	thyroid	NOUN
iajs-3480	95	85	function	function	NOUN
iajs-3480	95	86	tests	test	NOUN
iajs-3480	95	87	for	for	ADP
iajs-3480	95	88	multiple	multiple	ADJ
iajs-3480	95	89	comparisons	comparison	NOUN
iajs-3480	95	90	between	between	ADP
iajs-3480	95	91	groups	group	NOUN
iajs-3480	95	92	.	.	PUNCT
iajs-3480	96	1	post	post	VERB
iajs-3480	96	2	hoc	hoc	X
iajs-3480	96	3	test	test	NOUN
iajs-3480	96	4	for	for	ADP
iajs-3480	96	5	multiple	multiple	ADJ
iajs-3480	96	6	groups	group	NOUN
iajs-3480	96	7	comparisons	comparison	NOUN
iajs-3480	96	8	p	p	NOUN
iajs-3480	96	9	value	value	NOUN
iajs-3480	96	10	t3	t3	PROPN
iajs-3480	96	11	group	group	NOUN
iajs-3480	96	12	1	1	NUM
iajs-3480	96	13	group	group	NOUN
iajs-3480	96	14	2	2	NUM
iajs-3480	96	15	<	<	SYM
iajs-3480	96	16	0.001	0.001	NUM
iajs-3480	96	17	group	group	NOUN
iajs-3480	96	18	1	1	NUM
iajs-3480	96	19	group	group	NOUN
iajs-3480	96	20	3	3	NUM
iajs-3480	96	21	<	<	SYM
iajs-3480	96	22	0.001	0.001	NUM
iajs-3480	96	23	group	group	NOUN
iajs-3480	96	24	2	2	NUM
iajs-3480	96	25	group	group	NOUN
iajs-3480	96	26	3	3	NUM
iajs-3480	96	27	0.341	0.341	NUM
iajs-3480	96	28	t4	t4	PROPN
iajs-3480	96	29	group	group	NOUN
iajs-3480	96	30	1	1	NUM
iajs-3480	96	31	group	group	NOUN
iajs-3480	96	32	2	2	NUM
iajs-3480	96	33	<	<	SYM
iajs-3480	96	34	0.001	0.001	NUM
iajs-3480	96	35	group	group	NOUN
iajs-3480	96	36	1	1	NUM
iajs-3480	96	37	group	group	NOUN
iajs-3480	96	38	3	3	NUM
iajs-3480	96	39	<	<	SYM
iajs-3480	96	40	0.001	0.001	NUM
iajs-3480	96	41	group	group	NOUN
iajs-3480	96	42	2	2	NUM
iajs-3480	96	43	group	group	NOUN
iajs-3480	96	44	3	3	NUM
iajs-3480	96	45	0.729	0.729	NUM
iajs-3480	96	46	tsh	tsh	NOUN
iajs-3480	96	47	group	group	NOUN
iajs-3480	96	48	1	1	NUM
iajs-3480	96	49	group	group	NOUN
iajs-3480	96	50	2	2	NUM
iajs-3480	96	51	<	<	SYM
iajs-3480	96	52	0.001	0.001	NUM
iajs-3480	96	53	group	group	NOUN
iajs-3480	96	54	1	1	NUM
iajs-3480	96	55	group	group	NOUN
iajs-3480	96	56	3	3	NUM
iajs-3480	96	57	<	<	SYM
iajs-3480	96	58	0.001	0.001	NUM
iajs-3480	96	59	group	group	NOUN
iajs-3480	96	60	2	2	NUM
iajs-3480	96	61	group	group	NOUN
iajs-3480	96	62	3	3	NUM
iajs-3480	96	63	1.00	1.00	NUM
iajs-3480	96	64	t3	t3	NOUN
iajs-3480	96	65	:	:	PUNCT
iajs-3480	96	66	triiodothyronine	triiodothyronine	ADJ
iajs-3480	96	67	;	;	PUNCT
iajs-3480	96	68	t4	t4	PROPN
iajs-3480	96	69	:	:	PUNCT
iajs-3480	96	70	thyroxin	thyroxin	NOUN
iajs-3480	96	71	;	;	PUNCT
iajs-3480	96	72	tsh	tsh	ADJ
iajs-3480	96	73	:	:	PUNCT
iajs-3480	96	74	thyroid	thyroid	NOUN
iajs-3480	96	75	stimulating	stimulate	VERB
iajs-3480	96	76	hormone	hormone	NOUN
iajs-3480	96	77	.	.	PUNCT
iajs-3480	97	1	3.4	3.4	NUM
iajs-3480	97	2	.	.	PUNCT
iajs-3480	97	3	comparison	comparison	NOUN
iajs-3480	97	4	of	of	ADP
iajs-3480	97	5	serum	serum	NOUN
iajs-3480	97	6	hepcidin	hepcidin	PROPN
iajs-3480	97	7	and	and	CCONJ
iajs-3480	97	8	crp	crp	PROPN
iajs-3480	97	9	levels	level	NOUN
iajs-3480	97	10	between	between	ADP
iajs-3480	97	11	the	the	DET
iajs-3480	97	12	studied	study	VERB
iajs-3480	97	13	groups	group	NOUN
iajs-3480	97	14	the	the	DET
iajs-3480	97	15	highest	high	ADJ
iajs-3480	97	16	serum	serum	NOUN
iajs-3480	97	17	hepcidin	hepcidin	PROPN
iajs-3480	97	18	and	and	CCONJ
iajs-3480	97	19	crp	crp	PROPN
iajs-3480	97	20	levels	level	NOUN
iajs-3480	97	21	(	(	PUNCT
iajs-3480	97	22	11.77	11.77	NUM
iajs-3480	97	23	±	±	NUM
iajs-3480	97	24	0.98	0.98	NUM
iajs-3480	97	25	and	and	CCONJ
iajs-3480	97	26	14.61	14.61	NUM
iajs-3480	97	27	±	±	NUM
iajs-3480	97	28	2.49	2.49	NUM
iajs-3480	97	29	,	,	PUNCT
iajs-3480	97	30	respectively	respectively	ADV
iajs-3480	97	31	)	)	PUNCT
iajs-3480	97	32	were	be	AUX
iajs-3480	97	33	found	find	VERB
iajs-3480	97	34	in	in	ADP
iajs-3480	97	35	group	group	NOUN
iajs-3480	97	36	1	1	NUM
iajs-3480	97	37	patients	patient	NOUN
iajs-3480	97	38	;	;	PUNCT
iajs-3480	97	39	on	on	ADP
iajs-3480	97	40	the	the	DET
iajs-3480	97	41	contrary	contrary	NOUN
iajs-3480	97	42	,	,	PUNCT
iajs-3480	97	43	the	the	DET
iajs-3480	97	44	lowest	low	ADJ
iajs-3480	97	45	levels	level	NOUN
iajs-3480	97	46	(	(	PUNCT
iajs-3480	97	47	7.61	7.61	NUM
iajs-3480	97	48	±	±	NUM
iajs-3480	97	49	1.56	1.56	NUM
iajs-3480	97	50	and	and	CCONJ
iajs-3480	97	51	3.19	3.19	NUM
iajs-3480	97	52	±	±	NUM
iajs-3480	97	53	0.29	0.29	NUM
iajs-3480	97	54	,	,	PUNCT
iajs-3480	97	55	respectively	respectively	ADV
iajs-3480	97	56	)	)	PUNCT
iajs-3480	97	57	were	be	AUX
iajs-3480	97	58	present	present	ADJ
iajs-3480	97	59	in	in	ADP
iajs-3480	97	60	group	group	NOUN
iajs-3480	97	61	2	2	NUM
iajs-3480	97	62	patients	patient	NOUN
iajs-3480	97	63	.	.	PUNCT
iajs-3480	98	1	the	the	DET
iajs-3480	98	2	hepcidin	hepcidin	ADJ
iajs-3480	98	3	and	and	CCONJ
iajs-3480	98	4	crp	crp	NOUN
iajs-3480	98	5	levels	level	NOUN
iajs-3480	98	6	in	in	ADP
iajs-3480	98	7	healthy	healthy	ADJ
iajs-3480	98	8	subjects	subject	NOUN
iajs-3480	98	9	were	be	AUX
iajs-3480	98	10	8.45	8.45	NUM
iajs-3480	98	11	±	±	NUM
iajs-3480	98	12	0.53	0.53	NUM
iajs-3480	98	13	and	and	CCONJ
iajs-3480	98	14	3.51	3.51	NUM
iajs-3480	98	15	±	±	NUM
iajs-3480	98	16	0.91	0.91	NUM
iajs-3480	98	17	,	,	PUNCT
iajs-3480	98	18	respectively	respectively	ADV
iajs-3480	98	19	.	.	PUNCT
iajs-3480	99	1	accordingly	accordingly	ADV
iajs-3480	99	2	,	,	PUNCT
iajs-3480	99	3	there	there	PRON
iajs-3480	99	4	was	be	VERB
iajs-3480	99	5	a	a	DET
iajs-3480	99	6	significant	significant	ADJ
iajs-3480	99	7	difference	difference	NOUN
iajs-3480	99	8	in	in	ADP
iajs-3480	99	9	hepcidin	hepcidin	ADJ
iajs-3480	99	10	levels	level	NOUN
iajs-3480	99	11	between	between	ADP
iajs-3480	99	12	the	the	DET
iajs-3480	99	13	three	three	NUM
iajs-3480	99	14	studied	studied	ADJ
iajs-3480	99	15	groups	group	NOUN
iajs-3480	99	16	,	,	PUNCT
iajs-3480	99	17	as	as	SCONJ
iajs-3480	99	18	presented	present	VERB
iajs-3480	99	19	in	in	ADP
iajs-3480	99	20	table	table	NOUN
iajs-3480	99	21	4	4	NUM
iajs-3480	99	22	and	and	CCONJ
iajs-3480	99	23	figure	figure	VERB
iajs-3480	99	24	4	4	NUM
iajs-3480	99	25	.	.	PUNCT
iajs-3480	99	26	table	table	NOUN
iajs-3480	99	27	4	4	NUM
iajs-3480	99	28	.	.	PUNCT
iajs-3480	99	29	comparison	comparison	NOUN
iajs-3480	99	30	of	of	ADP
iajs-3480	99	31	serum	serum	NOUN
iajs-3480	99	32	hepcidin	hepcidin	NOUN
iajs-3480	99	33	level	level	NOUN
iajs-3480	99	34	between	between	ADP
iajs-3480	99	35	the	the	DET
iajs-3480	99	36	studied	study	VERB
iajs-3480	99	37	groups	group	NOUN
iajs-3480	99	38	.	.	PUNCT
iajs-3480	100	1	0	0	NUM
iajs-3480	100	2	5	5	NUM
iajs-3480	100	3	10	10	NUM
iajs-3480	100	4	15	15	NUM
iajs-3480	100	5	20	20	NUM
iajs-3480	100	6	t3	t3	NOUN
iajs-3480	100	7	(	(	PUNCT
iajs-3480	100	8	ng	ng	PROPN
iajs-3480	100	9	/	/	SYM
iajs-3480	100	10	ml	ml	PROPN
iajs-3480	100	11	)	)	PUNCT
iajs-3480	100	12	t4	t4	PROPN
iajs-3480	100	13	(	(	PUNCT
iajs-3480	100	14	µg	µg	PROPN
iajs-3480	100	15	/	/	SYM
iajs-3480	100	16	dl	dl	NOUN
iajs-3480	100	17	)	)	PUNCT
iajs-3480	100	18	tsh(µiu	tsh(µiu	NOUN
iajs-3480	100	19	/	/	SYM
iajs-3480	100	20	ml	ml	NOUN
iajs-3480	100	21	)	)	PUNCT
iajs-3480	100	22	0.47	0.47	NUM
iajs-3480	100	23	3.16	3.16	NUM
iajs-3480	100	24	19.72	19.72	NUM
iajs-3480	100	25	1.35	1.35	NUM
iajs-3480	100	26	8.06	8.06	NUM
iajs-3480	100	27	1.871.42	1.871.42	NUM
iajs-3480	100	28	8.71	8.71	NUM
iajs-3480	100	29	1.85	1.85	NUM
iajs-3480	100	30	group	group	NOUN
iajs-3480	100	31	1	1	NUM
iajs-3480	100	32	group	group	NOUN
iajs-3480	100	33	2	2	NUM
iajs-3480	100	34	group	group	NOUN
iajs-3480	100	35	3	3	NUM
iajs-3480	100	36	p	p	NOUN
iajs-3480	100	37	<	<	X
iajs-3480	100	38	0.001	0.001	NUM
iajs-3480	100	39	p	p	X
iajs-3480	100	40	<	<	X
iajs-3480	100	41	0.001	0.001	NUM
iajs-3480	100	42	p	p	X
iajs-3480	100	43	<	<	X
iajs-3480	100	44	0.001	0.001	NUM
iajs-3480	100	45	ihjpas	ihjpa	NOUN
iajs-3480	100	46	.	.	PUNCT
iajs-3480	101	1	2024	2024	NUM
iajs-3480	101	2	,	,	PUNCT
iajs-3480	101	3	37(4	37(4	NOUN
iajs-3480	101	4	)	)	PUNCT
iajs-3480	101	5	102	102	NUM
iajs-3480	101	6	parameters	parameter	NOUN
iajs-3480	101	7	hypothyroidism	hypothyroidism	NOUN
iajs-3480	101	8	without	without	ADP
iajs-3480	101	9	treatment	treatment	NOUN
iajs-3480	101	10	(	(	PUNCT
iajs-3480	101	11	group	group	NOUN
iajs-3480	101	12	1	1	NUM
iajs-3480	101	13	)	)	PUNCT
iajs-3480	101	14	hypothyroidism	hypothyroidism	NOUN
iajs-3480	101	15	with	with	ADP
iajs-3480	101	16	treatment	treatment	NOUN
iajs-3480	101	17	(	(	PUNCT
iajs-3480	101	18	group	group	NOUN
iajs-3480	101	19	2	2	NUM
iajs-3480	101	20	)	)	PUNCT
iajs-3480	101	21	controls	control	NOUN
iajs-3480	101	22	group	group	NOUN
iajs-3480	101	23	3	3	NUM
iajs-3480	101	24	p	p	NOUN
iajs-3480	101	25	value	value	NOUN
iajs-3480	101	26	serum	serum	NOUN
iajs-3480	101	27	hepcidin	hepcidin	VERB
iajs-3480	101	28	11.77	11.77	NUM
iajs-3480	101	29	±	±	NUM
iajs-3480	101	30	0.98	0.98	NUM
iajs-3480	101	31	7.61	7.61	NUM
iajs-3480	101	32	±	±	NUM
iajs-3480	101	33	1.56	1.56	NUM
iajs-3480	101	34	8.45	8.45	NUM
iajs-3480	101	35	±	±	NOUN
iajs-3480	101	36	0.53	0.53	NUM
iajs-3480	101	37	<	<	X
iajs-3480	101	38	0.001f	0.001f	PROPN
iajs-3480	101	39	s	s	PART
iajs-3480	101	40	serum	serum	PROPN
iajs-3480	101	41	crp	crp	PROPN
iajs-3480	101	42	14.61	14.61	NUM
iajs-3480	101	43	±	±	NUM
iajs-3480	101	44	2.49	2.49	NUM
iajs-3480	101	45	3.19	3.19	NUM
iajs-3480	101	46	±	±	NUM
iajs-3480	101	47	0.29	0.29	NUM
iajs-3480	101	48	3.51	3.51	NUM
iajs-3480	101	49	±	±	NUM
iajs-3480	101	50	0.91	0.91	NUM
iajs-3480	101	51	<	<	X
iajs-3480	101	52	0.001f	0.001f	NUM
iajs-3480	101	53	s	s	PART
iajs-3480	101	54	s	s	NOUN
iajs-3480	101	55	:	:	PUNCT
iajs-3480	101	56	significant	significant	ADJ
iajs-3480	101	57	(	(	PUNCT
iajs-3480	101	58	p	p	NOUN
iajs-3480	101	59	≤	≤	NUM
iajs-3480	101	60	0.05	0.05	NUM
iajs-3480	101	61	)	)	PUNCT
iajs-3480	101	62	;	;	PUNCT
iajs-3480	101	63	f	f	X
iajs-3480	101	64	:	:	PUNCT
iajs-3480	101	65	anova	anova	PROPN
iajs-3480	101	66	;	;	PUNCT
iajs-3480	101	67	crp	crp	NOUN
iajs-3480	101	68	:	:	PUNCT
iajs-3480	101	69	c	c	X
iajs-3480	101	70	-	-	PUNCT
iajs-3480	101	71	reactive	reactive	ADJ
iajs-3480	101	72	protein	protein	NOUN
iajs-3480	101	73	.	.	PUNCT
iajs-3480	102	1	figure	figure	NOUN
iajs-3480	102	2	4	4	NUM
iajs-3480	102	3	.	.	NOUN
iajs-3480	102	4	comparison	comparison	NOUN
iajs-3480	102	5	of	of	ADP
iajs-3480	102	6	serum	serum	NOUN
iajs-3480	102	7	hepcidin	hepcidin	PROPN
iajs-3480	102	8	&	&	CCONJ
iajs-3480	102	9	crp	crp	PROPN
iajs-3480	102	10	levels	level	NOUN
iajs-3480	102	11	between	between	ADP
iajs-3480	102	12	the	the	DET
iajs-3480	102	13	studied	study	VERB
iajs-3480	102	14	groups	group	NOUN
iajs-3480	102	15	.	.	PUNCT
iajs-3480	103	1	post	post	VERB
iajs-3480	103	2	hoc	hoc	X
iajs-3480	103	3	tests	test	NOUN
iajs-3480	103	4	of	of	ADP
iajs-3480	103	5	hepcidin	hepcidin	NOUN
iajs-3480	103	6	and	and	CCONJ
iajs-3480	103	7	crp	crp	NOUN
iajs-3480	103	8	(	(	PUNCT
iajs-3480	103	9	table	table	NOUN
iajs-3480	103	10	5	5	NUM
iajs-3480	103	11	)	)	PUNCT
iajs-3480	103	12	demonstrated	demonstrate	VERB
iajs-3480	103	13	a	a	DET
iajs-3480	103	14	significant	significant	ADJ
iajs-3480	103	15	difference	difference	NOUN
iajs-3480	103	16	(	(	PUNCT
iajs-3480	103	17	p	p	X
iajs-3480	103	18	<	<	X
iajs-3480	103	19	0.05	0.05	NUM
iajs-3480	103	20	)	)	PUNCT
iajs-3480	103	21	in	in	ADP
iajs-3480	103	22	all	all	DET
iajs-3480	103	23	parameters	parameter	NOUN
iajs-3480	103	24	between	between	ADP
iajs-3480	103	25	groups	group	NOUN
iajs-3480	103	26	1	1	NUM
iajs-3480	103	27	and	and	CCONJ
iajs-3480	103	28	2	2	NUM
iajs-3480	103	29	and	and	CCONJ
iajs-3480	103	30	between	between	ADP
iajs-3480	103	31	groups	group	NOUN
iajs-3480	103	32	1	1	NUM
iajs-3480	103	33	and	and	CCONJ
iajs-3480	103	34	3	3	NUM
iajs-3480	103	35	.	.	X
iajs-3480	104	1	there	there	PRON
iajs-3480	104	2	were	be	VERB
iajs-3480	104	3	also	also	ADV
iajs-3480	104	4	significant	significant	ADJ
iajs-3480	104	5	differences	difference	NOUN
iajs-3480	104	6	regarding	regard	VERB
iajs-3480	104	7	hepcidin	hepcidin	VERB
iajs-3480	104	8	(	(	PUNCT
iajs-3480	104	9	p=0.573	p=0.573	NOUN
iajs-3480	104	10	)	)	PUNCT
iajs-3480	104	11	and	and	CCONJ
iajs-3480	104	12	crp	crp	PROPN
iajs-3480	104	13	(	(	PUNCT
iajs-3480	104	14	p=0.988	p=0.988	NOUN
iajs-3480	104	15	)	)	PUNCT
iajs-3480	104	16	.	.	PUNCT
iajs-3480	105	1	table	table	NOUN
iajs-3480	105	2	5	5	NUM
iajs-3480	105	3	.	.	X
iajs-3480	105	4	post	post	VERB
iajs-3480	105	5	hoc	hoc	X
iajs-3480	105	6	test	test	NOUN
iajs-3480	105	7	of	of	ADP
iajs-3480	105	8	anova	anova	PROPN
iajs-3480	105	9	of	of	ADP
iajs-3480	105	10	iron	iron	NOUN
iajs-3480	105	11	status	status	NOUN
iajs-3480	105	12	,	,	PUNCT
iajs-3480	105	13	hepcidin	hepcidin	ADJ
iajs-3480	105	14	and	and	CCONJ
iajs-3480	105	15	crp	crp	NOUN
iajs-3480	105	16	levels	level	NOUN
iajs-3480	105	17	for	for	ADP
iajs-3480	105	18	multiple	multiple	ADJ
iajs-3480	105	19	comparisons	comparison	NOUN
iajs-3480	105	20	between	between	ADP
iajs-3480	105	21	groups	group	NOUN
iajs-3480	105	22	.	.	PUNCT
iajs-3480	106	1	post	post	VERB
iajs-3480	106	2	hoc	hoc	X
iajs-3480	106	3	test	test	NOUN
iajs-3480	106	4	for	for	ADP
iajs-3480	106	5	multiple	multiple	ADJ
iajs-3480	106	6	groups	group	NOUN
iajs-3480	106	7	comparisons	comparison	NOUN
iajs-3480	106	8	p	p	NOUN
iajs-3480	106	9	value	value	NOUN
iajs-3480	106	10	hepcidin	hepcidin	NOUN
iajs-3480	106	11	group	group	NOUN
iajs-3480	106	12	1	1	NUM
iajs-3480	106	13	group	group	NOUN
iajs-3480	106	14	2	2	NUM
iajs-3480	106	15	<	<	SYM
iajs-3480	106	16	0.001	0.001	NUM
iajs-3480	106	17	group	group	NOUN
iajs-3480	106	18	1	1	NUM
iajs-3480	106	19	group	group	NOUN
iajs-3480	106	20	3	3	NUM
iajs-3480	106	21	<	<	SYM
iajs-3480	106	22	0.001	0.001	NUM
iajs-3480	106	23	group	group	NOUN
iajs-3480	106	24	2	2	NUM
iajs-3480	106	25	group	group	NOUN
iajs-3480	106	26	3	3	NUM
iajs-3480	106	27	0.573	0.573	NUM
iajs-3480	106	28	crp	crp	PROPN
iajs-3480	106	29	group	group	NOUN
iajs-3480	106	30	1	1	NUM
iajs-3480	106	31	group	group	NOUN
iajs-3480	106	32	2	2	NUM
iajs-3480	106	33	<	<	SYM
iajs-3480	106	34	0.001	0.001	NUM
iajs-3480	106	35	group	group	NOUN
iajs-3480	106	36	1	1	NUM
iajs-3480	106	37	group	group	NOUN
iajs-3480	106	38	3	3	NUM
iajs-3480	106	39	<	<	SYM
iajs-3480	106	40	0.001	0.001	NUM
iajs-3480	106	41	group	group	NOUN
iajs-3480	106	42	2	2	NUM
iajs-3480	106	43	group	group	NOUN
iajs-3480	106	44	3	3	NUM
iajs-3480	106	45	0.988	0.988	NUM
iajs-3480	106	46	hypothyroidism	hypothyroidism	NOUN
iajs-3480	106	47	is	be	AUX
iajs-3480	106	48	one	one	NUM
iajs-3480	106	49	of	of	ADP
iajs-3480	106	50	the	the	DET
iajs-3480	106	51	thyroid	thyroid	NOUN
iajs-3480	106	52	disorders	disorder	NOUN
iajs-3480	106	53	that	that	PRON
iajs-3480	106	54	causes	cause	VERB
iajs-3480	106	55	elevated	elevated	ADJ
iajs-3480	106	56	levels	level	NOUN
iajs-3480	106	57	of	of	ADP
iajs-3480	106	58	highly	highly	ADV
iajs-3480	106	59	sensitive	sensitive	ADJ
iajs-3480	106	60	creactive	creactive	ADJ
iajs-3480	106	61	protein	protein	NOUN
iajs-3480	106	62	.	.	PUNCT
iajs-3480	107	1	the	the	DET
iajs-3480	107	2	results	result	NOUN
iajs-3480	107	3	of	of	ADP
iajs-3480	107	4	group	group	NOUN
iajs-3480	107	5	1	1	NUM
iajs-3480	107	6	showed	show	VERB
iajs-3480	107	7	an	an	DET
iajs-3480	107	8	increase	increase	NOUN
iajs-3480	107	9	in	in	ADP
iajs-3480	107	10	crp	crp	PROPN
iajs-3480	107	11	because	because	SCONJ
iajs-3480	107	12	they	they	PRON
iajs-3480	107	13	had	have	VERB
iajs-3480	107	14	hypothyroidism	hypothyroidism	NOUN
iajs-3480	107	15	,	,	PUNCT
iajs-3480	107	16	but	but	CCONJ
iajs-3480	107	17	compared	compare	VERB
iajs-3480	107	18	with	with	ADP
iajs-3480	107	19	groups	group	NOUN
iajs-3480	107	20	2	2	NUM
iajs-3480	107	21	,	,	PUNCT
iajs-3480	107	22	3	3	NUM
iajs-3480	107	23	,	,	PUNCT
iajs-3480	107	24	and	and	CCONJ
iajs-3480	107	25	4	4	NUM
iajs-3480	107	26	,	,	PUNCT
iajs-3480	107	27	there	there	PRON
iajs-3480	107	28	was	be	VERB
iajs-3480	107	29	no	no	DET
iajs-3480	107	30	significant	significant	ADJ
iajs-3480	107	31	increase	increase	NOUN
iajs-3480	107	32	in	in	ADP
iajs-3480	107	33	crp	crp	PROPN
iajs-3480	107	34	values	value	NOUN
iajs-3480	107	35	in	in	ADP
iajs-3480	107	36	healthy	healthy	ADJ
iajs-3480	107	37	subjects	subject	NOUN
iajs-3480	107	38	or	or	CCONJ
iajs-3480	107	39	treated	treat	VERB
iajs-3480	107	40	patients	patient	NOUN
iajs-3480	107	41	[	[	X
iajs-3480	107	42	15	15	NUM
iajs-3480	107	43	]	]	PUNCT
iajs-3480	107	44	.	.	PUNCT
iajs-3480	108	1	one	one	NUM
iajs-3480	108	2	of	of	ADP
iajs-3480	108	3	the	the	DET
iajs-3480	108	4	reasons	reason	NOUN
iajs-3480	108	5	for	for	ADP
iajs-3480	108	6	the	the	DET
iajs-3480	108	7	increase	increase	NOUN
iajs-3480	108	8	in	in	ADP
iajs-3480	108	9	crp	crp	PROPN
iajs-3480	108	10	in	in	ADP
iajs-3480	108	11	the	the	DET
iajs-3480	108	12	body	body	NOUN
iajs-3480	108	13	is	be	AUX
iajs-3480	108	14	the	the	DET
iajs-3480	108	15	presence	presence	NOUN
iajs-3480	108	16	of	of	ADP
iajs-3480	108	17	inflammation	inflammation	NOUN
iajs-3480	108	18	,	,	PUNCT
iajs-3480	108	19	and	and	CCONJ
iajs-3480	108	20	it	it	PRON
iajs-3480	108	21	is	be	AUX
iajs-3480	108	22	also	also	ADV
iajs-3480	108	23	mentioned	mention	VERB
iajs-3480	108	24	that	that	SCONJ
iajs-3480	108	25	hypothyroidism	hypothyroidism	NOUN
iajs-3480	108	26	due	due	ADP
iajs-3480	108	27	to	to	ADP
iajs-3480	108	28	autoimmune	autoimmune	ADJ
iajs-3480	108	29	disease	disease	NOUN
iajs-3480	108	30	can	can	AUX
iajs-3480	108	31	lead	lead	VERB
iajs-3480	108	32	to	to	ADP
iajs-3480	108	33	an	an	DET
iajs-3480	108	34	increase	increase	NOUN
iajs-3480	108	35	in	in	ADP
iajs-3480	108	36	the	the	DET
iajs-3480	108	37	rate	rate	NOUN
iajs-3480	108	38	of	of	ADP
iajs-3480	108	39	inflammation	inflammation	NOUN
iajs-3480	108	40	in	in	ADP
iajs-3480	108	41	the	the	DET
iajs-3480	108	42	body	body	NOUN
iajs-3480	108	43	and	and	CCONJ
iajs-3480	108	44	thus	thus	ADV
iajs-3480	108	45	lead	lead	VERB
iajs-3480	108	46	to	to	ADP
iajs-3480	108	47	an	an	DET
iajs-3480	108	48	increase	increase	NOUN
iajs-3480	108	49	in	in	ADP
iajs-3480	108	50	crp	crp	PROPN
iajs-3480	108	51	.	.	PUNCT
iajs-3480	109	1	primary	primary	ADJ
iajs-3480	109	2	autoimmune	autoimmune	ADJ
iajs-3480	109	3	hypothyroidism	hypothyroidism	NOUN
iajs-3480	109	4	is	be	AUX
iajs-3480	109	5	an	an	DET
iajs-3480	109	6	inflammatory	inflammatory	ADJ
iajs-3480	109	7	disease	disease	NOUN
iajs-3480	109	8	characterized	characterize	VERB
iajs-3480	109	9	by	by	ADP
iajs-3480	109	10	elevated	elevated	ADJ
iajs-3480	109	11	cytokine	cytokine	NOUN
iajs-3480	109	12	levels	level	NOUN
iajs-3480	109	13	that	that	PRON
iajs-3480	109	14	decrease	decrease	VERB
iajs-3480	109	15	with	with	ADP
iajs-3480	109	16	lt4	lt4	PROPN
iajs-3480	109	17	therapy	therapy	NOUN
iajs-3480	109	18	[	[	X
iajs-3480	109	19	16	16	NUM
iajs-3480	109	20	]	]	PUNCT
iajs-3480	109	21	.	.	PUNCT
iajs-3480	110	1	additionally	additionally	ADV
iajs-3480	110	2	,	,	PUNCT
iajs-3480	110	3	studies	study	NOUN
iajs-3480	110	4	suggest	suggest	VERB
iajs-3480	110	5	that	that	SCONJ
iajs-3480	110	6	individuals	individual	NOUN
iajs-3480	110	7	with	with	ADP
iajs-3480	110	8	thyroiditis	thyroiditis	NOUN
iajs-3480	110	9	or	or	CCONJ
iajs-3480	110	10	hashimato	hashimato	NOUN
iajs-3480	110	11	disease	disease	NOUN
iajs-3480	110	12	experience	experience	VERB
iajs-3480	110	13	a	a	DET
iajs-3480	110	14	significant	significant	ADJ
iajs-3480	110	15	increase	increase	NOUN
iajs-3480	110	16	in	in	ADP
iajs-3480	110	17	crp	crp	PROPN
iajs-3480	110	18	levels	level	NOUN
iajs-3480	110	19	,	,	PUNCT
iajs-3480	110	20	a	a	DET
iajs-3480	110	21	protein	protein	NOUN
iajs-3480	110	22	that	that	PRON
iajs-3480	110	23	increases	increase	VERB
iajs-3480	110	24	when	when	SCONJ
iajs-3480	110	25	the	the	DET
iajs-3480	110	26	body	body	NOUN
iajs-3480	110	27	experiences	experience	VERB
iajs-3480	110	28	inflammation	inflammation	NOUN
iajs-3480	110	29	[	[	X
iajs-3480	110	30	17	17	NUM
iajs-3480	110	31	]	]	PUNCT
iajs-3480	110	32	.	.	PUNCT
iajs-3480	111	1	the	the	DET
iajs-3480	111	2	rise	rise	NOUN
iajs-3480	111	3	crp	crp	PROPN
iajs-3480	111	4	is	be	AUX
iajs-3480	111	5	response	response	NOUN
iajs-3480	111	6	to	to	ADP
iajs-3480	111	7	the	the	DET
iajs-3480	111	8	rise	rise	NOUN
iajs-3480	111	9	of	of	ADP
iajs-3480	111	10	il6	il6	NOUN
iajs-3480	111	11	,	,	PUNCT
iajs-3480	111	12	and	and	CCONJ
iajs-3480	111	13	thus	thus	ADV
iajs-3480	111	14	leads	lead	VERB
iajs-3480	111	15	to	to	ADP
iajs-3480	111	16	a	a	DET
iajs-3480	111	17	rise	rise	NOUN
iajs-3480	111	18	in	in	ADP
iajs-3480	111	19	crp	crp	PROPN
iajs-3480	111	20	,	,	PUNCT
iajs-3480	111	21	0	0	NUM
iajs-3480	111	22	5	5	NUM
iajs-3480	111	23	10	10	NUM
iajs-3480	111	24	15	15	NUM
iajs-3480	111	25	serum	serum	NOUN
iajs-3480	111	26	hepcidin	hepcidin	NOUN
iajs-3480	111	27	(	(	PUNCT
iajs-3480	111	28	pg	pg	NOUN
iajs-3480	111	29	/	/	SYM
iajs-3480	111	30	ml	ml	NOUN
iajs-3480	111	31	)	)	PUNCT
iajs-3480	111	32	crp	crp	PROPN
iajs-3480	111	33	(	(	PUNCT
iajs-3480	111	34	mg	mg	PROPN
iajs-3480	111	35	/	/	SYM
iajs-3480	111	36	l	l	NOUN
iajs-3480	111	37	)	)	PUNCT
iajs-3480	111	38	11.77	11.77	NUM
iajs-3480	111	39	14.61	14.61	NUM
iajs-3480	111	40	7.91	7.91	NUM
iajs-3480	111	41	3.19	3.19	NUM
iajs-3480	111	42	8.45	8.45	NUM
iajs-3480	111	43	3.51	3.51	NUM
iajs-3480	111	44	p	p	NOUN
iajs-3480	111	45	<	<	X
iajs-3480	111	46	0.001	0.001	NUM
iajs-3480	111	47	p	p	X
iajs-3480	111	48	<	<	X
iajs-3480	111	49	0.001	0.001	NUM
iajs-3480	111	50	ihjpas	ihjpa	NOUN
iajs-3480	111	51	.	.	PUNCT
iajs-3480	112	1	2024	2024	NUM
iajs-3480	112	2	,	,	PUNCT
iajs-3480	112	3	37(4	37(4	NOUN
iajs-3480	112	4	)	)	PUNCT
iajs-3480	112	5	103	103	NUM
iajs-3480	112	6	where	where	SCONJ
iajs-3480	112	7	the	the	DET
iajs-3480	112	8	response	response	NOUN
iajs-3480	112	9	of	of	ADP
iajs-3480	112	10	il6	il6	NOUN
iajs-3480	112	11	is	be	AUX
iajs-3480	112	12	to	to	ADP
iajs-3480	112	13	the	the	DET
iajs-3480	112	14	presence	presence	NOUN
iajs-3480	112	15	of	of	ADP
iajs-3480	112	16	inflammation	inflammation	NOUN
iajs-3480	112	17	in	in	ADP
iajs-3480	112	18	the	the	DET
iajs-3480	112	19	body	body	NOUN
iajs-3480	112	20	,	,	PUNCT
iajs-3480	112	21	where	where	SCONJ
iajs-3480	112	22	it	it	PRON
iajs-3480	112	23	rise	rise	VERB
iajs-3480	112	24	leads	lead	VERB
iajs-3480	112	25	to	to	ADP
iajs-3480	112	26	a	a	DET
iajs-3480	112	27	positive	positive	ADJ
iajs-3480	112	28	response	response	NOUN
iajs-3480	112	29	in	in	ADP
iajs-3480	112	30	crp	crp	PROPN
iajs-3480	112	31	six	six	NUM
iajs-3480	112	32	hours	hour	NOUN
iajs-3480	112	33	after	after	ADP
iajs-3480	112	34	the	the	DET
iajs-3480	112	35	rise	rise	NOUN
iajs-3480	112	36	of	of	ADP
iajs-3480	112	37	il6	il6	NOUN
iajs-3480	113	1	[	[	X
iajs-3480	113	2	18	18	NUM
iajs-3480	113	3	]	]	PUNCT
iajs-3480	113	4	.	.	PUNCT
iajs-3480	114	1	as	as	ADP
iajs-3480	114	2	for	for	ADP
iajs-3480	114	3	the	the	DET
iajs-3480	114	4	hepcidin	hepcidin	VERB
iajs-3480	114	5	hormone	hormone	NOUN
iajs-3480	114	6	,	,	PUNCT
iajs-3480	114	7	it	it	PRON
iajs-3480	114	8	is	be	AUX
iajs-3480	114	9	a	a	DET
iajs-3480	114	10	response	response	NOUN
iajs-3480	114	11	to	to	ADP
iajs-3480	114	12	the	the	DET
iajs-3480	114	13	rise	rise	NOUN
iajs-3480	114	14	il-6	il-6	NOUN
iajs-3480	114	15	,	,	PUNCT
iajs-3480	114	16	where	where	SCONJ
iajs-3480	114	17	the	the	DET
iajs-3480	114	18	rise	rise	NOUN
iajs-3480	114	19	the	the	DET
iajs-3480	114	20	cytokine	cytokine	NOUN
iajs-3480	114	21	il-6	il-6	NOUN
iajs-3480	114	22	leads	lead	VERB
iajs-3480	114	23	to	to	ADP
iajs-3480	114	24	a	a	DET
iajs-3480	114	25	positive	positive	ADJ
iajs-3480	114	26	response	response	NOUN
iajs-3480	114	27	in	in	ADP
iajs-3480	114	28	the	the	DET
iajs-3480	114	29	hepcidin	hepcidin	VERB
iajs-3480	114	30	hormone	hormone	NOUN
iajs-3480	114	31	,	,	PUNCT
iajs-3480	114	32	therefore	therefore	ADV
iajs-3480	114	33	the	the	DET
iajs-3480	114	34	rise	rise	NOUN
iajs-3480	114	35	of	of	ADP
iajs-3480	114	36	this	this	DET
iajs-3480	114	37	hormone	hormone	NOUN
iajs-3480	114	38	leads	lead	VERB
iajs-3480	114	39	to	to	ADP
iajs-3480	114	40	a	a	DET
iajs-3480	114	41	reduction	reduction	NOUN
iajs-3480	114	42	in	in	ADP
iajs-3480	114	43	the	the	DET
iajs-3480	114	44	proportion	proportion	NOUN
iajs-3480	114	45	of	of	ADP
iajs-3480	114	46	iron	iron	NOUN
iajs-3480	114	47	in	in	ADP
iajs-3480	114	48	the	the	DET
iajs-3480	114	49	body	body	NOUN
iajs-3480	114	50	,	,	PUNCT
iajs-3480	114	51	and	and	CCONJ
iajs-3480	114	52	since	since	SCONJ
iajs-3480	114	53	it	it	PRON
iajs-3480	114	54	responds	respond	VERB
iajs-3480	114	55	to	to	ADP
iajs-3480	114	56	il-6	il-6	PRON
iajs-3480	114	57	,	,	PUNCT
iajs-3480	114	58	this	this	PRON
iajs-3480	114	59	means	mean	VERB
iajs-3480	114	60	that	that	SCONJ
iajs-3480	114	61	there	there	PRON
iajs-3480	114	62	is	be	VERB
iajs-3480	114	63	a	a	DET
iajs-3480	114	64	positive	positive	ADJ
iajs-3480	114	65	response	response	NOUN
iajs-3480	114	66	from	from	ADP
iajs-3480	114	67	this	this	DET
iajs-3480	114	68	hormone	hormone	NOUN
iajs-3480	114	69	to	to	ADP
iajs-3480	114	70	inflammation	inflammation	NOUN
iajs-3480	114	71	in	in	ADP
iajs-3480	114	72	the	the	DET
iajs-3480	114	73	body	body	NOUN
iajs-3480	114	74	[	[	X
iajs-3480	114	75	19	19	NUM
iajs-3480	114	76	]	]	PUNCT
iajs-3480	114	77	.	.	PUNCT
iajs-3480	115	1	3.5	3.5	NUM
iajs-3480	115	2	.	.	PUNCT
iajs-3480	116	1	correlations	correlation	NOUN
iajs-3480	116	2	between	between	ADP
iajs-3480	116	3	thyroids	thyroid	NOUN
iajs-3480	116	4	function	function	NOUN
iajs-3480	116	5	tests	test	NOUN
iajs-3480	116	6	and	and	CCONJ
iajs-3480	116	7	serum	serum	NOUN
iajs-3480	116	8	hepcidin	hepcidin	PROPN
iajs-3480	116	9	and	and	CCONJ
iajs-3480	116	10	crp	crp	PROPN
iajs-3480	116	11	levels	level	NOUN
iajs-3480	116	12	3.5.1	3.5.1	NUM
iajs-3480	116	13	.	.	PUNCT
iajs-3480	117	1	correlations	correlation	NOUN
iajs-3480	117	2	between	between	ADP
iajs-3480	117	3	thyroid	thyroid	NOUN
iajs-3480	117	4	function	function	NOUN
iajs-3480	117	5	tests	test	NOUN
iajs-3480	117	6	with	with	ADP
iajs-3480	117	7	serum	serum	NOUN
iajs-3480	117	8	hepcidin	hepcidin	PROPN
iajs-3480	117	9	and	and	CCONJ
iajs-3480	117	10	crp	crp	PROPN
iajs-3480	117	11	levels	level	NOUN
iajs-3480	117	12	in	in	ADP
iajs-3480	117	13	untreated	untreated	ADJ
iajs-3480	117	14	hypothyroid	hypothyroid	ADJ
iajs-3480	117	15	patients	patient	NOUN
iajs-3480	117	16	the	the	DET
iajs-3480	117	17	correlations	correlation	NOUN
iajs-3480	117	18	between	between	ADP
iajs-3480	117	19	thyroid	thyroid	NOUN
iajs-3480	117	20	function	function	NOUN
iajs-3480	117	21	tests	test	NOUN
iajs-3480	117	22	and	and	CCONJ
iajs-3480	117	23	iron	iron	NOUN
iajs-3480	117	24	hepcidin	hepcidin	VERB
iajs-3480	117	25	levels	level	NOUN
iajs-3480	117	26	in	in	ADP
iajs-3480	117	27	untreated	untreated	ADJ
iajs-3480	117	28	hypothyroid	hypothyroid	ADJ
iajs-3480	117	29	patients	patient	NOUN
iajs-3480	117	30	are	be	AUX
iajs-3480	117	31	presented	present	VERB
iajs-3480	117	32	in	in	ADP
iajs-3480	117	33	table	table	NOUN
iajs-3480	117	34	6	6	NUM
iajs-3480	117	35	.	.	PUNCT
iajs-3480	118	1	according	accord	VERB
iajs-3480	118	2	to	to	ADP
iajs-3480	118	3	the	the	DET
iajs-3480	118	4	results	result	NOUN
iajs-3480	118	5	,	,	PUNCT
iajs-3480	118	6	there	there	PRON
iajs-3480	118	7	were	be	VERB
iajs-3480	118	8	:	:	PUNCT
iajs-3480	118	9			X
iajs-3480	118	10	significant	significant	ADJ
iajs-3480	118	11	positive	positive	ADJ
iajs-3480	118	12	correlation	correlation	NOUN
iajs-3480	118	13	between	between	ADP
iajs-3480	118	14	t3	t3	NOUN
iajs-3480	118	15	and	and	CCONJ
iajs-3480	118	16	hepcidin	hepcidin	ADJ
iajs-3480	118	17	levels	level	NOUN
iajs-3480	118	18	(	(	PUNCT
iajs-3480	118	19	r=0.382	r=0.382	X
iajs-3480	118	20	&	&	CCONJ
iajs-3480	118	21	p=0.037	p=0.037	NOUN
iajs-3480	118	22	)	)	PUNCT
iajs-3480	118	23	(	(	PUNCT
iajs-3480	118	24	figure	figure	NOUN
iajs-3480	118	25	5	5	NUM
iajs-3480	118	26	)	)	PUNCT
iajs-3480	118	27	.	.	PUNCT
iajs-3480	119	1	table	table	NOUN
iajs-3480	119	2	6	6	NUM
iajs-3480	119	3	.	.	PUNCT
iajs-3480	119	4	correlation	correlation	NOUN
iajs-3480	119	5	between	between	ADP
iajs-3480	119	6	thyroid	thyroid	NOUN
iajs-3480	119	7	function	function	NOUN
iajs-3480	119	8	tests	test	NOUN
iajs-3480	119	9	with	with	ADP
iajs-3480	119	10	serum	serum	NOUN
iajs-3480	119	11	iron	iron	NOUN
iajs-3480	119	12	status	status	NOUN
iajs-3480	119	13	,	,	PUNCT
iajs-3480	119	14	hepcidin	hepcidin	ADJ
iajs-3480	119	15	and	and	CCONJ
iajs-3480	119	16	crp	crp	NOUN
iajs-3480	119	17	levels	level	NOUN
iajs-3480	119	18	in	in	ADP
iajs-3480	119	19	untreated	untreated	ADJ
iajs-3480	119	20	hypothyroid	hypothyroid	ADJ
iajs-3480	119	21	patients	patient	NOUN
iajs-3480	119	22	parameters	parameter	NOUN
iajs-3480	119	23	t3	t3	PROPN
iajs-3480	119	24	t4	t4	PROPN
iajs-3480	119	25	tsh	tsh	ADV
iajs-3480	119	26	hepcidin	hepcidin	VERB
iajs-3480	119	27	r	r	NOUN
iajs-3480	119	28	0.382	0.382	NUM
iajs-3480	119	29	*	*	PUNCT
iajs-3480	119	30	0.077	0.077	NUM
iajs-3480	119	31	-0.234	-0.234	PUNCT
iajs-3480	119	32	p	p	NOUN
iajs-3480	119	33	0.037	0.037	NUM
iajs-3480	119	34	0.686	0.686	NUM
iajs-3480	119	35	0.213	0.213	NUM
iajs-3480	119	36	crp	crp	NOUN
iajs-3480	119	37	(	(	PUNCT
iajs-3480	119	38	mg	mg	PROPN
iajs-3480	119	39	/	/	SYM
iajs-3480	119	40	l	l	NOUN
iajs-3480	119	41	)	)	PUNCT
iajs-3480	120	1	r	r	NOUN
iajs-3480	120	2	0.134	0.134	NUM
iajs-3480	120	3	-0.172	-0.172	NOUN
iajs-3480	120	4	-0.224	-0.224	PUNCT
iajs-3480	120	5	p	p	NOUN
iajs-3480	120	6	0.480	0.480	NUM
iajs-3480	120	7	0.362	0.362	NUM
iajs-3480	120	8	0.235	0.235	NUM
iajs-3480	120	9	pearson	pearson	PROPN
iajs-3480	120	10	’s	’s	PART
iajs-3480	120	11	correlation	correlation	NOUN
iajs-3480	120	12	coefficient	coefficient	NOUN
iajs-3480	120	13	;	;	PUNCT
iajs-3480	120	14	t3	t3	NOUN
iajs-3480	120	15	:	:	PUNCT
iajs-3480	120	16	triiodothyronine	triiodothyronine	NOUN
iajs-3480	120	17	;	;	PUNCT
iajs-3480	120	18	t4	t4	PROPN
iajs-3480	120	19	:	:	PUNCT
iajs-3480	120	20	thyroxin	thyroxin	NOUN
iajs-3480	120	21	;	;	PUNCT
iajs-3480	120	22	tsh	tsh	ADJ
iajs-3480	120	23	:	:	PUNCT
iajs-3480	120	24	thyroid	thyroid	NOUN
iajs-3480	120	25	stimulating	stimulate	VERB
iajs-3480	120	26	hormone	hormone	NOUN
iajs-3480	120	27	;	;	PUNCT
iajs-3480	120	28	crp	crp	NOUN
iajs-3480	120	29	:	:	PUNCT
iajs-3480	120	30	creactive	creactive	ADJ
iajs-3480	120	31	protein	protein	NOUN
iajs-3480	120	32	.	.	PUNCT
iajs-3480	121	1	figure	figure	NOUN
iajs-3480	121	2	5	5	NUM
iajs-3480	121	3	.	.	PUNCT
iajs-3480	121	4	correlation	correlation	NOUN
iajs-3480	121	5	between	between	ADP
iajs-3480	121	6	t3	t3	NOUN
iajs-3480	121	7	and	and	CCONJ
iajs-3480	121	8	hepcidin	hepcidin	ADJ
iajs-3480	121	9	levels	level	NOUN
iajs-3480	121	10	in	in	ADP
iajs-3480	121	11	untreated	untreated	ADJ
iajs-3480	121	12	hypothyroid	hypothyroid	ADJ
iajs-3480	121	13	patients	patient	NOUN
iajs-3480	121	14	.	.	PUNCT
iajs-3480	122	1	3.5.2.correlations	3.5.2.correlation	NOUN
iajs-3480	122	2	between	between	ADP
iajs-3480	122	3	thyroid	thyroid	NOUN
iajs-3480	122	4	function	function	NOUN
iajs-3480	122	5	tests	test	NOUN
iajs-3480	122	6	with	with	ADP
iajs-3480	122	7	hepcidin	hepcidin	ADJ
iajs-3480	122	8	and	and	CCONJ
iajs-3480	122	9	crp	crp	PROPN
iajs-3480	122	10	levels	level	NOUN
iajs-3480	122	11	in	in	ADP
iajs-3480	122	12	hypothyroid	hypothyroid	ADJ
iajs-3480	122	13	patients	patient	NOUN
iajs-3480	122	14	treated	treat	VERB
iajs-3480	122	15	with	with	ADP
iajs-3480	122	16	thyroxin	thyroxin	NOUN
iajs-3480	122	17	there	there	PRON
iajs-3480	122	18	were	be	VERB
iajs-3480	122	19	no	no	DET
iajs-3480	122	20	significant	significant	ADJ
iajs-3480	122	21	correlations	correlation	NOUN
iajs-3480	122	22	between	between	ADP
iajs-3480	122	23	thyroid	thyroid	NOUN
iajs-3480	122	24	tests	test	NOUN
iajs-3480	122	25	and	and	CCONJ
iajs-3480	122	26	hepcidin	hepcidin	ADJ
iajs-3480	122	27	levels	level	NOUN
iajs-3480	122	28	,	,	PUNCT
iajs-3480	122	29	as	as	SCONJ
iajs-3480	122	30	demonstrated	demonstrate	VERB
iajs-3480	122	31	in	in	ADP
iajs-3480	122	32	table	table	NOUN
iajs-3480	122	33	7	7	NUM
iajs-3480	122	34	.	.	PUNCT
iajs-3480	122	35	table	table	NOUN
iajs-3480	122	36	7	7	NUM
iajs-3480	122	37	.	.	PUNCT
iajs-3480	122	38	correlation	correlation	NOUN
iajs-3480	122	39	between	between	ADP
iajs-3480	122	40	thyroid	thyroid	NOUN
iajs-3480	122	41	function	function	NOUN
iajs-3480	122	42	tests	test	NOUN
iajs-3480	122	43	with	with	ADP
iajs-3480	122	44	serum	serum	NOUN
iajs-3480	122	45	hepcidin	hepcidin	PROPN
iajs-3480	122	46	and	and	CCONJ
iajs-3480	122	47	crp	crp	PROPN
iajs-3480	122	48	levels	level	NOUN
iajs-3480	122	49	in	in	ADP
iajs-3480	122	50	hypothyroid	hypothyroid	ADJ
iajs-3480	122	51	patients	patient	NOUN
iajs-3480	122	52	treated	treat	VERB
iajs-3480	122	53	with	with	ADP
iajs-3480	122	54	thyroxin	thyroxin	NOUN
iajs-3480	122	55	.	.	PUNCT
iajs-3480	123	1	parameters	parameter	NOUN
iajs-3480	123	2	t3	t3	PROPN
iajs-3480	123	3	t4	t4	PROPN
iajs-3480	123	4	tsh	tsh	ADP
iajs-3480	123	5	hepcidin	hepcidin	ADJ
iajs-3480	123	6	r	r	NOUN
iajs-3480	123	7	-0.141	-0.141	X
iajs-3480	123	8	0.083	0.083	NUM
iajs-3480	123	9	0.080	0.080	NUM
iajs-3480	123	10	p	p	VERB
iajs-3480	123	11	0.457	0.457	NUM
iajs-3480	123	12	0.662	0.662	NUM
iajs-3480	123	13	0.674	0.674	NUM
iajs-3480	123	14	crp	crp	NOUN
iajs-3480	123	15	(	(	PUNCT
iajs-3480	123	16	mg	mg	PROPN
iajs-3480	123	17	/	/	SYM
iajs-3480	123	18	l	l	NOUN
iajs-3480	123	19	)	)	PUNCT
iajs-3480	123	20	r	r	NOUN
iajs-3480	123	21	0.036	0.036	NUM
iajs-3480	123	22	0.189	0.189	NUM
iajs-3480	123	23	0.323	0.323	NUM
iajs-3480	123	24	p	p	NOUN
iajs-3480	123	25	0.851	0.851	NUM
iajs-3480	123	26	0.316	0.316	NUM
iajs-3480	123	27	0.082	0.082	NUM
iajs-3480	123	28	ihjpas	ihjpa	NOUN
iajs-3480	123	29	.	.	PUNCT
iajs-3480	124	1	2024	2024	NUM
iajs-3480	124	2	,	,	PUNCT
iajs-3480	124	3	37(4	37(4	NOUN
iajs-3480	124	4	)	)	PUNCT
iajs-3480	124	5	104	104	NUM
iajs-3480	124	6	pearson	pearson	PROPN
iajs-3480	124	7	’s	’s	PART
iajs-3480	124	8	correlation	correlation	NOUN
iajs-3480	124	9	coefficient	coefficient	NOUN
iajs-3480	124	10	;	;	PUNCT
iajs-3480	124	11	t3	t3	NOUN
iajs-3480	124	12	:	:	PUNCT
iajs-3480	124	13	triiodothyroxin	triiodothyroxin	ADV
iajs-3480	124	14	;	;	PUNCT
iajs-3480	124	15	t4	t4	PROPN
iajs-3480	124	16	:	:	PUNCT
iajs-3480	124	17	thyroxin	thyroxin	NOUN
iajs-3480	124	18	;	;	PUNCT
iajs-3480	124	19	tsh	tsh	ADJ
iajs-3480	124	20	:	:	PUNCT
iajs-3480	124	21	thyroid	thyroid	NOUN
iajs-3480	124	22	stimulating	stimulate	VERB
iajs-3480	124	23	hormone	hormone	NOUN
iajs-3480	124	24	;	;	PUNCT
iajs-3480	124	25	crp	crp	NOUN
iajs-3480	124	26	:	:	PUNCT
iajs-3480	124	27	creactive	creactive	ADJ
iajs-3480	124	28	protein	protein	NOUN
iajs-3480	124	29	3.5.3	3.5.3	NUM
iajs-3480	124	30	.	.	PUNCT
iajs-3480	125	1	correlations	correlation	NOUN
iajs-3480	125	2	between	between	ADP
iajs-3480	125	3	thyroids	thyroid	NOUN
iajs-3480	125	4	function	function	NOUN
iajs-3480	125	5	tests	test	NOUN
iajs-3480	125	6	with	with	ADP
iajs-3480	125	7	serum	serum	NOUN
iajs-3480	125	8	hepcidin	hepcidin	PROPN
iajs-3480	125	9	and	and	CCONJ
iajs-3480	125	10	crp	crp	PROPN
iajs-3480	125	11	levels	level	NOUN
iajs-3480	125	12	in	in	ADP
iajs-3480	125	13	healthy	healthy	ADJ
iajs-3480	125	14	control	control	NOUN
iajs-3480	125	15	group	group	NOUN
iajs-3480	125	16	there	there	PRON
iajs-3480	125	17	were	be	VERB
iajs-3480	125	18	also	also	ADV
iajs-3480	125	19	no	no	DET
iajs-3480	125	20	significant	significant	ADJ
iajs-3480	125	21	correlations	correlation	NOUN
iajs-3480	125	22	between	between	ADP
iajs-3480	125	23	t3	t3	PROPN
iajs-3480	125	24	,	,	PUNCT
iajs-3480	125	25	t4	t4	PROPN
iajs-3480	125	26	,	,	PUNCT
iajs-3480	125	27	tsh	tsh	NOUN
iajs-3480	125	28	,	,	PUNCT
iajs-3480	125	29	hepcidin	hepcidin	NOUN
iajs-3480	125	30	,	,	PUNCT
iajs-3480	125	31	and	and	CCONJ
iajs-3480	125	32	crp	crp	PROPN
iajs-3480	125	33	levels	level	NOUN
iajs-3480	125	34	in	in	ADP
iajs-3480	125	35	healthy	healthy	ADJ
iajs-3480	125	36	subjects	subject	NOUN
iajs-3480	125	37	(	(	PUNCT
iajs-3480	125	38	group	group	NOUN
iajs-3480	125	39	3	3	NUM
iajs-3480	125	40	)	)	PUNCT
iajs-3480	125	41	,	,	PUNCT
iajs-3480	125	42	as	as	SCONJ
iajs-3480	125	43	demonstrated	demonstrate	VERB
iajs-3480	125	44	in	in	ADP
iajs-3480	125	45	table	table	NOUN
iajs-3480	125	46	8	8	NUM
iajs-3480	125	47	.	.	PUNCT
iajs-3480	125	48	table	table	NOUN
iajs-3480	125	49	8	8	NUM
iajs-3480	125	50	.	.	PUNCT
iajs-3480	126	1	correlation	correlation	NOUN
iajs-3480	126	2	between	between	ADP
iajs-3480	126	3	thyroid	thyroid	NOUN
iajs-3480	126	4	function	function	NOUN
iajs-3480	126	5	tests	test	NOUN
iajs-3480	126	6	with	with	ADP
iajs-3480	126	7	serum	serum	NOUN
iajs-3480	126	8	hepcidin	hepcidin	VERB
iajs-3480	126	9	levels	level	NOUN
iajs-3480	126	10	in	in	ADP
iajs-3480	126	11	healthy	healthy	ADJ
iajs-3480	126	12	control	control	NOUN
iajs-3480	126	13	group	group	NOUN
iajs-3480	126	14	.	.	PUNCT
iajs-3480	127	1	parameters	parameter	NOUN
iajs-3480	127	2	t3	t3	PROPN
iajs-3480	127	3	t4	t4	PROPN
iajs-3480	127	4	tsh	tsh	ADV
iajs-3480	127	5	hepcidin	hepcidin	ADJ
iajs-3480	127	6	r	r	NOUN
iajs-3480	127	7	-0.243	-0.243	NOUN
iajs-3480	127	8	-0.043	-0.043	NOUN
iajs-3480	128	1	0.112	0.112	NUM
iajs-3480	128	2	p	p	NOUN
iajs-3480	128	3	0.196	0.196	NUM
iajs-3480	128	4	0.821	0.821	NUM
iajs-3480	128	5	0.554	0.554	NUM
iajs-3480	128	6	crp	crp	NOUN
iajs-3480	128	7	(	(	PUNCT
iajs-3480	128	8	mg	mg	PROPN
iajs-3480	128	9	/	/	SYM
iajs-3480	128	10	l	l	NOUN
iajs-3480	128	11	)	)	PUNCT
iajs-3480	128	12	r	r	NOUN
iajs-3480	128	13	0.053	0.053	NUM
iajs-3480	128	14	0.250	0.250	NUM
iajs-3480	128	15	0.055	0.055	NUM
iajs-3480	128	16	p	p	VERB
iajs-3480	128	17	0.779	0.779	NUM
iajs-3480	128	18	0.183	0.183	NUM
iajs-3480	128	19	0.775	0.775	NUM
iajs-3480	128	20	pearson	pearson	PROPN
iajs-3480	128	21	’s	’s	PART
iajs-3480	128	22	correlation	correlation	NOUN
iajs-3480	128	23	coefficient	coefficient	NOUN
iajs-3480	128	24	;	;	PUNCT
iajs-3480	128	25	t3	t3	NOUN
iajs-3480	128	26	:	:	PUNCT
iajs-3480	128	27	triiodothyroxin	triiodothyroxin	ADV
iajs-3480	128	28	;	;	PUNCT
iajs-3480	128	29	t4	t4	PROPN
iajs-3480	128	30	:	:	PUNCT
iajs-3480	128	31	thyroxin	thyroxin	NOUN
iajs-3480	128	32	;	;	PUNCT
iajs-3480	128	33	tsh	tsh	ADJ
iajs-3480	128	34	:	:	PUNCT
iajs-3480	128	35	thyroid	thyroid	NOUN
iajs-3480	128	36	stimulating	stimulate	VERB
iajs-3480	128	37	hormone	hormone	NOUN
iajs-3480	128	38	;	;	PUNCT
iajs-3480	128	39	crp	crp	NOUN
iajs-3480	128	40	:	:	PUNCT
iajs-3480	128	41	creactive	creactive	ADJ
iajs-3480	128	42	protein	protein	NOUN
iajs-3480	128	43	3.5.4	3.5.4	NUM
iajs-3480	128	44	.	.	PUNCT
iajs-3480	129	1	correlations	correlation	NOUN
iajs-3480	129	2	between	between	ADP
iajs-3480	129	3	hepcidin	hepcidin	VERB
iajs-3480	129	4	with	with	ADP
iajs-3480	129	5	crp	crp	PROPN
iajs-3480	129	6	levels	level	NOUN
iajs-3480	129	7	in	in	ADP
iajs-3480	129	8	untreated	untreated	ADJ
iajs-3480	129	9	hypothyroid	hypothyroid	ADJ
iajs-3480	129	10	patients	patient	NOUN
iajs-3480	129	11	(	(	PUNCT
iajs-3480	129	12	group	group	NOUN
iajs-3480	129	13	1	1	NUM
iajs-3480	129	14	)	)	PUNCT
iajs-3480	129	15	there	there	PRON
iajs-3480	129	16	was	be	VERB
iajs-3480	129	17	positive	positive	ADJ
iajs-3480	129	18	significant	significant	ADJ
iajs-3480	129	19	correlation	correlation	NOUN
iajs-3480	129	20	between	between	ADP
iajs-3480	129	21	serum	serum	NOUN
iajs-3480	129	22	hepcidin	hepcidin	VERB
iajs-3480	129	23	with	with	ADP
iajs-3480	129	24	serum	serum	NOUN
iajs-3480	129	25	crp	crp	PROPN
iajs-3480	129	26	(	(	PUNCT
iajs-3480	129	27	r=0.683	r=0.683	PROPN
iajs-3480	129	28	&	&	CCONJ
iajs-3480	129	29	p	p	X
iajs-3480	129	30	<	<	X
iajs-3480	129	31	0.001	0.001	NUM
iajs-3480	129	32	)	)	PUNCT
iajs-3480	129	33	;	;	PUNCT
iajs-3480	129	34	however	however	ADV
iajs-3480	129	35	serum	serum	PROPN
iajs-3480	129	36	hepcidin	hepcidin	PROPN
iajs-3480	129	37	,	,	PUNCT
iajs-3480	129	38	as	as	SCONJ
iajs-3480	129	39	illustrated	illustrate	VERB
iajs-3480	129	40	in	in	ADP
iajs-3480	129	41	table	table	NOUN
iajs-3480	129	42	9	9	NUM
iajs-3480	129	43	and	and	CCONJ
iajs-3480	129	44	figure	figure	VERB
iajs-3480	129	45	6	6	NUM
iajs-3480	129	46	.	.	PUNCT
iajs-3480	129	47	table	table	NOUN
iajs-3480	129	48	9	9	NUM
iajs-3480	129	49	.	.	PUNCT
iajs-3480	130	1	correlations	correlation	NOUN
iajs-3480	130	2	between	between	ADP
iajs-3480	130	3	hepcidin	hepcidin	VERB
iajs-3480	130	4	and	and	CCONJ
iajs-3480	130	5	crp	crp	NOUN
iajs-3480	130	6	levels	level	NOUN
iajs-3480	130	7	in	in	ADP
iajs-3480	130	8	untreated	untreated	ADJ
iajs-3480	130	9	hypothyroid	hypothyroid	ADJ
iajs-3480	130	10	patients	patient	NOUN
iajs-3480	130	11	.	.	PUNCT
iajs-3480	131	1	correlation	correlation	NOUN
iajs-3480	131	2	between	between	ADP
iajs-3480	131	3	serum	serum	NOUN
iajs-3480	131	4	hepcidin	hepcidin	VERB
iajs-3480	131	5	with	with	ADP
iajs-3480	131	6	pearson	pearson	PROPN
iajs-3480	131	7	’s	’s	PART
iajs-3480	131	8	correlation	correlation	NOUN
iajs-3480	131	9	coefficient	coefficient	NOUN
iajs-3480	131	10	p	p	NOUN
iajs-3480	131	11	value	value	NOUN
iajs-3480	131	12	crp	crp	NOUN
iajs-3480	131	13	0.683	0.683	NUM
iajs-3480	131	14	*	*	PUNCT
iajs-3480	131	15	<	<	X
iajs-3480	131	16	0.001	0.001	NUM
iajs-3480	131	17	crp	crp	NOUN
iajs-3480	131	18	:	:	PUNCT
iajs-3480	131	19	c	c	X
iajs-3480	131	20	-	-	PUNCT
iajs-3480	131	21	reactive	reactive	ADJ
iajs-3480	131	22	protein	protein	NOUN
iajs-3480	131	23	figure	figure	NOUN
iajs-3480	131	24	6	6	NUM
iajs-3480	131	25	.	.	PUNCT
iajs-3480	132	1	correlations	correlation	NOUN
iajs-3480	132	2	between	between	ADP
iajs-3480	132	3	hepcidin	hepcidin	VERB
iajs-3480	132	4	and	and	CCONJ
iajs-3480	132	5	crp	crp	NOUN
iajs-3480	132	6	levels	level	NOUN
iajs-3480	132	7	in	in	ADP
iajs-3480	132	8	untreated	untreated	ADJ
iajs-3480	132	9	hypothyroid	hypothyroid	ADJ
iajs-3480	132	10	patients	patient	NOUN
iajs-3480	132	11	.	.	PUNCT
iajs-3480	133	1	the	the	DET
iajs-3480	133	2	aim	aim	NOUN
iajs-3480	133	3	of	of	ADP
iajs-3480	133	4	this	this	DET
iajs-3480	133	5	study	study	NOUN
iajs-3480	133	6	was	be	AUX
iajs-3480	133	7	to	to	PART
iajs-3480	133	8	measure	measure	VERB
iajs-3480	133	9	hepcidin	hepcidin	VERB
iajs-3480	133	10	in	in	ADP
iajs-3480	133	11	a	a	DET
iajs-3480	133	12	prospective	prospective	ADJ
iajs-3480	133	13	study	study	NOUN
iajs-3480	133	14	of	of	ADP
iajs-3480	133	15	patients	patient	NOUN
iajs-3480	133	16	with	with	ADP
iajs-3480	133	17	newly	newly	ADV
iajs-3480	133	18	diagnosed	diagnose	VERB
iajs-3480	133	19	hypothyroidism	hypothyroidism	NOUN
iajs-3480	133	20	in	in	ADP
iajs-3480	133	21	the	the	DET
iajs-3480	133	22	context	context	NOUN
iajs-3480	133	23	of	of	ADP
iajs-3480	133	24	thyroiditis	thyroiditis	NOUN
iajs-3480	133	25	and	and	CCONJ
iajs-3480	133	26	after	after	ADP
iajs-3480	133	27	successful	successful	ADJ
iajs-3480	133	28	treatment	treatment	NOUN
iajs-3480	133	29	.	.	PUNCT
iajs-3480	134	1	the	the	DET
iajs-3480	134	2	study	study	NOUN
iajs-3480	134	3	consisted	consist	VERB
iajs-3480	134	4	of	of	ADP
iajs-3480	134	5	conducting	conduct	VERB
iajs-3480	134	6	clinical	clinical	ADJ
iajs-3480	134	7	evaluations	evaluation	NOUN
iajs-3480	134	8	and	and	CCONJ
iajs-3480	134	9	tests	test	NOUN
iajs-3480	134	10	.	.	PUNCT
iajs-3480	135	1	the	the	DET
iajs-3480	135	2	study	study	NOUN
iajs-3480	135	3	was	be	AUX
iajs-3480	135	4	found	find	VERB
iajs-3480	135	5	that	that	SCONJ
iajs-3480	135	6	there	there	PRON
iajs-3480	135	7	is	be	VERB
iajs-3480	135	8	a	a	DET
iajs-3480	135	9	positive	positive	ADJ
iajs-3480	135	10	correlation	correlation	NOUN
iajs-3480	135	11	between	between	ADP
iajs-3480	135	12	hypothyroidism	hypothyroidism	NOUN
iajs-3480	135	13	and	and	CCONJ
iajs-3480	135	14	hepcidin	hepcidin	NOUN
iajs-3480	135	15	,	,	PUNCT
iajs-3480	135	16	where	where	SCONJ
iajs-3480	135	17	in	in	ADP
iajs-3480	135	18	group	group	NOUN
iajs-3480	135	19	1	1	NUM
iajs-3480	135	20	patients	patient	NOUN
iajs-3480	135	21	who	who	PRON
iajs-3480	135	22	had	have	VERB
iajs-3480	135	23	a	a	DET
iajs-3480	135	24	decrease	decrease	NOUN
iajs-3480	135	25	in	in	ADP
iajs-3480	135	26	t4	t4	PROPN
iajs-3480	135	27	and	and	CCONJ
iajs-3480	135	28	an	an	DET
iajs-3480	135	29	increase	increase	NOUN
iajs-3480	135	30	in	in	ADP
iajs-3480	135	31	tsh	tsh	NOUN
iajs-3480	135	32	,	,	PUNCT
iajs-3480	135	33	they	they	PRON
iajs-3480	135	34	had	have	VERB
iajs-3480	135	35	a	a	DET
iajs-3480	135	36	rise	rise	NOUN
iajs-3480	135	37	in	in	ADP
iajs-3480	135	38	hepcidin	hepcidin	ADJ
iajs-3480	135	39	rates	rate	NOUN
iajs-3480	135	40	for	for	ADP
iajs-3480	135	41	group	group	NOUN
iajs-3480	135	42	2	2	NUM
iajs-3480	135	43	who	who	PRON
iajs-3480	135	44	were	be	AUX
iajs-3480	135	45	treated	treat	VERB
iajs-3480	135	46	and	and	CCONJ
iajs-3480	135	47	group	group	NOUN
iajs-3480	135	48	3	3	NUM
iajs-3480	135	49	healthy	healthy	ADJ
iajs-3480	135	50	people	people	NOUN
iajs-3480	135	51	,	,	PUNCT
iajs-3480	135	52	and	and	CCONJ
iajs-3480	135	53	it	it	PRON
iajs-3480	135	54	was	be	AUX
iajs-3480	135	55	observed	observe	VERB
iajs-3480	135	56	.	.	PUNCT
iajs-3480	136	1	also	also	ADV
iajs-3480	136	2	,	,	PUNCT
iajs-3480	136	3	a	a	DET
iajs-3480	136	4	decrease	decrease	NOUN
iajs-3480	136	5	in	in	ADP
iajs-3480	136	6	the	the	DET
iajs-3480	136	7	concentration	concentration	NOUN
iajs-3480	136	8	of	of	ADP
iajs-3480	136	9	hepcidin	hepcidin	VERB
iajs-3480	136	10	during	during	ADP
iajs-3480	136	11	the	the	DET
iajs-3480	136	12	transition	transition	NOUN
iajs-3480	136	13	from	from	ADP
iajs-3480	136	14	hypothyroidism	hypothyroidism	NOUN
iajs-3480	136	15	to	to	ADP
iajs-3480	136	16	a	a	DET
iajs-3480	136	17	healthy	healthy	ADJ
iajs-3480	136	18	thyroid	thyroid	NOUN
iajs-3480	136	19	condition	condition	NOUN
iajs-3480	136	20	in	in	ADP
iajs-3480	136	21	patients	patient	NOUN
iajs-3480	136	22	is	be	AUX
iajs-3480	136	23	associated	associate	VERB
iajs-3480	136	24	with	with	ADP
iajs-3480	136	25	the	the	DET
iajs-3480	136	26	observed	observe	VERB
iajs-3480	136	27	dynamics	dynamic	NOUN
iajs-3480	136	28	in	in	ADP
iajs-3480	136	29	the	the	DET
iajs-3480	136	30	iron	iron	NOUN
iajs-3480	136	31	balance	balance	NOUN
iajs-3480	136	32	.	.	PUNCT
iajs-3480	137	1	ihjpas	ihjpas	PROPN
iajs-3480	137	2	.	.	PUNCT
iajs-3480	138	1	2024	2024	NUM
iajs-3480	138	2	,	,	PUNCT
iajs-3480	138	3	37(4	37(4	NOUN
iajs-3480	138	4	)	)	PUNCT
iajs-3480	138	5	105	105	NUM
iajs-3480	138	6	this	this	PRON
iajs-3480	138	7	means	mean	VERB
iajs-3480	138	8	that	that	SCONJ
iajs-3480	138	9	there	there	PRON
iajs-3480	138	10	is	be	VERB
iajs-3480	138	11	a	a	DET
iajs-3480	138	12	positive	positive	ADJ
iajs-3480	138	13	correlation	correlation	NOUN
iajs-3480	138	14	between	between	ADP
iajs-3480	138	15	t3	t3	PROPN
iajs-3480	138	16	and	and	CCONJ
iajs-3480	138	17	t4	t4	PROPN
iajs-3480	138	18	,	,	PUNCT
iajs-3480	138	19	as	as	ADV
iajs-3480	138	20	well	well	ADV
iajs-3480	138	21	as	as	ADP
iajs-3480	138	22	between	between	ADP
iajs-3480	138	23	hepcidin	hepcidin	NOUN
iajs-3480	138	24	,	,	PUNCT
iajs-3480	138	25	in	in	ADP
iajs-3480	138	26	subjects	subject	NOUN
iajs-3480	138	27	with	with	ADP
iajs-3480	138	28	inflammatory	inflammatory	ADJ
iajs-3480	138	29	hypothyroidism	hypothyroidism	NOUN
iajs-3480	138	30	[	[	X
iajs-3480	138	31	20	20	NUM
iajs-3480	138	32	]	]	PUNCT
iajs-3480	138	33	.	.	PUNCT
iajs-3480	139	1	studies	study	NOUN
iajs-3480	139	2	have	have	AUX
iajs-3480	139	3	shown	show	VERB
iajs-3480	139	4	that	that	SCONJ
iajs-3480	139	5	there	there	PRON
iajs-3480	139	6	is	be	VERB
iajs-3480	139	7	a	a	DET
iajs-3480	139	8	link	link	NOUN
iajs-3480	139	9	between	between	ADP
iajs-3480	139	10	the	the	DET
iajs-3480	139	11	hormone	hormone	NOUN
iajs-3480	139	12	hepcidin	hepcidin	NOUN
iajs-3480	139	13	and	and	CCONJ
iajs-3480	139	14	interleukin-6	interleukin-6	NOUN
iajs-3480	139	15	.	.	PUNCT
iajs-3480	140	1	this	this	PRON
iajs-3480	140	2	is	be	AUX
iajs-3480	140	3	because	because	SCONJ
iajs-3480	140	4	interleukin-6	interleukin-6	NUM
iajs-3480	140	5	levels	level	NOUN
iajs-3480	140	6	rise	rise	VERB
iajs-3480	140	7	when	when	SCONJ
iajs-3480	140	8	the	the	DET
iajs-3480	140	9	body	body	NOUN
iajs-3480	140	10	's	's	PART
iajs-3480	140	11	inflammation	inflammation	ADJ
iajs-3480	140	12	level	level	NOUN
iajs-3480	140	13	rises	rise	NOUN
iajs-3480	140	14	,	,	PUNCT
iajs-3480	140	15	so	so	CCONJ
iajs-3480	140	16	the	the	DET
iajs-3480	140	17	rise	rise	NOUN
iajs-3480	140	18	in	in	ADP
iajs-3480	140	19	levels	level	NOUN
iajs-3480	140	20	of	of	ADP
iajs-3480	140	21	this	this	DET
iajs-3480	140	22	cytokine	cytokine	NOUN
iajs-3480	140	23	can	can	AUX
iajs-3480	140	24	be	be	AUX
iajs-3480	140	25	linked	link	VERB
iajs-3480	140	26	to	to	ADP
iajs-3480	140	27	the	the	DET
iajs-3480	140	28	hormone	hormone	NOUN
iajs-3480	140	29	hepcidin	hepcidin	NOUN
iajs-3480	140	30	.	.	PUNCT
iajs-3480	141	1	in	in	ADP
iajs-3480	141	2	addition	addition	NOUN
iajs-3480	141	3	,	,	PUNCT
iajs-3480	141	4	crp	crp	PROPN
iajs-3480	141	5	rises	rise	VERB
iajs-3480	141	6	with	with	ADP
iajs-3480	141	7	an	an	DET
iajs-3480	141	8	increase	increase	NOUN
iajs-3480	141	9	in	in	ADP
iajs-3480	141	10	interleukin-6	interleukin-6	NUM
iajs-3480	141	11	,	,	PUNCT
iajs-3480	141	12	which	which	PRON
iajs-3480	141	13	means	mean	VERB
iajs-3480	141	14	that	that	SCONJ
iajs-3480	141	15	there	there	PRON
iajs-3480	141	16	is	be	VERB
iajs-3480	141	17	a	a	DET
iajs-3480	141	18	possible	possible	ADJ
iajs-3480	141	19	relationship	relationship	NOUN
iajs-3480	141	20	between	between	ADP
iajs-3480	141	21	crp	crp	PROPN
iajs-3480	141	22	and	and	CCONJ
iajs-3480	141	23	hepsidin	hepsidin	ADJ
iajs-3480	141	24	hormone	hormone	NOUN
iajs-3480	141	25	,	,	PUNCT
iajs-3480	141	26	and	and	CCONJ
iajs-3480	141	27	this	this	PRON
iajs-3480	141	28	is	be	AUX
iajs-3480	141	29	what	what	PRON
iajs-3480	141	30	appears	appear	VERB
iajs-3480	141	31	in	in	ADP
iajs-3480	141	32	the	the	DET
iajs-3480	141	33	results	result	NOUN
iajs-3480	141	34	of	of	ADP
iajs-3480	141	35	the	the	DET
iajs-3480	141	36	study	study	NOUN
iajs-3480	141	37	in	in	ADP
iajs-3480	141	38	people	people	NOUN
iajs-3480	141	39	with	with	ADP
iajs-3480	141	40	inflammatory	inflammatory	ADJ
iajs-3480	141	41	hypothyroidism	hypothyroidism	NOUN
iajs-3480	141	42	[	[	X
iajs-3480	141	43	21	21	NUM
iajs-3480	141	44	,	,	PUNCT
iajs-3480	141	45	22	22	NUM
iajs-3480	141	46	]	]	PUNCT
iajs-3480	141	47	.	.	PUNCT
iajs-3480	142	1	also	also	ADV
iajs-3480	142	2	hepcidin	hepcidin	VERB
iajs-3480	142	3	,	,	PUNCT
iajs-3480	142	4	a	a	DET
iajs-3480	142	5	hormone	hormone	NOUN
iajs-3480	142	6	that	that	PRON
iajs-3480	142	7	regulates	regulate	VERB
iajs-3480	142	8	iron	iron	NOUN
iajs-3480	142	9	,	,	PUNCT
iajs-3480	142	10	is	be	AUX
iajs-3480	142	11	a	a	DET
iajs-3480	142	12	promising	promising	ADJ
iajs-3480	142	13	diagnostic	diagnostic	NOUN
iajs-3480	142	14	for	for	ADP
iajs-3480	142	15	distinguishing	distinguish	VERB
iajs-3480	142	16	between	between	ADP
iajs-3480	142	17	iron	iron	NOUN
iajs-3480	142	18	shortage	shortage	NOUN
iajs-3480	142	19	and	and	CCONJ
iajs-3480	142	20	inflammatory	inflammatory	ADJ
iajs-3480	142	21	anemia	anemia	NOUN
iajs-3480	142	22	.	.	PUNCT
iajs-3480	143	1	when	when	SCONJ
iajs-3480	143	2	there	there	PRON
iajs-3480	143	3	is	be	VERB
iajs-3480	143	4	inflammation	inflammation	NOUN
iajs-3480	143	5	,	,	PUNCT
iajs-3480	143	6	both	both	CCONJ
iajs-3480	143	7	the	the	DET
iajs-3480	143	8	amounts	amount	NOUN
iajs-3480	143	9	of	of	ADP
iajs-3480	143	10	smaller	small	ADJ
iajs-3480	143	11	,	,	PUNCT
iajs-3480	143	12	non	non	ADJ
iajs-3480	143	13	-	-	ADJ
iajs-3480	143	14	biologically	biologically	ADV
iajs-3480	143	15	active	active	ADJ
iajs-3480	143	16	hepcidin	hepcidin	ADJ
iajs-3480	143	17	isoforms	isoform	NOUN
iajs-3480	143	18	and	and	CCONJ
iajs-3480	143	19	the	the	DET
iajs-3480	143	20	concentration	concentration	NOUN
iajs-3480	143	21	of	of	ADP
iajs-3480	143	22	hepcidin	hepcidin	VERB
iajs-3480	143	23	in	in	ADP
iajs-3480	143	24	the	the	DET
iajs-3480	143	25	plasma	plasma	NOUN
iajs-3480	143	26	increase	increase	NOUN
iajs-3480	143	27	.	.	PUNCT
iajs-3480	144	1	when	when	SCONJ
iajs-3480	144	2	the	the	DET
iajs-3480	144	3	concentration	concentration	NOUN
iajs-3480	144	4	of	of	ADP
iajs-3480	144	5	hepcidin	hepcidin	ADJ
iajs-3480	144	6	increases	increase	NOUN
iajs-3480	144	7	as	as	ADP
iajs-3480	144	8	a	a	DET
iajs-3480	144	9	result	result	NOUN
iajs-3480	144	10	of	of	ADP
iajs-3480	144	11	inflammation	inflammation	NOUN
iajs-3480	144	12	,	,	PUNCT
iajs-3480	144	13	the	the	DET
iajs-3480	144	14	increased	increase	VERB
iajs-3480	144	15	concentration	concentration	NOUN
iajs-3480	144	16	leads	lead	VERB
iajs-3480	144	17	to	to	ADP
iajs-3480	144	18	a	a	DET
iajs-3480	144	19	reduction	reduction	NOUN
iajs-3480	144	20	in	in	ADP
iajs-3480	144	21	the	the	DET
iajs-3480	144	22	level	level	NOUN
iajs-3480	144	23	of	of	ADP
iajs-3480	144	24	iron	iron	NOUN
iajs-3480	144	25	in	in	ADP
iajs-3480	144	26	the	the	DET
iajs-3480	144	27	body	body	NOUN
iajs-3480	144	28	.	.	PUNCT
iajs-3480	145	1	this	this	PRON
iajs-3480	145	2	implies	imply	VERB
iajs-3480	145	3	a	a	DET
iajs-3480	145	4	correlation	correlation	NOUN
iajs-3480	145	5	between	between	ADP
iajs-3480	145	6	the	the	DET
iajs-3480	145	7	elevated	elevated	ADJ
iajs-3480	145	8	crp	crp	NOUN
iajs-3480	145	9	due	due	ADP
iajs-3480	145	10	to	to	ADP
iajs-3480	145	11	autoimmunity	autoimmunity	NOUN
iajs-3480	145	12	and	and	CCONJ
iajs-3480	145	13	thyroiditis	thyroiditis	NOUN
iajs-3480	145	14	and	and	CCONJ
iajs-3480	145	15	the	the	DET
iajs-3480	145	16	hormone	hormone	NOUN
iajs-3480	145	17	hepsidin	hepsidin	PROPN
iajs-3480	145	18	,	,	PUNCT
iajs-3480	145	19	which	which	PRON
iajs-3480	145	20	regulates	regulate	VERB
iajs-3480	145	21	the	the	DET
iajs-3480	145	22	body	body	NOUN
iajs-3480	145	23	's	's	PART
iajs-3480	145	24	iron	iron	NOUN
iajs-3480	145	25	levels	level	NOUN
iajs-3480	145	26	[	[	X
iajs-3480	145	27	23	23	NUM
iajs-3480	145	28	,	,	PUNCT
iajs-3480	145	29	24	24	NUM
iajs-3480	145	30	]	]	PUNCT
iajs-3480	145	31	.	.	PUNCT
iajs-3480	146	1	also	also	ADV
iajs-3480	146	2	elevated	elevated	ADJ
iajs-3480	146	3	levels	level	NOUN
iajs-3480	146	4	of	of	ADP
iajs-3480	146	5	the	the	DET
iajs-3480	146	6	inflammatory	inflammatory	ADJ
iajs-3480	146	7	markers	marker	NOUN
iajs-3480	146	8	crp	crp	PROPN
iajs-3480	146	9	and	and	CCONJ
iajs-3480	146	10	il-6	il-6	NOUN
iajs-3480	146	11	are	be	AUX
iajs-3480	146	12	associated	associate	VERB
iajs-3480	146	13	with	with	ADP
iajs-3480	146	14	subclinical	subclinical	ADJ
iajs-3480	146	15	hypothyroidism	hypothyroidism	NOUN
iajs-3480	146	16	.	.	PUNCT
iajs-3480	147	1	therefore	therefore	ADV
iajs-3480	147	2	,	,	PUNCT
iajs-3480	147	3	individuals	individual	NOUN
iajs-3480	147	4	directly	directly	ADV
iajs-3480	147	5	linked	link	VERB
iajs-3480	147	6	to	to	ADP
iajs-3480	147	7	the	the	DET
iajs-3480	147	8	hepcidin	hepcidin	VERB
iajs-3480	147	9	hormone	hormone	NOUN
iajs-3480	147	10	exhibit	exhibit	VERB
iajs-3480	147	11	a	a	DET
iajs-3480	147	12	positive	positive	ADJ
iajs-3480	147	13	correlation	correlation	NOUN
iajs-3480	147	14	between	between	ADP
iajs-3480	147	15	elevated	elevate	VERB
iajs-3480	147	16	inflammatory	inflammatory	ADJ
iajs-3480	147	17	markers	marker	NOUN
iajs-3480	147	18	and	and	CCONJ
iajs-3480	147	19	elevated	elevated	ADJ
iajs-3480	147	20	hepcidin	hepcidin	ADJ
iajs-3480	147	21	levels	level	NOUN
iajs-3480	147	22	in	in	ADP
iajs-3480	147	23	subclinical	subclinical	ADJ
iajs-3480	147	24	hypothyroidism	hypothyroidism	NOUN
iajs-3480	148	1	[	[	X
iajs-3480	148	2	25	25	NUM
iajs-3480	148	3	,	,	PUNCT
iajs-3480	148	4	26	26	NUM
iajs-3480	148	5	]	]	PUNCT
iajs-3480	148	6	.	.	PUNCT
iajs-3480	149	1	in	in	ADP
iajs-3480	149	2	another	another	DET
iajs-3480	149	3	study	study	NOUN
iajs-3480	149	4	,	,	PUNCT
iajs-3480	149	5	a	a	DET
iajs-3480	149	6	correlation	correlation	NOUN
iajs-3480	149	7	was	be	AUX
iajs-3480	149	8	shown	show	VERB
iajs-3480	149	9	between	between	ADP
iajs-3480	149	10	patients	patient	NOUN
iajs-3480	149	11	with	with	ADP
iajs-3480	149	12	hashimoto	hashimoto	NOUN
iajs-3480	149	13	's	's	PART
iajs-3480	149	14	thyroiditis	thyroiditis	NOUN
iajs-3480	149	15	and	and	CCONJ
iajs-3480	149	16	elevated	elevated	ADJ
iajs-3480	149	17	il6	il6	NOUN
iajs-3480	149	18	and	and	CCONJ
iajs-3480	149	19	crp	crp	PROPN
iajs-3480	149	20	,	,	PUNCT
iajs-3480	149	21	as	as	SCONJ
iajs-3480	149	22	we	we	PRON
iajs-3480	149	23	mentioned	mention	VERB
iajs-3480	149	24	earlier	early	ADV
iajs-3480	149	25	,	,	PUNCT
iajs-3480	149	26	and	and	CCONJ
iajs-3480	149	27	the	the	DET
iajs-3480	149	28	results	result	NOUN
iajs-3480	149	29	of	of	ADP
iajs-3480	149	30	this	this	DET
iajs-3480	149	31	research	research	NOUN
iajs-3480	149	32	confirm	confirm	VERB
iajs-3480	149	33	a	a	DET
iajs-3480	149	34	positive	positive	ADJ
iajs-3480	149	35	relationship	relationship	NOUN
iajs-3480	149	36	between	between	ADP
iajs-3480	149	37	hypothyroidism	hypothyroidism	NOUN
iajs-3480	149	38	and	and	CCONJ
iajs-3480	149	39	elevated	elevated	ADJ
iajs-3480	149	40	crp	crp	PROPN
iajs-3480	149	41	and	and	CCONJ
iajs-3480	149	42	il6	il6	PROPN
iajs-3480	149	43	,	,	PUNCT
iajs-3480	149	44	which	which	PRON
iajs-3480	149	45	are	be	AUX
iajs-3480	149	46	also	also	ADV
iajs-3480	149	47	positively	positively	ADV
iajs-3480	149	48	associated	associate	VERB
iajs-3480	149	49	with	with	ADP
iajs-3480	149	50	the	the	DET
iajs-3480	149	51	hormone	hormone	NOUN
iajs-3480	149	52	that	that	PRON
iajs-3480	149	53	controls	control	VERB
iajs-3480	149	54	the	the	DET
iajs-3480	149	55	level	level	NOUN
iajs-3480	149	56	of	of	ADP
iajs-3480	149	57	iron	iron	NOUN
iajs-3480	149	58	.	.	PUNCT
iajs-3480	150	1	it	it	PRON
iajs-3480	150	2	's	be	AUX
iajs-3480	150	3	called	call	VERB
iajs-3480	150	4	hepcidin	hepcidin	NOUN
iajs-3480	150	5	[	[	X
iajs-3480	150	6	27	27	NUM
iajs-3480	150	7	,	,	PUNCT
iajs-3480	150	8	28	28	NUM
iajs-3480	150	9	]	]	PUNCT
iajs-3480	150	10	.	.	PUNCT
iajs-3480	151	1	another	another	DET
iajs-3480	151	2	study	study	NOUN
iajs-3480	151	3	confirmed	confirm	VERB
iajs-3480	151	4	that	that	SCONJ
iajs-3480	151	5	people	people	NOUN
iajs-3480	151	6	with	with	ADP
iajs-3480	151	7	hypothyroidism	hypothyroidism	NOUN
iajs-3480	151	8	due	due	ADP
iajs-3480	151	9	to	to	ADP
iajs-3480	151	10	hashimoto	hashimoto	NOUN
iajs-3480	151	11	's	's	PART
iajs-3480	151	12	disease	disease	NOUN
iajs-3480	151	13	had	have	VERB
iajs-3480	151	14	an	an	DET
iajs-3480	151	15	increase	increase	NOUN
iajs-3480	151	16	in	in	ADP
iajs-3480	151	17	the	the	DET
iajs-3480	151	18	inflammatory	inflammatory	ADJ
iajs-3480	151	19	indicators	indicator	NOUN
iajs-3480	151	20	crp	crp	NOUN
iajs-3480	151	21	and	and	CCONJ
iajs-3480	151	22	il6	il6	PROPN
iajs-3480	151	23	,	,	PUNCT
iajs-3480	151	24	and	and	CCONJ
iajs-3480	151	25	after	after	ADP
iajs-3480	151	26	treatment	treatment	NOUN
iajs-3480	151	27	with	with	ADP
iajs-3480	151	28	levothyroxine	levothyroxine	NOUN
iajs-3480	151	29	,	,	PUNCT
iajs-3480	151	30	the	the	DET
iajs-3480	151	31	rate	rate	NOUN
iajs-3480	151	32	of	of	ADP
iajs-3480	151	33	inflammation	inflammation	NOUN
iajs-3480	151	34	in	in	ADP
iajs-3480	151	35	the	the	DET
iajs-3480	151	36	thyroid	thyroid	NOUN
iajs-3480	151	37	gland	gland	NOUN
iajs-3480	151	38	and	and	CCONJ
iajs-3480	151	39	the	the	DET
iajs-3480	151	40	inflammatory	inflammatory	ADJ
iajs-3480	151	41	indicators	indicator	NOUN
iajs-3480	151	42	crp	crp	PROPN
iajs-3480	151	43	and	and	CCONJ
iajs-3480	151	44	il6	il6	NOUN
iajs-3480	151	45	significantly	significantly	ADV
iajs-3480	151	46	decreased	decrease	VERB
iajs-3480	151	47	[	[	X
iajs-3480	151	48	29	29	NUM
iajs-3480	151	49	,	,	PUNCT
iajs-3480	151	50	30	30	NUM
iajs-3480	151	51	]	]	PUNCT
iajs-3480	151	52	.	.	PUNCT
iajs-3480	152	1	4	4	X
iajs-3480	152	2	.	.	X
iajs-3480	152	3	conclusions	conclusion	NOUN
iajs-3480	152	4	the	the	DET
iajs-3480	152	5	current	current	ADJ
iajs-3480	152	6	study	study	NOUN
iajs-3480	152	7	yielded	yield	VERB
iajs-3480	152	8	the	the	DET
iajs-3480	152	9	following	follow	VERB
iajs-3480	152	10	conclusions	conclusion	NOUN
iajs-3480	152	11	:	:	PUNCT
iajs-3480	152	12	women	woman	NOUN
iajs-3480	152	13	had	have	VERB
iajs-3480	152	14	a	a	DET
iajs-3480	152	15	higher	high	ADJ
iajs-3480	152	16	risk	risk	NOUN
iajs-3480	152	17	of	of	ADP
iajs-3480	152	18	hyperthyroidism	hyperthyroidism	NOUN
iajs-3480	152	19	than	than	ADP
iajs-3480	152	20	men	man	NOUN
iajs-3480	152	21	.	.	PUNCT
iajs-3480	153	1	t3	t3	PROPN
iajs-3480	153	2	and	and	CCONJ
iajs-3480	153	3	t4	t4	PROPN
iajs-3480	153	4	decreased	decrease	VERB
iajs-3480	153	5	,	,	PUNCT
iajs-3480	153	6	whereas	whereas	SCONJ
iajs-3480	153	7	tsh	tsh	NOUN
iajs-3480	153	8	increased	increase	VERB
iajs-3480	153	9	in	in	ADP
iajs-3480	153	10	hypothyroid	hypothyroid	ADJ
iajs-3480	153	11	patients	patient	NOUN
iajs-3480	153	12	with	with	ADP
iajs-3480	153	13	clinical	clinical	ADJ
iajs-3480	153	14	hypothyroidism	hypothyroidism	NOUN
iajs-3480	153	15	and	and	CCONJ
iajs-3480	153	16	thyroidite	thyroidite	ADJ
iajs-3480	153	17	auto	auto	NOUN
iajs-3480	153	18	-	-	PUNCT
iajs-3480	153	19	immune	immune	ADJ
iajs-3480	153	20	hashimoto	hashimoto	NOUN
iajs-3480	153	21	.	.	PUNCT
iajs-3480	154	1	t3	t3	PROPN
iajs-3480	154	2	and	and	CCONJ
iajs-3480	154	3	t4	t4	PROPN
iajs-3480	154	4	increased	increase	VERB
iajs-3480	154	5	while	while	SCONJ
iajs-3480	154	6	tsh	tsh	NOUN
iajs-3480	154	7	decreased	decrease	VERB
iajs-3480	154	8	in	in	ADP
iajs-3480	154	9	hypothyroid	hypothyroid	ADJ
iajs-3480	154	10	patients	patient	NOUN
iajs-3480	154	11	treated	treat	VERB
iajs-3480	154	12	with	with	ADP
iajs-3480	154	13	the	the	DET
iajs-3480	154	14	levothyroxine	levothyroxine	NOUN
iajs-3480	154	15	drug	drug	NOUN
iajs-3480	154	16	.	.	PUNCT
iajs-3480	155	1	additionally	additionally	ADV
iajs-3480	155	2	,	,	PUNCT
iajs-3480	155	3	hypothyroid	hypothyroid	ADJ
iajs-3480	155	4	patients	patient	NOUN
iajs-3480	155	5	experienced	experience	VERB
iajs-3480	155	6	an	an	DET
iajs-3480	155	7	increase	increase	NOUN
iajs-3480	155	8	in	in	ADP
iajs-3480	155	9	crp	crp	PROPN
iajs-3480	155	10	levels	level	NOUN
iajs-3480	155	11	,	,	PUNCT
iajs-3480	155	12	which	which	PRON
iajs-3480	155	13	subsequently	subsequently	ADV
iajs-3480	155	14	decreased	decrease	VERB
iajs-3480	155	15	after	after	ADP
iajs-3480	155	16	a	a	DET
iajs-3480	155	17	year	year	NOUN
iajs-3480	155	18	or	or	CCONJ
iajs-3480	155	19	less	less	ADJ
iajs-3480	155	20	of	of	ADP
iajs-3480	155	21	levothyroxine	levothyroxine	NOUN
iajs-3480	155	22	treatment	treatment	NOUN
iajs-3480	155	23	.	.	PUNCT
iajs-3480	156	1	hypothyroid	hypothyroid	ADJ
iajs-3480	156	2	patients	patient	NOUN
iajs-3480	156	3	experienced	experience	VERB
iajs-3480	156	4	an	an	DET
iajs-3480	156	5	increase	increase	NOUN
iajs-3480	156	6	in	in	ADP
iajs-3480	156	7	hepcidin	hepcidin	ADJ
iajs-3480	156	8	levels	level	NOUN
iajs-3480	156	9	,	,	PUNCT
iajs-3480	156	10	which	which	PRON
iajs-3480	156	11	continued	continue	VERB
iajs-3480	156	12	to	to	PART
iajs-3480	156	13	decrease	decrease	VERB
iajs-3480	156	14	after	after	ADP
iajs-3480	156	15	treatment	treatment	NOUN
iajs-3480	156	16	with	with	ADP
iajs-3480	156	17	the	the	DET
iajs-3480	156	18	levothyroxine	levothyroxine	NOUN
iajs-3480	156	19	drug	drug	NOUN
iajs-3480	156	20	.	.	PUNCT
iajs-3480	157	1	studies	study	NOUN
iajs-3480	157	2	have	have	AUX
iajs-3480	157	3	also	also	ADV
iajs-3480	157	4	shown	show	VERB
iajs-3480	157	5	that	that	SCONJ
iajs-3480	157	6	levothyroxine	levothyroxine	NOUN
iajs-3480	157	7	has	have	VERB
iajs-3480	157	8	a	a	DET
iajs-3480	157	9	positive	positive	ADJ
iajs-3480	157	10	effect	effect	NOUN
iajs-3480	157	11	on	on	ADP
iajs-3480	157	12	hepcidin	hepcidin	VERB
iajs-3480	157	13	in	in	ADP
iajs-3480	157	14	treated	treat	VERB
iajs-3480	157	15	patients	patient	NOUN
iajs-3480	157	16	.	.	PUNCT
iajs-3480	158	1	the	the	DET
iajs-3480	158	2	results	result	NOUN
iajs-3480	158	3	indicated	indicate	VERB
iajs-3480	158	4	an	an	DET
iajs-3480	158	5	increase	increase	NOUN
iajs-3480	158	6	in	in	ADP
iajs-3480	158	7	hepcidin	hepcidin	VERB
iajs-3480	158	8	and	and	CCONJ
iajs-3480	158	9	c	c	NOUN
iajs-3480	158	10	-	-	PUNCT
iajs-3480	158	11	reactive	reactive	ADJ
iajs-3480	158	12	protein	protein	NOUN
iajs-3480	158	13	levels	level	NOUN
iajs-3480	158	14	in	in	ADP
iajs-3480	158	15	patients	patient	NOUN
iajs-3480	158	16	with	with	ADP
iajs-3480	158	17	untreated	untreated	ADJ
iajs-3480	158	18	hypothyroidism	hypothyroidism	NOUN
iajs-3480	158	19	,	,	PUNCT
iajs-3480	158	20	which	which	PRON
iajs-3480	158	21	is	be	AUX
iajs-3480	158	22	caused	cause	VERB
iajs-3480	158	23	by	by	ADP
iajs-3480	158	24	autoimmunity	autoimmunity	NOUN
iajs-3480	158	25	,	,	PUNCT
iajs-3480	158	26	such	such	ADJ
iajs-3480	158	27	as	as	ADP
iajs-3480	158	28	hashimoto	hashimoto	NOUN
iajs-3480	158	29	disease	disease	NOUN
iajs-3480	158	30	,	,	PUNCT
iajs-3480	158	31	or	or	CCONJ
iajs-3480	158	32	subclinical	subclinical	ADJ
iajs-3480	158	33	hypothyroidism	hypothyroidism	NOUN
iajs-3480	158	34	.	.	PUNCT
iajs-3480	159	1	these	these	DET
iajs-3480	159	2	conditions	condition	NOUN
iajs-3480	159	3	are	be	AUX
iajs-3480	159	4	the	the	DET
iajs-3480	159	5	most	most	ADV
iajs-3480	159	6	common	common	ADJ
iajs-3480	159	7	causes	cause	NOUN
iajs-3480	159	8	of	of	ADP
iajs-3480	159	9	hypothyroidism	hypothyroidism	NOUN
iajs-3480	159	10	,	,	PUNCT
iajs-3480	159	11	and	and	CCONJ
iajs-3480	159	12	they	they	PRON
iajs-3480	159	13	are	be	AUX
iajs-3480	159	14	associated	associate	VERB
iajs-3480	159	15	with	with	ADP
iajs-3480	159	16	high	high	ADJ
iajs-3480	159	17	levels	level	NOUN
iajs-3480	159	18	of	of	ADP
iajs-3480	159	19	inflammation	inflammation	NOUN
iajs-3480	159	20	,	,	PUNCT
iajs-3480	159	21	which	which	PRON
iajs-3480	159	22	are	be	AUX
iajs-3480	159	23	linked	link	VERB
iajs-3480	159	24	to	to	ADP
iajs-3480	159	25	high	high	ADJ
iajs-3480	159	26	crp	crp	PROPN
iajs-3480	159	27	and	and	CCONJ
iajs-3480	159	28	hepcidin	hepcidin	NOUN
iajs-3480	159	29	.	.	PUNCT
iajs-3480	160	1	however	however	ADV
iajs-3480	160	2	,	,	PUNCT
iajs-3480	160	3	the	the	DET
iajs-3480	160	4	results	result	NOUN
iajs-3480	160	5	also	also	ADV
iajs-3480	160	6	showed	show	VERB
iajs-3480	160	7	a	a	DET
iajs-3480	160	8	decrease	decrease	NOUN
iajs-3480	160	9	in	in	ADP
iajs-3480	160	10	hepcidin	hepcidin	ADJ
iajs-3480	160	11	and	and	CCONJ
iajs-3480	160	12	protein	protein	NOUN
iajs-3480	160	13	levels	level	NOUN
iajs-3480	160	14	after	after	ADP
iajs-3480	160	15	treatment	treatment	NOUN
iajs-3480	160	16	.	.	PUNCT
iajs-3480	161	1	after	after	ADP
iajs-3480	161	2	treatment	treatment	NOUN
iajs-3480	161	3	,	,	PUNCT
iajs-3480	161	4	the	the	DET
iajs-3480	161	5	drug	drug	NOUN
iajs-3480	161	6	levothyroxine	levothyroxine	NOUN
iajs-3480	161	7	reduced	reduce	VERB
iajs-3480	161	8	the	the	DET
iajs-3480	161	9	rate	rate	NOUN
iajs-3480	161	10	of	of	ADP
iajs-3480	161	11	inflammation	inflammation	NOUN
iajs-3480	161	12	resulting	result	VERB
iajs-3480	161	13	from	from	ADP
iajs-3480	161	14	hypothyroidism	hypothyroidism	NOUN
iajs-3480	161	15	.	.	PUNCT
iajs-3480	162	1	acknowledgment	acknowledgment	NOUN
iajs-3480	162	2	many	many	ADJ
iajs-3480	162	3	thanks	thank	NOUN
iajs-3480	162	4	to	to	ADP
iajs-3480	162	5	editor	editor	NOUN
iajs-3480	162	6	-	-	PUNCT
iajs-3480	162	7	in	in	ADP
iajs-3480	162	8	-	-	PUNCT
iajs-3480	162	9	chief	chief	NOUN
iajs-3480	162	10	and	and	CCONJ
iajs-3480	162	11	members	member	NOUN
iajs-3480	162	12	of	of	ADP
iajs-3480	162	13	the	the	DET
iajs-3480	162	14	editorial	editorial	ADJ
iajs-3480	162	15	committee	committee	NOUN
iajs-3480	162	16	in	in	ADP
iajs-3480	162	17	ibn	ibn	PROPN
iajs-3480	162	18	al	al	PROPN
iajs-3480	162	19	-	-	PUNCT
iajs-3480	162	20	haitham	haitham	PROPN
iajs-3480	162	21	journal	journal	PROPN
iajs-3480	162	22	for	for	ADP
iajs-3480	162	23	pure	pure	ADJ
iajs-3480	162	24	and	and	CCONJ
iajs-3480	162	25	applied	applied	ADJ
iajs-3480	162	26	sciences	science	NOUN
iajs-3480	162	27	.	.	PUNCT
iajs-3480	163	1	ihjpas	ihjpas	PROPN
iajs-3480	163	2	.	.	PUNCT
iajs-3480	164	1	2024	2024	NUM
iajs-3480	164	2	,	,	PUNCT
iajs-3480	164	3	37(4	37(4	NOUN
iajs-3480	164	4	)	)	PUNCT
iajs-3480	164	5	106	106	NUM
iajs-3480	164	6	conflict	conflict	NOUN
iajs-3480	164	7	of	of	ADP
iajs-3480	164	8	interest	interest	NOUN
iajs-3480	164	9	there	there	PRON
iajs-3480	164	10	is	be	VERB
iajs-3480	164	11	no	no	DET
iajs-3480	164	12	conflict	conflict	NOUN
iajs-3480	164	13	of	of	ADP
iajs-3480	164	14	interest	interest	NOUN
iajs-3480	164	15	.	.	PUNCT
iajs-3480	165	1	funding	funding	NOUN
iajs-3480	165	2	there	there	PRON
iajs-3480	165	3	is	be	VERB
iajs-3480	165	4	no	no	DET
iajs-3480	165	5	funding	funding	NOUN
iajs-3480	165	6	for	for	ADP
iajs-3480	165	7	the	the	DET
iajs-3480	165	8	article	article	NOUN
iajs-3480	165	9	.	.	PUNCT
iajs-3480	166	1	references	reference	NOUN
iajs-3480	166	2	1	1	NUM
iajs-3480	166	3	.	.	PUNCT
iajs-3480	166	4	chaker	chaker	PROPN
iajs-3480	166	5	,	,	PUNCT
iajs-3480	166	6	l.	l.	PROPN
iajs-3480	166	7	;	;	PUNCT
iajs-3480	166	8	razvi	razvi	VERB
iajs-3480	166	9	,	,	PUNCT
iajs-3480	166	10	s.	s.	PROPN
iajs-3480	166	11	;	;	PUNCT
iajs-3480	166	12	bensenor	bensenor	PROPN
iajs-3480	166	13	,	,	PUNCT
iajs-3480	166	14	i.m	i.m	PROPN
iajs-3480	166	15	.	.	PROPN
iajs-3480	166	16	;	;	PUNCT
iajs-3480	167	1	azizi	azizi	PROPN
iajs-3480	167	2	,	,	PUNCT
iajs-3480	167	3	f	f	PROPN
iajs-3480	167	4	;	;	PUNCT
iajs-3480	167	5	,	,	PUNCT
iajs-3480	167	6	pearce	pearce	PROPN
iajs-3480	167	7	,	,	PUNCT
iajs-3480	167	8	e.n	e.n	PROPN
iajs-3480	167	9	.	.	PROPN
iajs-3480	167	10	;	;	PUNCT
iajs-3480	167	11	peeters	peeter	NOUN
iajs-3480	167	12	,	,	PUNCT
iajs-3480	167	13	r.p	r.p	PROPN
iajs-3480	167	14	.	.	PROPN
iajs-3480	167	15	hypothyroidism	hypothyroidism	PROPN
iajs-3480	167	16	nature	nature	NOUN
iajs-3480	167	17	reviews	review	VERB
iajs-3480	167	18	disease	disease	NOUN
iajs-3480	167	19	primers	primer	NOUN
iajs-3480	167	20	2022	2022	NUM
iajs-3480	167	21	,	,	PUNCT
iajs-3480	167	22	8(1	8(1	NOUN
iajs-3480	167	23	)	)	PUNCT
iajs-3480	167	24	,	,	PUNCT
iajs-3480	167	25	30	30	NUM
iajs-3480	167	26	.	.	PUNCT
iajs-3480	167	27	https://doi.org/10.1038/s41572-022-00357-7	https://doi.org/10.1038/s41572-022-00357-7	NUM
iajs-3480	167	28	.	.	PUNCT
iajs-3480	168	1	2	2	X
iajs-3480	168	2	.	.	X
iajs-3480	169	1	hughes	hughe	NOUN
iajs-3480	169	2	,	,	PUNCT
iajs-3480	169	3	k.	k.	PROPN
iajs-3480	169	4	;	;	PUNCT
iajs-3480	169	5	eastman	eastman	PROPN
iajs-3480	169	6	,	,	PUNCT
iajs-3480	169	7	c.	c.	PROPN
iajs-3480	169	8	thyroid	thyroid	PROPN
iajs-3480	169	9	disease	disease	NOUN
iajs-3480	169	10	:	:	PUNCT
iajs-3480	169	11	long	long	ADJ
iajs-3480	169	12	-	-	PUNCT
iajs-3480	169	13	term	term	NOUN
iajs-3480	169	14	management	management	NOUN
iajs-3480	169	15	of	of	ADP
iajs-3480	169	16	hyperthyroidism	hyperthyroidism	NOUN
iajs-3480	169	17	and	and	CCONJ
iajs-3480	169	18	hypothyroidism	hypothyroidism	NOUN
iajs-3480	169	19	.	.	PUNCT
iajs-3480	170	1	australian	australian	ADJ
iajs-3480	170	2	journal	journal	NOUN
iajs-3480	170	3	of	of	ADP
iajs-3480	170	4	general	general	ADJ
iajs-3480	170	5	practice	practice	NOUN
iajs-3480	170	6	2021	2021	NUM
iajs-3480	170	7	,	,	PUNCT
iajs-3480	170	8	50(1	50(1	NUM
iajs-3480	170	9	-	-	SYM
iajs-3480	170	10	2	2	NUM
iajs-3480	170	11	)	)	PUNCT
iajs-3480	170	12	,	,	PUNCT
iajs-3480	170	13	36	36	NUM
iajs-3480	170	14	–	–	SYM
iajs-3480	170	15	42	42	NUM
iajs-3480	170	16	.	.	PUNCT
iajs-3480	171	1	https://doi.org/10.31128/ajgp-09-20-5653	https://doi.org/10.31128/ajgp-09-20-5653	X
iajs-3480	171	2	.	.	NOUN
iajs-3480	172	1	3	3	X
iajs-3480	172	2	.	.	X
iajs-3480	172	3	lei	lei	PROPN
iajs-3480	172	4	,	,	PUNCT
iajs-3480	172	5	y.	y.	PROPN
iajs-3480	172	6	;	;	PUNCT
iajs-3480	172	7	yang	yang	PROPN
iajs-3480	172	8	,	,	PUNCT
iajs-3480	172	9	j.	j.	PROPN
iajs-3480	172	10	;	;	PUNCT
iajs-3480	172	11	li	li	PROPN
iajs-3480	172	12	,	,	PUNCT
iajs-3480	172	13	h.	h.	PROPN
iajs-3480	172	14	;	;	PUNCT
iajs-3480	172	15	zhong	zhong	PROPN
iajs-3480	172	16	,	,	PUNCT
iajs-3480	172	17	h.	h.	PROPN
iajs-3480	172	18	;	;	PUNCT
iajs-3480	172	19	wan	wan	PROPN
iajs-3480	172	20	,	,	PUNCT
iajs-3480	172	21	q.	q.	PROPN
iajs-3480	172	22	changes	change	NOUN
iajs-3480	172	23	in	in	ADP
iajs-3480	172	24	glucose	glucose	NOUN
iajs-3480	172	25	-	-	PUNCT
iajs-3480	172	26	lipid	lipid	NOUN
iajs-3480	172	27	metabolism	metabolism	NOUN
iajs-3480	172	28	,	,	PUNCT
iajs-3480	172	29	insulin	insulin	NOUN
iajs-3480	172	30	resistance	resistance	NOUN
iajs-3480	172	31	,	,	PUNCT
iajs-3480	172	32	and	and	CCONJ
iajs-3480	172	33	inflammatory	inflammatory	ADJ
iajs-3480	172	34	factors	factor	NOUN
iajs-3480	172	35	in	in	ADP
iajs-3480	172	36	patients	patient	NOUN
iajs-3480	172	37	with	with	ADP
iajs-3480	172	38	autoimmune	autoimmune	ADJ
iajs-3480	172	39	thyroid	thyroid	NOUN
iajs-3480	172	40	disease	disease	NOUN
iajs-3480	172	41	.	.	PUNCT
iajs-3480	173	1	journal	journal	NOUN
iajs-3480	173	2	of	of	ADP
iajs-3480	173	3	clinical	clinical	ADJ
iajs-3480	173	4	laboratory	laboratory	NOUN
iajs-3480	173	5	analysis	analysis	NOUN
iajs-3480	173	6	2019	2019	NUM
iajs-3480	173	7	,	,	PUNCT
iajs-3480	173	8	33(7	33(7	NUM
iajs-3480	173	9	)	)	PUNCT
iajs-3480	173	10	,	,	PUNCT
iajs-3480	173	11	e22929	e22929	NOUN
iajs-3480	173	12	.	.	PUNCT
iajs-3480	174	1	https://doi.org/10.1002/jcla.22929	https://doi.org/10.1002/jcla.22929	NOUN
iajs-3480	174	2	.	.	PUNCT
iajs-3480	175	1	4	4	X
iajs-3480	175	2	.	.	X
iajs-3480	175	3	kwiatek	kwiatek	PROPN
iajs-3480	175	4	-	-	PUNCT
iajs-3480	175	5	majkusiak	majkusiak	PROPN
iajs-3480	175	6	,	,	PUNCT
iajs-3480	175	7	j.	j.	PROPN
iajs-3480	175	8	;	;	PUNCT
iajs-3480	175	9	geremek	geremek	NOUN
iajs-3480	175	10	,	,	PUNCT
iajs-3480	175	11	m.	m.	NOUN
iajs-3480	175	12	;	;	PUNCT
iajs-3480	175	13	koziorowski	koziorowski	PROPN
iajs-3480	175	14	,	,	PUNCT
iajs-3480	175	15	d.	d.	PROPN
iajs-3480	175	16	;	;	PUNCT
iajs-3480	175	17	tomasiuk	tomasiuk	NOUN
iajs-3480	175	18	,	,	PUNCT
iajs-3480	175	19	r.	r.	PROPN
iajs-3480	175	20	;	;	PUNCT
iajs-3480	175	21	szlufik	szlufik	NOUN
iajs-3480	175	22	,	,	PUNCT
iajs-3480	175	23	s.	s.	PROPN
iajs-3480	175	24	;	;	PUNCT
iajs-3480	175	25	friedman	friedman	PROPN
iajs-3480	175	26	,	,	PUNCT
iajs-3480	175	27	a.	a.	NOUN
iajs-3480	175	28	serum	serum	PROPN
iajs-3480	175	29	levels	level	NOUN
iajs-3480	175	30	of	of	ADP
iajs-3480	175	31	hepcidin	hepcidin	NOUN
iajs-3480	175	32	and	and	CCONJ
iajs-3480	175	33	interleukin	interleukin	NOUN
iajs-3480	175	34	6	6	NUM
iajs-3480	175	35	in	in	ADP
iajs-3480	175	36	parkinson	parkinson	NOUN
iajs-3480	175	37	’s	’s	PART
iajs-3480	175	38	disease	disease	NOUN
iajs-3480	175	39	.	.	PUNCT
iajs-3480	176	1	acta	acta	PROPN
iajs-3480	176	2	neurobiologiae	neurobiologiae	PROPN
iajs-3480	176	3	experimentalis	experimentali	NOUN
iajs-3480	176	4	2020	2020	NUM
iajs-3480	176	5	,	,	PUNCT
iajs-3480	176	6	80(3	80(3	NUM
iajs-3480	176	7	)	)	PUNCT
iajs-3480	176	8	,	,	PUNCT
iajs-3480	176	9	297	297	NUM
iajs-3480	176	10	-	-	SYM
iajs-3480	176	11	304	304	NUM
iajs-3480	176	12	.	.	PUNCT
iajs-3480	177	1	5	5	NUM
iajs-3480	177	2	.	.	X
iajs-3480	177	3	yu	yu	PROPN
iajs-3480	177	4	,	,	PUNCT
iajs-3480	177	5	y.t	y.t	PROPN
iajs-3480	177	6	.	.	PROPN
iajs-3480	177	7	;	;	PUNCT
iajs-3480	178	1	ho	ho	PROPN
iajs-3480	178	2	,	,	PUNCT
iajs-3480	178	3	c.t	c.t	PROPN
iajs-3480	178	4	.	.	PROPN
iajs-3480	178	5	;	;	PUNCT
iajs-3480	178	6	hsu	hsu	PROPN
iajs-3480	178	7	,	,	PUNCT
iajs-3480	178	8	h.s	h.s	PROPN
iajs-3480	178	9	.	.	PROPN
iajs-3480	178	10	;	;	PUNCT
iajs-3480	178	11	li	li	PROPN
iajs-3480	178	12	,	,	PUNCT
iajs-3480	178	13	c.i	c.i	PROPN
iajs-3480	178	14	.	.	PROPN
iajs-3480	178	15	;	;	PUNCT
iajs-3480	178	16	davidson	davidson	PROPN
iajs-3480	178	17	,	,	PUNCT
iajs-3480	178	18	l.e	l.e	PROPN
iajs-3480	178	19	.	.	PROPN
iajs-3480	178	20	;	;	PUNCT
iajs-3480	179	1	liu	liu	PROPN
iajs-3480	179	2	,	,	PUNCT
iajs-3480	179	3	c.s	c.s	PROPN
iajs-3480	179	4	.	.	PROPN
iajs-3480	179	5	;	;	PUNCT
iajs-3480	179	6	lin	lin	PROPN
iajs-3480	179	7	,	,	PUNCT
iajs-3480	179	8	w.y	w.y	PROPN
iajs-3480	179	9	.	.	PROPN
iajs-3480	179	10	subclinical	subclinical	ADJ
iajs-3480	179	11	hypothyroidism	hypothyroidism	NOUN
iajs-3480	179	12	is	be	AUX
iajs-3480	179	13	associated	associate	VERB
iajs-3480	179	14	with	with	ADP
iajs-3480	179	15	elevated	elevated	ADJ
iajs-3480	179	16	high	high	ADJ
iajs-3480	179	17	-	-	PUNCT
iajs-3480	179	18	sensitive	sensitive	ADJ
iajs-3480	179	19	c	c	NOUN
iajs-3480	179	20	-	-	ADJ
iajs-3480	179	21	reactive	reactive	ADJ
iajs-3480	179	22	protein	protein	NOUN
iajs-3480	179	23	among	among	ADP
iajs-3480	179	24	adult	adult	NOUN
iajs-3480	179	25	taiwanese	taiwanese	PROPN
iajs-3480	179	26	.	.	PUNCT
iajs-3480	180	1	endocrine	endocrine	PROPN
iajs-3480	180	2	2013	2013	NUM
iajs-3480	180	3	,	,	PUNCT
iajs-3480	180	4	44	44	NUM
iajs-3480	180	5	,	,	PUNCT
iajs-3480	180	6	716	716	NUM
iajs-3480	180	7	-	-	SYM
iajs-3480	180	8	722	722	NUM
iajs-3480	180	9	.	.	PUNCT
iajs-3480	181	1	https://doi.org/10.1007/s12020-013-9915-0	https://doi.org/10.1007/s12020-013-9915-0	NUM
iajs-3480	181	2	.	.	PUNCT
iajs-3480	182	1	6	6	NUM
iajs-3480	182	2	.	.	X
iajs-3480	182	3	krysiak	krysiak	PROPN
iajs-3480	182	4	,	,	PUNCT
iajs-3480	182	5	r.	r.	PROPN
iajs-3480	182	6	;	;	PUNCT
iajs-3480	182	7	okopien	okopien	PROPN
iajs-3480	182	8	,	,	PUNCT
iajs-3480	182	9	b.	b.	PROPN
iajs-3480	182	10	the	the	DET
iajs-3480	182	11	effect	effect	NOUN
iajs-3480	182	12	of	of	ADP
iajs-3480	182	13	levothyroxine	levothyroxine	NOUN
iajs-3480	182	14	and	and	CCONJ
iajs-3480	182	15	selenomethionine	selenomethionine	NOUN
iajs-3480	182	16	on	on	ADP
iajs-3480	182	17	lymphocyte	lymphocyte	ADJ
iajs-3480	182	18	and	and	CCONJ
iajs-3480	182	19	monocyte	monocyte	ADJ
iajs-3480	182	20	cytokine	cytokine	NOUN
iajs-3480	182	21	release	release	NOUN
iajs-3480	182	22	in	in	ADP
iajs-3480	182	23	women	woman	NOUN
iajs-3480	182	24	with	with	ADP
iajs-3480	182	25	hashimoto	hashimoto	NOUN
iajs-3480	182	26	's	's	PART
iajs-3480	182	27	thyroiditis	thyroiditis	NOUN
iajs-3480	182	28	.	.	PUNCT
iajs-3480	183	1	the	the	DET
iajs-3480	183	2	journal	journal	NOUN
iajs-3480	183	3	of	of	ADP
iajs-3480	183	4	clinical	clinical	ADJ
iajs-3480	183	5	endocrinology	endocrinology	NOUN
iajs-3480	183	6	and	and	CCONJ
iajs-3480	183	7	metabolism	metabolism	NOUN
iajs-3480	183	8	2011	2011	NUM
iajs-3480	183	9	,	,	PUNCT
iajs-3480	183	10	96(7	96(7	NUM
iajs-3480	183	11	)	)	PUNCT
iajs-3480	183	12	,	,	PUNCT
iajs-3480	183	13	2206	2206	NUM
iajs-3480	183	14	-	-	SYM
iajs-3480	183	15	2215	2215	NUM
iajs-3480	183	16	.	.	PUNCT
iajs-3480	184	1	https://doi.org/10.1210/jc.2010-2986	https://doi.org/10.1210/jc.2010-2986	NOUN
iajs-3480	184	2	.	.	PUNCT
iajs-3480	185	1	7	7	X
iajs-3480	185	2	.	.	X
iajs-3480	185	3	ahmed	ahmed	PROPN
iajs-3480	185	4	,	,	PUNCT
iajs-3480	185	5	m.j	m.j	PROPN
iajs-3480	185	6	.	.	PROPN
iajs-3480	185	7	;	;	PUNCT
iajs-3480	185	8	mohammed	mohammed	PROPN
iajs-3480	185	9	,	,	PUNCT
iajs-3480	185	10	a.a	a.a	PROPN
iajs-3480	185	11	.	.	PROPN
iajs-3480	185	12	;	;	PUNCT
iajs-3480	185	13	qasim	qasim	PROPN
iajs-3480	185	14	,	,	PUNCT
iajs-3480	185	15	b.a	b.a	PROPN
iajs-3480	185	16	.	.	PROPN
iajs-3480	185	17	lipid	lipid	PROPN
iajs-3480	185	18	profile	profile	NOUN
iajs-3480	185	19	in	in	ADP
iajs-3480	185	20	subclinical	subclinical	ADJ
iajs-3480	185	21	hypothyroidism	hypothyroidism	NOUN
iajs-3480	185	22	:	:	PUNCT
iajs-3480	185	23	a	a	DET
iajs-3480	185	24	two	two	NUM
iajs-3480	185	25	centers	center	NOUN
iajs-3480	185	26	experience	experience	NOUN
iajs-3480	185	27	.	.	PUNCT
iajs-3480	186	1	duhok	duhok	PROPN
iajs-3480	186	2	medical	medical	PROPN
iajs-3480	186	3	journal	journal	PROPN
iajs-3480	186	4	2019	2019	NUM
iajs-3480	186	5	,	,	PUNCT
iajs-3480	186	6	13(1	13(1	NUM
iajs-3480	186	7	)	)	PUNCT
iajs-3480	186	8	,	,	PUNCT
iajs-3480	186	9	56	56	NUM
iajs-3480	186	10	-	-	SYM
iajs-3480	186	11	65	65	NUM
iajs-3480	186	12	.	.	PUNCT
iajs-3480	187	1	https://doi.org/10.31386/dmj.2019.13.1.6	https://doi.org/10.31386/dmj.2019.13.1.6	X
iajs-3480	187	2	.	.	PROPN
iajs-3480	187	3	8	8	NUM
iajs-3480	187	4	.	.	PUNCT
iajs-3480	188	1	mendes	mende	NOUN
iajs-3480	188	2	,	,	PUNCT
iajs-3480	188	3	d.	d.	PROPN
iajs-3480	188	4	;	;	PUNCT
iajs-3480	188	5	alves	alves	PROPN
iajs-3480	188	6	,	,	PUNCT
iajs-3480	188	7	c.	c.	PROPN
iajs-3480	188	8	;	;	PUNCT
iajs-3480	188	9	silverio	silverio	PROPN
iajs-3480	188	10	,	,	PUNCT
iajs-3480	188	11	n.	n.	PROPN
iajs-3480	188	12	;	;	PUNCT
iajs-3480	188	13	marques	marques	PROPN
iajs-3480	188	14	,	,	PUNCT
iajs-3480	188	15	f.b	f.b	PROPN
iajs-3480	188	16	.	.	PROPN
iajs-3480	188	17	prevalence	prevalence	NOUN
iajs-3480	188	18	of	of	ADP
iajs-3480	188	19	undiagnosed	undiagnosed	ADJ
iajs-3480	188	20	hypothyroidism	hypothyroidism	NOUN
iajs-3480	188	21	in	in	ADP
iajs-3480	188	22	europe	europe	PROPN
iajs-3480	188	23	:	:	PUNCT
iajs-3480	188	24	a	a	DET
iajs-3480	188	25	systematic	systematic	ADJ
iajs-3480	188	26	review	review	NOUN
iajs-3480	188	27	and	and	CCONJ
iajs-3480	188	28	meta	meta	ADJ
iajs-3480	188	29	-	-	PUNCT
iajs-3480	188	30	analysis	analysis	NOUN
iajs-3480	188	31	.	.	PUNCT
iajs-3480	189	1	european	european	PROPN
iajs-3480	189	2	thyroid	thyroid	PROPN
iajs-3480	189	3	journal	journal	PROPN
iajs-3480	189	4	2019	2019	NUM
iajs-3480	189	5	,	,	PUNCT
iajs-3480	189	6	8(3	8(3	NUM
iajs-3480	189	7	)	)	PUNCT
iajs-3480	189	8	,	,	PUNCT
iajs-3480	189	9	130	130	NUM
iajs-3480	189	10	-	-	SYM
iajs-3480	189	11	143	143	NUM
iajs-3480	189	12	.	.	PUNCT
iajs-3480	190	1	https://doi.org/10.1159/000499751	https://doi.org/10.1159/000499751	NOUN
iajs-3480	190	2	.	.	PUNCT
iajs-3480	191	1	9	9	X
iajs-3480	191	2	.	.	X
iajs-3480	191	3	dunn	dunn	PROPN
iajs-3480	191	4	,	,	PUNCT
iajs-3480	191	5	d.	d.	PROPN
iajs-3480	191	6	;	;	PUNCT
iajs-3480	191	7	turner	turner	PROPN
iajs-3480	191	8	,	,	PUNCT
iajs-3480	191	9	c.	c.	PROPN
iajs-3480	191	10	hypothyroidism	hypothyroidism	NOUN
iajs-3480	191	11	in	in	ADP
iajs-3480	191	12	women	woman	NOUN
iajs-3480	191	13	.	.	PUNCT
iajs-3480	192	1	nursing	nurse	VERB
iajs-3480	192	2	for	for	ADP
iajs-3480	192	3	women	woman	NOUN
iajs-3480	192	4	's	's	PART
iajs-3480	192	5	health	health	NOUN
iajs-3480	192	6	2016	2016	NUM
iajs-3480	192	7	,	,	PUNCT
iajs-3480	192	8	20(1	20(1	NUM
iajs-3480	192	9	)	)	PUNCT
iajs-3480	192	10	,	,	PUNCT
iajs-3480	192	11	93	93	NUM
iajs-3480	192	12	-	-	SYM
iajs-3480	192	13	98	98	NUM
iajs-3480	192	14	.	.	PUNCT
iajs-3480	193	1	doi	doi	NOUN
iajs-3480	193	2	:	:	PUNCT
iajs-3480	193	3	https://doi.org/10.1016/j.nwh.2015.12.002	https://doi.org/10.1016/j.nwh.2015.12.002	PROPN
iajs-3480	193	4	.	.	PROPN
iajs-3480	194	1	10	10	NUM
iajs-3480	194	2	.	.	X
iajs-3480	195	1	livingston	livingston	PROPN
iajs-3480	195	2	,	,	PUNCT
iajs-3480	195	3	e.h	e.h	PROPN
iajs-3480	195	4	.	.	PROPN
iajs-3480	195	5	subclinical	subclinical	ADJ
iajs-3480	195	6	hypothyroidism	hypothyroidism	NOUN
iajs-3480	195	7	.	.	PUNCT
iajs-3480	196	1	jama	jama	PROPN
iajs-3480	196	2	2019	2019	NUM
iajs-3480	196	3	,	,	PUNCT
iajs-3480	196	4	322(2	322(2	NUM
iajs-3480	196	5	)	)	PUNCT
iajs-3480	196	6	,	,	PUNCT
iajs-3480	196	7	180	180	NUM
iajs-3480	196	8	-	-	SYM
iajs-3480	196	9	180	180	NUM
iajs-3480	196	10	.	.	PUNCT
iajs-3480	197	1	https://doi.org/10.1001/jama.2019.9508	https://doi.org/10.1001/jama.2019.9508	X
iajs-3480	197	2	.	.	PUNCT
iajs-3480	198	1	11	11	NUM
iajs-3480	198	2	.	.	PUNCT
iajs-3480	199	1	rosinha	rosinha	NOUN
iajs-3480	199	2	,	,	PUNCT
iajs-3480	199	3	p.	p.	NOUN
iajs-3480	199	4	;	;	PUNCT
iajs-3480	199	5	dantas	dantas	PROPN
iajs-3480	199	6	,	,	PUNCT
iajs-3480	199	7	r.	r.	PROPN
iajs-3480	199	8	;	;	PUNCT
iajs-3480	199	9	alves	alves	PROPN
iajs-3480	199	10	,	,	PUNCT
iajs-3480	199	11	m.	m.	NOUN
iajs-3480	199	12	;	;	PUNCT
iajs-3480	199	13	azevedo	azevedo	PROPN
iajs-3480	199	14	,	,	PUNCT
iajs-3480	199	15	t.	t.	PROPN
iajs-3480	199	16	;	;	PUNCT
iajs-3480	199	17	inácio	inácio	PROPN
iajs-3480	199	18	,	,	PUNCT
iajs-3480	199	19	i.	i.	PROPN
iajs-3480	199	20	;	;	PUNCT
iajs-3480	199	21	esteves	esteves	PROPN
iajs-3480	199	22	-	-	PUNCT
iajs-3480	199	23	ferreira	ferreira	PROPN
iajs-3480	199	24	,	,	PUNCT
iajs-3480	199	25	s.	s.	PROPN
iajs-3480	199	26	;	;	PUNCT
iajs-3480	199	27	guimarães	guimarães	PROPN
iajs-3480	199	28	,	,	PUNCT
iajs-3480	199	29	j.	j.	PROPN
iajs-3480	199	30	subclinical	subclinical	PROPN
iajs-3480	199	31	hypothyroidism	hypothyroidism	NOUN
iajs-3480	199	32	in	in	ADP
iajs-3480	199	33	pediatric	pediatric	ADJ
iajs-3480	199	34	age	age	NOUN
iajs-3480	199	35	:	:	PUNCT
iajs-3480	199	36	how	how	SCONJ
iajs-3480	199	37	important	important	ADJ
iajs-3480	199	38	is	be	AUX
iajs-3480	199	39	autoimmunity	autoimmunity	NOUN
iajs-3480	199	40	?	?	PUNCT
iajs-3480	200	1	cureus	cureus	NOUN
iajs-3480	200	2	2022	2022	NUM
iajs-3480	200	3	,	,	PUNCT
iajs-3480	200	4	14(8	14(8	NUM
iajs-3480	200	5	)	)	PUNCT
iajs-3480	200	6	,	,	PUNCT
iajs-3480	200	7	e28507	e28507	PROPN
iajs-3480	200	8	.	.	PUNCT
iajs-3480	201	1	https://doi.org/10.7759%2fcureus.28507	https://doi.org/10.7759%2fcureus.28507	NOUN
iajs-3480	201	2	.	.	PROPN
iajs-3480	201	3	12	12	NUM
iajs-3480	201	4	.	.	PUNCT
iajs-3480	202	1	almandoz	almandoz	PROPN
iajs-3480	202	2	,	,	PUNCT
iajs-3480	202	3	j.p	j.p	PROPN
iajs-3480	202	4	.	.	PROPN
iajs-3480	202	5	;	;	PUNCT
iajs-3480	202	6	gharib	gharib	PROPN
iajs-3480	202	7	,	,	PUNCT
iajs-3480	202	8	h.	h.	PROPN
iajs-3480	202	9	hypothyroidism	hypothyroidism	PROPN
iajs-3480	202	10	:	:	PUNCT
iajs-3480	202	11	etiology	etiology	NOUN
iajs-3480	202	12	,	,	PUNCT
iajs-3480	202	13	diagnosis	diagnosis	NOUN
iajs-3480	202	14	,	,	PUNCT
iajs-3480	202	15	and	and	CCONJ
iajs-3480	202	16	management	management	NOUN
iajs-3480	202	17	.	.	PUNCT
iajs-3480	203	1	medical	medical	ADJ
iajs-3480	203	2	clinics	clinic	NOUN
iajs-3480	203	3	2012	2012	NUM
iajs-3480	203	4	,	,	PUNCT
iajs-3480	203	5	96(2	96(2	NUM
iajs-3480	203	6	)	)	PUNCT
iajs-3480	203	7	,	,	PUNCT
iajs-3480	203	8	203	203	NUM
iajs-3480	203	9	-	-	SYM
iajs-3480	203	10	221	221	NUM
iajs-3480	203	11	.	.	PUNCT
iajs-3480	204	1	https://doi.org/10.1016/j.mcna.2012.01.005	https://doi.org/10.1016/j.mcna.2012.01.005	NOUN
iajs-3480	204	2	.	.	PUNCT
iajs-3480	205	1	13	13	NUM
iajs-3480	205	2	.	.	PUNCT
iajs-3480	205	3	hueston	hueston	PROPN
iajs-3480	205	4	,	,	PUNCT
iajs-3480	205	5	w.j	w.j	PROPN
iajs-3480	205	6	.	.	PROPN
iajs-3480	205	7	treatment	treatment	NOUN
iajs-3480	205	8	of	of	ADP
iajs-3480	205	9	hypothyroidism	hypothyroidism	NOUN
iajs-3480	205	10	.	.	PUNCT
iajs-3480	206	1	american	american	ADJ
iajs-3480	206	2	family	family	PROPN
iajs-3480	206	3	physician	physician	NOUN
iajs-3480	206	4	2001	2001	NUM
iajs-3480	206	5	,	,	PUNCT
iajs-3480	206	6	64(10	64(10	NUM
iajs-3480	206	7	)	)	PUNCT
iajs-3480	206	8	,	,	PUNCT
iajs-3480	206	9	1717	1717	NUM
iajs-3480	206	10	.	.	PUNCT
iajs-3480	207	1	14	14	NUM
iajs-3480	207	2	.	.	PUNCT
iajs-3480	208	1	hennessey	hennessey	PROPN
iajs-3480	208	2	,	,	PUNCT
iajs-3480	208	3	j.v	j.v	PROPN
iajs-3480	208	4	.	.	PROPN
iajs-3480	208	5	;	;	PUNCT
iajs-3480	208	6	espaillat	espaillat	PROPN
iajs-3480	208	7	,	,	PUNCT
iajs-3480	208	8	r.	r.	PROPN
iajs-3480	208	9	current	current	ADJ
iajs-3480	208	10	evidence	evidence	NOUN
iajs-3480	208	11	for	for	ADP
iajs-3480	208	12	the	the	DET
iajs-3480	208	13	treatment	treatment	NOUN
iajs-3480	208	14	of	of	ADP
iajs-3480	208	15	hypothyroidism	hypothyroidism	NOUN
iajs-3480	208	16	with	with	ADP
iajs-3480	208	17	levothyroxine	levothyroxine	NOUN
iajs-3480	208	18	/	/	SYM
iajs-3480	208	19	levotriiodothyronine	levotriiodothyronine	NOUN
iajs-3480	208	20	combination	combination	NOUN
iajs-3480	208	21	therapy	therapy	NOUN
iajs-3480	208	22	versus	versus	ADP
iajs-3480	208	23	levothyroxine	levothyroxine	PROPN
iajs-3480	208	24	monotherapy	monotherapy	NOUN
iajs-3480	208	25	.	.	PUNCT
iajs-3480	209	1	international	international	ADJ
iajs-3480	209	2	journal	journal	PROPN
iajs-3480	209	3	of	of	ADP
iajs-3480	209	4	clinical	clinical	ADJ
iajs-3480	209	5	practice	practice	NOUN
iajs-3480	209	6	2018	2018	NUM
iajs-3480	209	7	,	,	PUNCT
iajs-3480	209	8	72(2	72(2	NUM
iajs-3480	209	9	)	)	PUNCT
iajs-3480	209	10	,	,	PUNCT
iajs-3480	209	11	e13062	e13062	PRON
iajs-3480	209	12	.	.	PUNCT
iajs-3480	210	1	https://doi.org/10.1111/ijcp.13062	https://doi.org/10.1111/ijcp.13062	X
iajs-3480	210	2	.	.	PUNCT
iajs-3480	211	1	15	15	NUM
iajs-3480	211	2	.	.	X
iajs-3480	211	3	kazemi	kazemi	PROPN
iajs-3480	211	4	tanha	tanha	PROPN
iajs-3480	211	5	,	,	PUNCT
iajs-3480	211	6	m.	m.	NOUN
iajs-3480	211	7	;	;	PUNCT
iajs-3480	211	8	nayebifar	nayebifar	ADV
iajs-3480	211	9	,	,	PUNCT
iajs-3480	211	10	s.	s.	PROPN
iajs-3480	211	11	;	;	PUNCT
iajs-3480	211	12	ghasemi	ghasemi	PROPN
iajs-3480	211	13	,	,	PUNCT
iajs-3480	211	14	e.	e.	PROPN
iajs-3480	211	15	;	;	PUNCT
iajs-3480	211	16	nosrat	nosrat	PROPN
iajs-3480	211	17	zehi	zehi	PROPN
iajs-3480	211	18	,	,	PUNCT
iajs-3480	211	19	s.	s.	PROPN
iajs-3480	211	20	investigating	investigate	VERB
iajs-3480	211	21	the	the	DET
iajs-3480	211	22	synergistic	synergistic	ADJ
iajs-3480	211	23	effect	effect	NOUN
iajs-3480	211	24	of	of	ADP
iajs-3480	211	25	nasturtium	nasturtium	NOUN
iajs-3480	211	26	officinale	officinale	NOUN
iajs-3480	211	27	extract	extract	NOUN
iajs-3480	211	28	and	and	CCONJ
iajs-3480	211	29	high	high	ADJ
iajs-3480	211	30	-	-	PUNCT
iajs-3480	211	31	intensity	intensity	NOUN
iajs-3480	211	32	interval	interval	NOUN
iajs-3480	211	33	training	training	NOUN
iajs-3480	211	34	on	on	ADP
iajs-3480	211	35	fatty	fatty	ADJ
iajs-3480	211	36	acid	acid	NOUN
iajs-3480	211	37	-	-	PUNCT
iajs-3480	211	38	binding	bind	VERB
iajs-3480	211	39	protein	protein	NOUN
iajs-3480	211	40	4	4	NUM
iajs-3480	211	41	(	(	PUNCT
iajs-3480	211	42	fabp4	fabp4	NOUN
iajs-3480	211	43	)	)	PUNCT
iajs-3480	211	44	and	and	CCONJ
iajs-3480	211	45	high	high	ADJ
iajs-3480	211	46	-	-	PUNCT
iajs-3480	211	47	sensitivity	sensitivity	NOUN
iajs-3480	211	48	c	c	NOUN
iajs-3480	211	49	-	-	PUNCT
iajs-3480	211	50	reactive	reactive	ADJ
iajs-3480	211	51	protein	protein	NOUN
iajs-3480	211	52	(	(	PUNCT
iajs-3480	211	53	hs	hs	NOUN
iajs-3480	211	54	-	-	PROPN
iajs-3480	211	55	crp	crp	NOUN
iajs-3480	211	56	)	)	PUNCT
iajs-3480	211	57	in	in	ADP
iajs-3480	211	58	overweight	overweight	ADJ
iajs-3480	211	59	subclinical	subclinical	ADJ
iajs-3480	211	60	hypothyroid	hypothyroid	ADJ
iajs-3480	211	61	patients	patient	NOUN
iajs-3480	211	62	:	:	PUNCT
iajs-3480	211	63	a	a	DET
iajs-3480	211	64	rand	rand	NOUN
iajs-3480	211	65	.	.	PUNCT
iajs-3480	212	1	sport	sport	NOUN
iajs-3480	212	2	physiology	physiology	NOUN
iajs-3480	212	3	2023	2023	NUM
iajs-3480	212	4	,	,	PUNCT
iajs-3480	212	5	14(56	14(56	NUM
iajs-3480	212	6	)	)	PUNCT
iajs-3480	212	7	,	,	PUNCT
iajs-3480	212	8	175	175	NUM
iajs-3480	212	9	-	-	SYM
iajs-3480	212	10	198	198	NUM
iajs-3480	212	11	.	.	PUNCT
iajs-3480	213	1	https://doi.org/10.22089/spj.2022.13463.2214	https://doi.org/10.22089/spj.2022.13463.2214	PROPN
iajs-3480	213	2	.	.	PUNCT
iajs-3480	213	3	https://doi.org/10.1038/s41572-022-00357-7	https://doi.org/10.1038/s41572-022-00357-7	PROPN
iajs-3480	214	1	https://doi.org/10.31128/ajgp-09-20-5653	https://doi.org/10.31128/ajgp-09-20-5653	X
iajs-3480	214	2	https://doi.org/10.1002/jcla.22929	https://doi.org/10.1002/jcla.22929	NOUN
iajs-3480	214	3	https://doi.org/10.1007/s12020-013-9915-0	https://doi.org/10.1007/s12020-013-9915-0	NUM
iajs-3480	214	4	https://doi.org/10.1210/jc.2010-2986	https://doi.org/10.1210/jc.2010-2986	NOUN
iajs-3480	214	5	https://doi.org/10.1210/jc.2010-2986	https://doi.org/10.1210/jc.2010-2986	NOUN
iajs-3480	215	1	https://doi.org/10.31386/dmj.2019.13.1.6	https://doi.org/10.31386/dmj.2019.13.1.6	INTJ
iajs-3480	215	2	https://doi.org/10.1159/000499751	https://doi.org/10.1159/000499751	ADV
iajs-3480	215	3	https://doi.org/10.1016/j.nwh.2015.12.002	https://doi.org/10.1016/j.nwh.2015.12.002	VERB
iajs-3480	215	4	https://doi.org/10.1001/jama.2019.9508	https://doi.org/10.1001/jama.2019.9508	PROPN
iajs-3480	215	5	https://doi.org/10.7759%2fcureus.28507	https://doi.org/10.7759%2fcureus.28507	NOUN
iajs-3480	215	6	https://doi.org/10.1016/j.mcna.2012.01.005	https://doi.org/10.1016/j.mcna.2012.01.005	VERB
iajs-3480	215	7	https://doi.org/10.1111/ijcp.13062	https://doi.org/10.1111/ijcp.13062	PRON
iajs-3480	215	8	https://doi.org/10.22089/spj.2022.13463.2214	https://doi.org/10.22089/spj.2022.13463.2214	PRON
iajs-3480	215	9	ihjpas	ihjpas	PROPN
iajs-3480	215	10	.	.	PUNCT
iajs-3480	216	1	2024	2024	NUM
iajs-3480	216	2	,	,	PUNCT
iajs-3480	216	3	37(4	37(4	NOUN
iajs-3480	216	4	)	)	PUNCT
iajs-3480	216	5	107	107	NUM
iajs-3480	216	6	16	16	NUM
iajs-3480	216	7	.	.	PUNCT
iajs-3480	217	1	tayde	tayde	NOUN
iajs-3480	217	2	,	,	PUNCT
iajs-3480	217	3	p.s	p.s	PROPN
iajs-3480	217	4	.	.	PROPN
iajs-3480	217	5	;	;	PUNCT
iajs-3480	218	1	bhagwat	bhagwat	NOUN
iajs-3480	218	2	,	,	PUNCT
iajs-3480	218	3	n.m	n.m	PROPN
iajs-3480	218	4	.	.	PROPN
iajs-3480	218	5	;	;	PUNCT
iajs-3480	218	6	sharma	sharma	PROPN
iajs-3480	218	7	,	,	PUNCT
iajs-3480	218	8	p.	p.	NOUN
iajs-3480	218	9	;	;	PUNCT
iajs-3480	218	10	sharma	sharma	PROPN
iajs-3480	218	11	,	,	PUNCT
iajs-3480	218	12	b.	b.	PROPN
iajs-3480	218	13	;	;	PUNCT
iajs-3480	218	14	dalwadi	dalwadi	NOUN
iajs-3480	218	15	,	,	PUNCT
iajs-3480	218	16	p.p	p.p	PROPN
iajs-3480	218	17	.	.	PROPN
iajs-3480	218	18	;	;	PUNCT
iajs-3480	218	19	sonawane	sonawane	NOUN
iajs-3480	218	20	,	,	PUNCT
iajs-3480	218	21	a.	a.	NOUN
iajs-3480	218	22	;	;	PUNCT
iajs-3480	218	23	varthakavi	varthakavi	PROPN
iajs-3480	218	24	,	,	PUNCT
iajs-3480	218	25	p.k	p.k	PROPN
iajs-3480	218	26	.	.	PROPN
iajs-3480	218	27	hypothyroidism	hypothyroidism	PROPN
iajs-3480	218	28	and	and	CCONJ
iajs-3480	218	29	depression	depression	NOUN
iajs-3480	218	30	:	:	PUNCT
iajs-3480	218	31	are	be	AUX
iajs-3480	218	32	cytokines	cytokine	VERB
iajs-3480	218	33	the	the	DET
iajs-3480	218	34	link	link	NOUN
iajs-3480	218	35	?	?	PUNCT
iajs-3480	218	36	.	.	PUNCT
iajs-3480	219	1	indian	indian	PROPN
iajs-3480	219	2	journal	journal	PROPN
iajs-3480	219	3	of	of	ADP
iajs-3480	219	4	endocrinology	endocrinology	NOUN
iajs-3480	219	5	and	and	CCONJ
iajs-3480	219	6	metabolism	metabolism	NOUN
iajs-3480	219	7	2017	2017	NUM
iajs-3480	219	8	,	,	PUNCT
iajs-3480	219	9	21(6	21(6	NUM
iajs-3480	219	10	)	)	PUNCT
iajs-3480	219	11	,	,	PUNCT
iajs-3480	219	12	886	886	NUM
iajs-3480	219	13	.	.	PUNCT
iajs-3480	219	14	https://doi.org/10.4103%2fijem.ijem_265_17	https://doi.org/10.4103%2fijem.ijem_265_17	X
iajs-3480	219	15	.	.	PUNCT
iajs-3480	220	1	17	17	NUM
iajs-3480	220	2	.	.	PUNCT
iajs-3480	221	1	erge	erge	PROPN
iajs-3480	221	2	,	,	PUNCT
iajs-3480	221	3	e.	e.	PROPN
iajs-3480	221	4	;	;	PUNCT
iajs-3480	221	5	kiziltunc	kiziltunc	PROPN
iajs-3480	221	6	,	,	PUNCT
iajs-3480	221	7	c.	c.	NOUN
iajs-3480	221	8	;	;	PUNCT
iajs-3480	221	9	balci	balci	NOUN
iajs-3480	221	10	,	,	PUNCT
iajs-3480	221	11	s.b	s.b	PROPN
iajs-3480	221	12	.	.	PROPN
iajs-3480	221	13	;	;	PUNCT
iajs-3480	221	14	atak	atak	PROPN
iajs-3480	221	15	tel	tel	PROPN
iajs-3480	221	16	,	,	PUNCT
iajs-3480	221	17	b.m	b.m	PROPN
iajs-3480	221	18	.	.	PROPN
iajs-3480	221	19	;	;	PUNCT
iajs-3480	221	20	bilgin	bilgin	NOUN
iajs-3480	221	21	,	,	PUNCT
iajs-3480	221	22	s.	s.	PROPN
iajs-3480	221	23	;	;	PUNCT
iajs-3480	221	24	duman	duman	PROPN
iajs-3480	221	25	,	,	PUNCT
iajs-3480	221	26	t.t	t.t	PROPN
iajs-3480	221	27	.	.	PROPN
iajs-3480	221	28	;	;	PUNCT
iajs-3480	221	29	aktas	aktas	PROPN
iajs-3480	221	30	,	,	PUNCT
iajs-3480	222	1	g.	g.	PROPN
iajs-3480	222	2	a	a	DET
iajs-3480	222	3	novel	novel	ADJ
iajs-3480	222	4	inflammatory	inflammatory	ADJ
iajs-3480	222	5	marker	marker	NOUN
iajs-3480	222	6	for	for	ADP
iajs-3480	222	7	the	the	DET
iajs-3480	222	8	diagnosis	diagnosis	NOUN
iajs-3480	222	9	of	of	ADP
iajs-3480	222	10	hashimoto	hashimoto	NOUN
iajs-3480	222	11	’s	’s	PART
iajs-3480	222	12	thyroiditis	thyroiditis	NOUN
iajs-3480	222	13	:	:	PUNCT
iajs-3480	222	14	platelet	platelet	ADJ
iajs-3480	222	15	-	-	PUNCT
iajs-3480	222	16	count	count	NOUN
iajs-3480	222	17	-	-	PUNCT
iajs-3480	222	18	to	to	ADP
iajs-3480	222	19	-	-	PUNCT
iajs-3480	222	20	lymphocytecount	lymphocytecount	VERB
iajs-3480	222	21	ratio	ratio	NOUN
iajs-3480	222	22	.	.	PUNCT
iajs-3480	223	1	diseases	disease	NOUN
iajs-3480	223	2	2023	2023	NUM
iajs-3480	223	3	,	,	PUNCT
iajs-3480	223	4	11(1	11(1	NUM
iajs-3480	223	5	)	)	PUNCT
iajs-3480	223	6	,	,	PUNCT
iajs-3480	223	7	15	15	NUM
iajs-3480	223	8	.	.	PUNCT
iajs-3480	224	1	https://doi.org/10.3390/diseases11010015	https://doi.org/10.3390/diseases11010015	PROPN
iajs-3480	224	2	.	.	PUNCT
iajs-3480	225	1	18	18	NUM
iajs-3480	225	2	.	.	X
iajs-3480	226	1	ji	ji	PROPN
iajs-3480	226	2	,	,	PUNCT
iajs-3480	226	3	j.	j.	PROPN
iajs-3480	226	4	;	;	PUNCT
iajs-3480	226	5	sun	sun	PROPN
iajs-3480	226	6	,	,	PUNCT
iajs-3480	226	7	c.l	c.l	PROPN
iajs-3480	226	8	.	.	PROPN
iajs-3480	226	9	;	;	PUNCT
iajs-3480	226	10	cohen	cohen	PROPN
iajs-3480	226	11	,	,	PUNCT
iajs-3480	226	12	h.j	h.j	PROPN
iajs-3480	226	13	.	.	PROPN
iajs-3480	226	14	;	;	PUNCT
iajs-3480	226	15	synold	synold	ADJ
iajs-3480	226	16	,	,	PUNCT
iajs-3480	226	17	t.	t.	PROPN
iajs-3480	226	18	;	;	PUNCT
iajs-3480	226	19	muss	muss	PROPN
iajs-3480	226	20	,	,	PUNCT
iajs-3480	226	21	h.	h.	PROPN
iajs-3480	226	22	;	;	PUNCT
iajs-3480	226	23	sedrak	sedrak	ADJ
iajs-3480	226	24	,	,	PUNCT
iajs-3480	226	25	m.s	m.s	PROPN
iajs-3480	226	26	.	.	PROPN
iajs-3480	226	27	inflammation	inflammation	NOUN
iajs-3480	226	28	and	and	CCONJ
iajs-3480	226	29	clinical	clinical	ADJ
iajs-3480	226	30	decline	decline	NOUN
iajs-3480	226	31	after	after	ADP
iajs-3480	226	32	adjuvant	adjuvant	ADJ
iajs-3480	226	33	chemotherapy	chemotherapy	NOUN
iajs-3480	226	34	in	in	ADP
iajs-3480	226	35	older	old	ADJ
iajs-3480	226	36	adults	adult	NOUN
iajs-3480	226	37	with	with	ADP
iajs-3480	226	38	breast	breast	NOUN
iajs-3480	226	39	cancer	cancer	NOUN
iajs-3480	226	40	:	:	PUNCT
iajs-3480	226	41	results	result	NOUN
iajs-3480	226	42	from	from	ADP
iajs-3480	226	43	the	the	DET
iajs-3480	226	44	hurria	hurria	NOUN
iajs-3480	226	45	older	old	ADJ
iajs-3480	226	46	patients	patient	NOUN
iajs-3480	226	47	prospective	prospective	ADJ
iajs-3480	226	48	study	study	NOUN
iajs-3480	226	49	.	.	PUNCT
iajs-3480	227	1	journal	journal	NOUN
iajs-3480	227	2	of	of	ADP
iajs-3480	227	3	clinical	clinical	ADJ
iajs-3480	227	4	oncology	oncology	NOUN
iajs-3480	227	5	2023	2023	NUM
iajs-3480	227	6	,	,	PUNCT
iajs-3480	227	7	41(2	41(2	NUM
iajs-3480	227	8	)	)	PUNCT
iajs-3480	227	9	,	,	PUNCT
iajs-3480	227	10	307	307	NUM
iajs-3480	227	11	-	-	SYM
iajs-3480	227	12	315	315	NUM
iajs-3480	227	13	.	.	PUNCT
iajs-3480	228	1	https://doi.org/10.1200/jco.22.01217	https://doi.org/10.1200/jco.22.01217	NOUN
iajs-3480	228	2	.	.	PUNCT
iajs-3480	229	1	19	19	NUM
iajs-3480	229	2	.	.	PUNCT
iajs-3480	229	3	nemeth	nemeth	PROPN
iajs-3480	229	4	,	,	PUNCT
iajs-3480	229	5	e.	e.	PROPN
iajs-3480	229	6	;	;	PUNCT
iajs-3480	229	7	ganz	ganz	PROPN
iajs-3480	229	8	,	,	PUNCT
iajs-3480	229	9	t.	t.	NOUN
iajs-3480	229	10	hepcidin	hepcidin	NOUN
iajs-3480	229	11	and	and	CCONJ
iajs-3480	229	12	iron	iron	NOUN
iajs-3480	229	13	in	in	ADP
iajs-3480	229	14	health	health	NOUN
iajs-3480	229	15	and	and	CCONJ
iajs-3480	229	16	disease	disease	NOUN
iajs-3480	229	17	.	.	PUNCT
iajs-3480	230	1	annual	annual	ADJ
iajs-3480	230	2	review	review	NOUN
iajs-3480	230	3	of	of	ADP
iajs-3480	230	4	medicine	medicine	NOUN
iajs-3480	230	5	,	,	PUNCT
iajs-3480	230	6	2023	2023	NUM
iajs-3480	230	7	,	,	PUNCT
iajs-3480	230	8	74	74	NUM
iajs-3480	230	9	,	,	PUNCT
iajs-3480	230	10	261	261	NUM
iajs-3480	230	11	-	-	SYM
iajs-3480	230	12	277	277	NUM
iajs-3480	230	13	.	.	PUNCT
iajs-3480	231	1	https://doi.org/10.1146%2fannurev-med-043021-032816	https://doi.org/10.1146%2fannurev-med-043021-032816	PROPN
iajs-3480	231	2	.	.	PROPN
iajs-3480	232	1	20	20	NUM
iajs-3480	232	2	.	.	X
iajs-3480	232	3	hernik	hernik	NOUN
iajs-3480	232	4	,	,	PUNCT
iajs-3480	232	5	a.	a.	NOUN
iajs-3480	232	6	;	;	PUNCT
iajs-3480	232	7	szczepanek	szczepanek	NOUN
iajs-3480	232	8	-	-	PUNCT
iajs-3480	232	9	parulska	parulska	ADJ
iajs-3480	232	10	,	,	PUNCT
iajs-3480	232	11	e.	e.	PROPN
iajs-3480	232	12	;	;	PUNCT
iajs-3480	232	13	filipowicz	filipowicz	PROPN
iajs-3480	232	14	,	,	PUNCT
iajs-3480	232	15	d.	d.	PROPN
iajs-3480	232	16	;	;	PUNCT
iajs-3480	232	17	abdolall	abdolall	PROPN
iajs-3480	232	18	,	,	PUNCT
iajs-3480	232	19	a.	a.	NOUN
iajs-3480	232	20	;	;	PUNCT
iajs-3480	232	21	borowczyk	borowczyk	VERB
iajs-3480	232	22	,	,	PUNCT
iajs-3480	232	23	m.	m.	NOUN
iajs-3480	232	24	;	;	PUNCT
iajs-3480	232	25	wrotkowska	wrotkowska	PROPN
iajs-3480	232	26	,	,	PUNCT
iajs-3480	232	27	e.	e.	PROPN
iajs-3480	232	28	;	;	PUNCT
iajs-3480	232	29	ruchała	ruchała	NOUN
iajs-3480	232	30	,	,	PUNCT
iajs-3480	232	31	m.	m.	NOUN
iajs-3480	232	32	the	the	DET
iajs-3480	232	33	hepcidin	hepcidin	ADJ
iajs-3480	232	34	concentration	concentration	NOUN
iajs-3480	232	35	decreases	decrease	NOUN
iajs-3480	232	36	in	in	ADP
iajs-3480	232	37	hypothyroid	hypothyroid	ADJ
iajs-3480	232	38	patients	patient	NOUN
iajs-3480	232	39	with	with	ADP
iajs-3480	232	40	hashimoto	hashimoto	NOUN
iajs-3480	232	41	’s	’s	PART
iajs-3480	232	42	thyroiditis	thyroiditis	NOUN
iajs-3480	232	43	following	follow	VERB
iajs-3480	232	44	restoration	restoration	NOUN
iajs-3480	232	45	of	of	ADP
iajs-3480	232	46	euthyroidism	euthyroidism	NOUN
iajs-3480	232	47	.	.	PUNCT
iajs-3480	233	1	scientific	scientific	ADJ
iajs-3480	233	2	reports	report	NOUN
iajs-3480	233	3	2019	2019	NUM
iajs-3480	233	4	,	,	PUNCT
iajs-3480	233	5	9(1	9(1	NUM
iajs-3480	233	6	)	)	PUNCT
iajs-3480	233	7	,	,	PUNCT
iajs-3480	233	8	16222	16222	NUM
iajs-3480	233	9	.	.	PUNCT
iajs-3480	234	1	https://doi.org/10.1038/s41598-019-52715-3	https://doi.org/10.1038/s41598-019-52715-3	NUM
iajs-3480	234	2	.	.	PUNCT
iajs-3480	235	1	21	21	NUM
iajs-3480	235	2	.	.	X
iajs-3480	236	1	wrighting	wrighte	VERB
iajs-3480	236	2	,	,	PUNCT
iajs-3480	236	3	d.m	d.m	PROPN
iajs-3480	236	4	.	.	PUNCT
iajs-3480	236	5	;	;	PUNCT
iajs-3480	236	6	andrews	andrews	PROPN
iajs-3480	236	7	,	,	PUNCT
iajs-3480	236	8	n.c	n.c	PROPN
iajs-3480	236	9	.	.	PROPN
iajs-3480	236	10	interleukin-6	interleukin-6	PROPN
iajs-3480	236	11	induces	induce	VERB
iajs-3480	236	12	hepcidin	hepcidin	ADJ
iajs-3480	236	13	expression	expression	NOUN
iajs-3480	236	14	through	through	ADP
iajs-3480	236	15	stat3	stat3	PROPN
iajs-3480	236	16	.	.	PUNCT
iajs-3480	237	1	blood	blood	NOUN
iajs-3480	237	2	2006	2006	NUM
iajs-3480	237	3	,	,	PUNCT
iajs-3480	237	4	108(9	108(9	NUM
iajs-3480	237	5	)	)	PUNCT
iajs-3480	237	6	,	,	PUNCT
iajs-3480	237	7	3204	3204	NUM
iajs-3480	237	8	-	-	SYM
iajs-3480	237	9	3209	3209	NUM
iajs-3480	237	10	.	.	PUNCT
iajs-3480	238	1	https://doi.org/10.1182/blood-2006-06-027631	https://doi.org/10.1182/blood-2006-06-027631	INTJ
iajs-3480	238	2	.	.	PUNCT
iajs-3480	239	1	22	22	NUM
iajs-3480	239	2	.	.	PUNCT
iajs-3480	240	1	banzet	banzet	PROPN
iajs-3480	240	2	,	,	PUNCT
iajs-3480	240	3	s.	s.	PROPN
iajs-3480	240	4	;	;	PUNCT
iajs-3480	240	5	sanchez	sanchez	PROPN
iajs-3480	240	6	,	,	PUNCT
iajs-3480	240	7	h.	h.	PROPN
iajs-3480	240	8	;	;	PUNCT
iajs-3480	240	9	chapot	chapot	PROPN
iajs-3480	240	10	,	,	PUNCT
iajs-3480	240	11	r.	r.	PROPN
iajs-3480	240	12	;	;	PUNCT
iajs-3480	240	13	bigard	bigard	ADV
iajs-3480	240	14	,	,	PUNCT
iajs-3480	240	15	x.	x.	NOUN
iajs-3480	240	16	;	;	PUNCT
iajs-3480	240	17	vaulont	vaulont	PROPN
iajs-3480	240	18	,	,	PUNCT
iajs-3480	240	19	s.	s.	PROPN
iajs-3480	240	20	;	;	PUNCT
iajs-3480	240	21	koulmann	koulmann	PROPN
iajs-3480	240	22	,	,	PUNCT
iajs-3480	240	23	n.	n.	NOUN
iajs-3480	240	24	interleukin-6	interleukin-6	NUM
iajs-3480	240	25	contributes	contribute	VERB
iajs-3480	240	26	to	to	ADP
iajs-3480	240	27	hepcidin	hepcidin	VERB
iajs-3480	240	28	mrna	mrna	PROPN
iajs-3480	240	29	increase	increase	NOUN
iajs-3480	240	30	in	in	ADP
iajs-3480	240	31	response	response	NOUN
iajs-3480	240	32	to	to	PART
iajs-3480	240	33	exercise	exercise	VERB
iajs-3480	240	34	.	.	PUNCT
iajs-3480	241	1	cytokine	cytokine	NOUN
iajs-3480	241	2	2012	2012	NUM
iajs-3480	241	3	,	,	PUNCT
iajs-3480	241	4	58(2	58(2	NUM
iajs-3480	241	5	)	)	PUNCT
iajs-3480	241	6	,	,	PUNCT
iajs-3480	241	7	158	158	NUM
iajs-3480	241	8	-	-	SYM
iajs-3480	241	9	161	161	NUM
iajs-3480	241	10	.	.	PUNCT
iajs-3480	242	1	https://doi.org/10.1016/j.cyto.2012.01.006	https://doi.org/10.1016/j.cyto.2012.01.006	NOUN
iajs-3480	242	2	.	.	PUNCT
iajs-3480	242	3	23	23	NUM
iajs-3480	242	4	.	.	X
iajs-3480	243	1	oppen	oppen	PROPN
iajs-3480	243	2	,	,	PUNCT
iajs-3480	243	3	k.	k.	PROPN
iajs-3480	243	4	;	;	PUNCT
iajs-3480	243	5	brede	brede	PROPN
iajs-3480	243	6	,	,	PUNCT
iajs-3480	243	7	c.	c.	PROPN
iajs-3480	243	8	;	;	PUNCT
iajs-3480	243	9	skadberg	skadberg	PROPN
iajs-3480	243	10	,	,	PUNCT
iajs-3480	243	11	ã.y	ã.y	PROPN
iajs-3480	243	12	.	.	NOUN
iajs-3480	243	13	;	;	PUNCT
iajs-3480	243	14	steinsvik	steinsvik	ADJ
iajs-3480	243	15	,	,	PUNCT
iajs-3480	243	16	t.	t.	PROPN
iajs-3480	243	17	;	;	PUNCT
iajs-3480	243	18	holter	holter	PROPN
iajs-3480	243	19	,	,	PUNCT
iajs-3480	243	20	j.c	j.c	PROPN
iajs-3480	243	21	.	.	PROPN
iajs-3480	243	22	;	;	PUNCT
iajs-3480	243	23	michelsen	michelsen	PROPN
iajs-3480	243	24	,	,	PUNCT
iajs-3480	243	25	a.e	a.e	PROPN
iajs-3480	243	26	.	.	PROPN
iajs-3480	243	27	;	;	PUNCT
iajs-3480	243	28	heggelund	heggelund	PROPN
iajs-3480	243	29	,	,	PUNCT
iajs-3480	243	30	l.	l.	PROPN
iajs-3480	244	1	hepcidin	hepcidin	VERB
iajs-3480	244	2	analysis	analysis	NOUN
iajs-3480	244	3	in	in	ADP
iajs-3480	244	4	pneumonia	pneumonia	NOUN
iajs-3480	244	5	-	-	PUNCT
iajs-3480	244	6	comparison	comparison	NOUN
iajs-3480	244	7	of	of	ADP
iajs-3480	244	8	immunoassay	immunoassay	PROPN
iajs-3480	244	9	and	and	CCONJ
iajs-3480	244	10	lc	lc	PROPN
iajs-3480	244	11	-	-	PUNCT
iajs-3480	244	12	ms	ms	PROPN
iajs-3480	244	13	/	/	SYM
iajs-3480	244	14	ms	ms	PROPN
iajs-3480	244	15	.	.	PROPN
iajs-3480	244	16	annals	annal	NOUN
iajs-3480	244	17	of	of	ADP
iajs-3480	244	18	clinical	clinical	ADJ
iajs-3480	244	19	biochemistry	biochemistry	NOUN
iajs-3480	244	20	2023	2023	NUM
iajs-3480	244	21	,	,	PUNCT
iajs-3480	244	22	60(5	60(5	NOUN
iajs-3480	244	23	)	)	PUNCT
iajs-3480	244	24	,	,	PUNCT
iajs-3480	244	25	298–305	298–305	NUM
iajs-3480	244	26	.	.	PUNCT
iajs-3480	245	1	https://doi.org/10.1177/00045632231159529	https://doi.org/10.1177/00045632231159529	ADV
iajs-3480	245	2	.	.	PUNCT
iajs-3480	246	1	24	24	NUM
iajs-3480	246	2	.	.	PUNCT
iajs-3480	247	1	gupta	gupta	PROPN
iajs-3480	247	2	,	,	PUNCT
iajs-3480	247	3	g.	g.	PROPN
iajs-3480	247	4	;	;	PUNCT
iajs-3480	247	5	sharma	sharma	PROPN
iajs-3480	247	6	,	,	PUNCT
iajs-3480	247	7	p.	p.	PROPN
iajs-3480	247	8	;	;	PUNCT
iajs-3480	247	9	kumar	kumar	PROPN
iajs-3480	247	10	,	,	PUNCT
iajs-3480	247	11	p.	p.	PROPN
iajs-3480	247	12	;	;	PUNCT
iajs-3480	247	13	itagappa	itagappa	NOUN
iajs-3480	247	14	,	,	PUNCT
iajs-3480	247	15	m.	m.	NOUN
iajs-3480	247	16	study	study	NOUN
iajs-3480	247	17	on	on	ADP
iajs-3480	247	18	subclinical	subclinical	ADJ
iajs-3480	247	19	hypothyroidism	hypothyroidism	NOUN
iajs-3480	247	20	and	and	CCONJ
iajs-3480	247	21	its	its	PRON
iajs-3480	247	22	association	association	NOUN
iajs-3480	247	23	with	with	ADP
iajs-3480	247	24	various	various	ADJ
iajs-3480	247	25	inflammatory	inflammatory	ADJ
iajs-3480	247	26	markers	marker	NOUN
iajs-3480	247	27	.	.	PUNCT
iajs-3480	248	1	journal	journal	PROPN
iajs-3480	248	2	of	of	ADP
iajs-3480	248	3	clinical	clinical	ADJ
iajs-3480	248	4	and	and	CCONJ
iajs-3480	248	5	diagnostic	diagnostic	ADJ
iajs-3480	248	6	research	research	NOUN
iajs-3480	248	7	:	:	PUNCT
iajs-3480	248	8	jcdr	jcdr	PROPN
iajs-3480	248	9	2015	2015	NUM
iajs-3480	248	10	,	,	PUNCT
iajs-3480	248	11	9(11	9(11	NUM
iajs-3480	248	12	)	)	PUNCT
iajs-3480	248	13	,	,	PUNCT
iajs-3480	248	14	bc04	bc04	PROPN
iajs-3480	248	15	.	.	PUNCT
iajs-3480	249	1	https://doi.org/10.7860%2fjcdr%2f2015%2f14640.6806	https://doi.org/10.7860%2fjcdr%2f2015%2f14640.6806	NOUN
iajs-3480	249	2	.	.	NOUN
iajs-3480	250	1	25	25	NUM
iajs-3480	250	2	.	.	PUNCT
iajs-3480	250	3	taddei	taddei	PROPN
iajs-3480	250	4	,	,	PUNCT
iajs-3480	250	5	s.	s.	PROPN
iajs-3480	250	6	;	;	PUNCT
iajs-3480	250	7	caraccio	caraccio	PROPN
iajs-3480	250	8	,	,	PUNCT
iajs-3480	250	9	n.	n.	PROPN
iajs-3480	250	10	;	;	PUNCT
iajs-3480	250	11	virdis	virdis	PROPN
iajs-3480	250	12	,	,	PUNCT
iajs-3480	250	13	a.	a.	NOUN
iajs-3480	250	14	;	;	PUNCT
iajs-3480	250	15	dardano	dardano	PROPN
iajs-3480	250	16	,	,	PUNCT
iajs-3480	250	17	a.	a.	NOUN
iajs-3480	250	18	;	;	PUNCT
iajs-3480	250	19	versari	versari	X
iajs-3480	250	20	,	,	PUNCT
iajs-3480	250	21	d.	d.	PROPN
iajs-3480	250	22	;	;	PUNCT
iajs-3480	250	23	ghiadoni	ghiadoni	PROPN
iajs-3480	250	24	,	,	PUNCT
iajs-3480	250	25	l.	l.	PROPN
iajs-3480	250	26	;	;	PUNCT
iajs-3480	250	27	monzani	monzani	PROPN
iajs-3480	250	28	,	,	PUNCT
iajs-3480	250	29	f.	f.	PROPN
iajs-3480	250	30	low	low	ADJ
iajs-3480	250	31	-	-	PUNCT
iajs-3480	250	32	grade	grade	NOUN
iajs-3480	250	33	systemic	systemic	ADJ
iajs-3480	250	34	inflammation	inflammation	NOUN
iajs-3480	250	35	causes	cause	VERB
iajs-3480	250	36	endothelial	endothelial	ADJ
iajs-3480	250	37	dysfunction	dysfunction	NOUN
iajs-3480	250	38	in	in	ADP
iajs-3480	250	39	patients	patient	NOUN
iajs-3480	250	40	with	with	ADP
iajs-3480	250	41	hashimoto	hashimoto	NOUN
iajs-3480	250	42	’s	’s	PART
iajs-3480	250	43	thyroiditis	thyroiditis	NOUN
iajs-3480	250	44	.	.	PUNCT
iajs-3480	251	1	the	the	DET
iajs-3480	251	2	journal	journal	NOUN
iajs-3480	251	3	of	of	ADP
iajs-3480	251	4	clinical	clinical	ADJ
iajs-3480	251	5	endocrinology	endocrinology	NOUN
iajs-3480	251	6	and	and	CCONJ
iajs-3480	251	7	metabolism	metabolism	NOUN
iajs-3480	251	8	2006	2006	NUM
iajs-3480	251	9	,	,	PUNCT
iajs-3480	251	10	91(12	91(12	NUM
iajs-3480	251	11	)	)	PUNCT
iajs-3480	251	12	,	,	PUNCT
iajs-3480	251	13	5076	5076	NUM
iajs-3480	251	14	-	-	SYM
iajs-3480	251	15	5082	5082	NUM
iajs-3480	251	16	.	.	PUNCT
iajs-3480	252	1	https://doi.org/10.1210/jc.2006-1075	https://doi.org/10.1210/jc.2006-1075	PROPN
iajs-3480	252	2	.	.	PUNCT
iajs-3480	253	1	26	26	NUM
iajs-3480	253	2	.	.	X
iajs-3480	254	1	marchiori	marchiori	PROPN
iajs-3480	254	2	,	,	PUNCT
iajs-3480	254	3	r.c	r.c	PROPN
iajs-3480	254	4	.	.	PROPN
iajs-3480	254	5	;	;	PUNCT
iajs-3480	254	6	pereira	pereira	PROPN
iajs-3480	254	7	,	,	PUNCT
iajs-3480	254	8	l.a	l.a	PROPN
iajs-3480	254	9	.	.	PROPN
iajs-3480	254	10	;	;	PUNCT
iajs-3480	254	11	naujorks	naujork	NOUN
iajs-3480	254	12	,	,	PUNCT
iajs-3480	254	13	a.a	a.a	PROPN
iajs-3480	254	14	.	.	PROPN
iajs-3480	254	15	;	;	PUNCT
iajs-3480	254	16	rovaris	rovaris	PROPN
iajs-3480	254	17	,	,	PUNCT
iajs-3480	254	18	d.l	d.l	PROPN
iajs-3480	254	19	.	.	PROPN
iajs-3480	254	20	;	;	PUNCT
iajs-3480	254	21	meinerz	meinerz	PROPN
iajs-3480	254	22	,	,	PUNCT
iajs-3480	254	23	d.f	d.f	PROPN
iajs-3480	254	24	.	.	PROPN
iajs-3480	254	25	;	;	PUNCT
iajs-3480	254	26	duarte	duarte	PROPN
iajs-3480	254	27	,	,	PUNCT
iajs-3480	254	28	m.	m.	NOUN
iajs-3480	254	29	m.	m.	NOUN
iajs-3480	254	30	;	;	PUNCT
iajs-3480	254	31	rocha	rocha	PROPN
iajs-3480	254	32	,	,	PUNCT
iajs-3480	254	33	j.b	j.b	PROPN
iajs-3480	254	34	.	.	PUNCT
iajs-3480	254	35	improvement	improvement	NOUN
iajs-3480	254	36	of	of	ADP
iajs-3480	254	37	blood	blood	NOUN
iajs-3480	254	38	inflammatory	inflammatory	ADJ
iajs-3480	254	39	marker	marker	NOUN
iajs-3480	254	40	levels	level	NOUN
iajs-3480	254	41	in	in	ADP
iajs-3480	254	42	patients	patient	NOUN
iajs-3480	254	43	with	with	ADP
iajs-3480	254	44	hypothyroidism	hypothyroidism	NOUN
iajs-3480	254	45	under	under	ADP
iajs-3480	254	46	levothyroxine	levothyroxine	PROPN
iajs-3480	254	47	treatment	treatment	NOUN
iajs-3480	254	48	.	.	PUNCT
iajs-3480	255	1	bmc	bmc	ADJ
iajs-3480	255	2	endocrine	endocrine	ADJ
iajs-3480	255	3	disorders	disorder	NOUN
iajs-3480	255	4	2015	2015	NUM
iajs-3480	255	5	,	,	PUNCT
iajs-3480	255	6	15(1	15(1	NUM
iajs-3480	255	7	)	)	PUNCT
iajs-3480	255	8	,	,	PUNCT
iajs-3480	255	9	1	1	NUM
iajs-3480	255	10	-	-	SYM
iajs-3480	255	11	9	9	NUM
iajs-3480	255	12	.	.	PUNCT
iajs-3480	256	1	https://doi.org/10.1186/s12902015-0032-3	https://doi.org/10.1186/s12902015-0032-3	PROPN
iajs-3480	256	2	.	.	PUNCT
iajs-3480	257	1	27	27	NUM
iajs-3480	257	2	.	.	X
iajs-3480	258	1	ross	ross	PROPN
iajs-3480	258	2	,	,	PUNCT
iajs-3480	258	3	e.	e.	PROPN
iajs-3480	258	4	;	;	PUNCT
iajs-3480	258	5	ganz	ganz	PROPN
iajs-3480	258	6	,	,	PUNCT
iajs-3480	258	7	t.	t.	NOUN
iajs-3480	258	8	hepcidin	hepcidin	NOUN
iajs-3480	258	9	and	and	CCONJ
iajs-3480	258	10	iron	iron	NOUN
iajs-3480	258	11	in	in	ADP
iajs-3480	258	12	health	health	NOUN
iajs-3480	258	13	and	and	CCONJ
iajs-3480	258	14	disease	disease	NOUN
iajs-3480	258	15	.	.	PUNCT
iajs-3480	259	1	annals	annal	NOUN
iajs-3480	259	2	of	of	ADP
iajs-3480	259	3	clinical	clinical	ADJ
iajs-3480	259	4	biochemistry	biochemistry	NOUN
iajs-3480	259	5	,	,	PUNCT
iajs-3480	259	6	2023	2023	NUM
iajs-3480	259	7	,	,	PUNCT
iajs-3480	259	8	54	54	NUM
iajs-3480	259	9	,	,	PUNCT
iajs-3480	259	10	261	261	NUM
iajs-3480	259	11	-	-	SYM
iajs-3480	259	12	277	277	NUM
iajs-3480	259	13	.	.	PUNCT
iajs-3480	260	1	https://doi.org/10.1146%2fannurev-med-043021-032816	https://doi.org/10.1146%2fannurev-med-043021-032816	PROPN
iajs-3480	260	2	.	.	PUNCT
iajs-3480	261	1	28	28	NUM
iajs-3480	261	2	.	.	PUNCT
iajs-3480	262	1	koorts	koort	NOUN
iajs-3480	262	2	,	,	PUNCT
iajs-3480	262	3	a.m.	a.m.	ADV
iajs-3480	262	4	;	;	PUNCT
iajs-3480	262	5	viljoen	viljoen	X
iajs-3480	262	6	,	,	PUNCT
iajs-3480	262	7	m.	m.	NOUN
iajs-3480	262	8	acute	acute	NOUN
iajs-3480	262	9	phase	phase	NOUN
iajs-3480	262	10	proteins	protein	NOUN
iajs-3480	262	11	:	:	PUNCT
iajs-3480	262	12	ferritin	ferritin	ADJ
iajs-3480	262	13	and	and	CCONJ
iajs-3480	262	14	ferritin	ferritin	ADJ
iajs-3480	262	15	isoforms	isoform	NOUN
iajs-3480	262	16	.	.	PUNCT
iajs-3480	263	1	in	in	ADP
iajs-3480	263	2	:	:	PUNCT
iajs-3480	263	3	acute	acute	ADJ
iajs-3480	263	4	phase	phase	NOUN
iajs-3480	263	5	proteinsregulation	proteinsregulation	NOUN
iajs-3480	263	6	and	and	CCONJ
iajs-3480	263	7	functions	function	NOUN
iajs-3480	263	8	of	of	ADP
iajs-3480	263	9	acute	acute	ADJ
iajs-3480	263	10	phase	phase	NOUN
iajs-3480	263	11	proteins	protein	NOUN
iajs-3480	263	12	.	.	PUNCT
iajs-3480	264	1	veas	veas	PROPN
iajs-3480	264	2	,	,	PUNCT
iajs-3480	264	3	f.	f.	PROPN
iajs-3480	264	4	edn	edn	PROPN
iajs-3480	264	5	.	.	PUNCT
iajs-3480	265	1	intechopen	intechopen	ADJ
iajs-3480	265	2	,	,	PUNCT
iajs-3480	265	3	2011	2011	NUM
iajs-3480	265	4	.	.	PUNCT
iajs-3480	266	1	https://doi.org/10.5772/20586	https://doi.org/10.5772/20586	VERB
iajs-3480	266	2	.	.	PUNCT
iajs-3480	267	1	29	29	NUM
iajs-3480	267	2	.	.	X
iajs-3480	267	3	gehrer	gehrer	NOUN
iajs-3480	267	4	,	,	PUNCT
iajs-3480	267	5	c.m	c.m	PROPN
iajs-3480	267	6	.	.	PROPN
iajs-3480	267	7	;	;	PUNCT
iajs-3480	267	8	mitterstiller	mitterstiller	NOUN
iajs-3480	267	9	,	,	PUNCT
iajs-3480	267	10	a.m.	a.m.	ADV
iajs-3480	267	11	;	;	PUNCT
iajs-3480	267	12	grubwieser	grubwieser	ADJ
iajs-3480	267	13	,	,	PUNCT
iajs-3480	267	14	p.	p.	NOUN
iajs-3480	267	15	;	;	PUNCT
iajs-3480	267	16	meyron	meyron	NOUN
iajs-3480	267	17	-	-	PUNCT
iajs-3480	267	18	holtz	holtz	NOUN
iajs-3480	267	19	,	,	PUNCT
iajs-3480	267	20	e.g.	e.g.	ADV
iajs-3480	267	21	;	;	PUNCT
iajs-3480	267	22	weiss	weiss	PROPN
iajs-3480	267	23	,	,	PUNCT
iajs-3480	267	24	g.	g.	PROPN
iajs-3480	267	25	;	;	PUNCT
iajs-3480	267	26	nairz	nairz	PROPN
iajs-3480	267	27	,	,	PUNCT
iajs-3480	267	28	m.	m.	NOUN
iajs-3480	267	29	advances	advance	NOUN
iajs-3480	267	30	in	in	ADP
iajs-3480	267	31	ferritin	ferritin	ADJ
iajs-3480	267	32	physiology	physiology	NOUN
iajs-3480	267	33	and	and	CCONJ
iajs-3480	267	34	possible	possible	ADJ
iajs-3480	267	35	implications	implication	NOUN
iajs-3480	267	36	in	in	ADP
iajs-3480	267	37	bacterial	bacterial	ADJ
iajs-3480	267	38	infection	infection	NOUN
iajs-3480	267	39	.	.	PUNCT
iajs-3480	268	1	indian	indian	ADJ
iajs-3480	268	2	journal	journal	PROPN
iajs-3480	268	3	of	of	ADP
iajs-3480	268	4	endocrinology	endocrinology	NOUN
iajs-3480	268	5	and	and	CCONJ
iajs-3480	268	6	metabolism	metabolism	NOUN
iajs-3480	268	7	2017	2017	NUM
iajs-3480	268	8	,	,	PUNCT
iajs-3480	268	9	31(4	31(4	NUM
iajs-3480	268	10	)	)	PUNCT
iajs-3480	268	11	,	,	PUNCT
iajs-3480	268	12	146	146	NUM
iajs-3480	268	13	.	.	PUNCT
iajs-3480	268	14	https://doi.org/10.3390/ijms24054659	https://doi.org/10.3390/ijms24054659	NOUN
iajs-3480	268	15	.	.	PUNCT
iajs-3480	269	1	30	30	NUM
iajs-3480	269	2	.	.	X
iajs-3480	270	1	oppen	oppen	PROPN
iajs-3480	270	2	,	,	PUNCT
iajs-3480	270	3	k.	k.	PROPN
iajs-3480	270	4	;	;	PUNCT
iajs-3480	270	5	ueland	ueland	ADJ
iajs-3480	270	6	,	,	PUNCT
iajs-3480	270	7	t.	t.	PROPN
iajs-3480	270	8	;	;	PUNCT
iajs-3480	270	9	siljan	siljan	NOUN
iajs-3480	270	10	,	,	PUNCT
iajs-3480	270	11	w.w	w.w	PROPN
iajs-3480	270	12	.	.	PROPN
iajs-3480	270	13	;	;	PUNCT
iajs-3480	270	14	skadberg	skadberg	PROPN
iajs-3480	270	15	,	,	PUNCT
iajs-3480	270	16	ø	ø	PROPN
iajs-3480	270	17	.	.	PUNCT
iajs-3480	270	18	;	;	PUNCT
iajs-3480	270	19	brede	brede	PROPN
iajs-3480	270	20	,	,	PUNCT
iajs-3480	270	21	c.	c.	PROPN
iajs-3480	270	22	;	;	PUNCT
iajs-3480	270	23	lauritzen	lauritzen	PROPN
iajs-3480	270	24	,	,	PUNCT
iajs-3480	270	25	t.	t.	PROPN
iajs-3480	270	26	;	;	PUNCT
iajs-3480	270	27	aukrust	aukrust	ADV
iajs-3480	270	28	,	,	PUNCT
iajs-3480	270	29	p.	p.	NOUN
iajs-3480	270	30	;	;	PUNCT
iajs-3480	270	31	steinsvik	steinsvik	ADJ
iajs-3480	270	32	,	,	PUNCT
iajs-3480	270	33	t.	t.	PROPN
iajs-3480	270	34	;	;	PUNCT
iajs-3480	270	35	husebye	husebye	PROPN
iajs-3480	270	36	,	,	PUNCT
iajs-3480	270	37	e.	e.	PROPN
iajs-3480	270	38	;	;	PUNCT
iajs-3480	270	39	michelsen	michelsen	PROPN
iajs-3480	270	40	,	,	PUNCT
iajs-3480	270	41	a.e	a.e	PROPN
iajs-3480	270	42	.	.	PROPN
iajs-3480	270	43	;	;	PUNCT
iajs-3480	270	44	holter	holter	PROPN
iajs-3480	270	45	,	,	PUNCT
iajs-3480	270	46	j.c	j.c	PROPN
iajs-3480	270	47	.	.	PROPN
iajs-3480	270	48	;	;	PUNCT
iajs-3480	270	49	heggelund	heggelund	PROPN
iajs-3480	270	50	,	,	PUNCT
iajs-3480	270	51	l.	l.	PROPN
iajs-3480	270	52	hepcidin	hepcidin	PROPN
iajs-3480	270	53	and	and	CCONJ
iajs-3480	270	54	ferritin	ferritin	ADJ
iajs-3480	270	55	predict	predict	VERB
iajs-3480	270	56	microbial	microbial	ADJ
iajs-3480	270	57	etiology	etiology	NOUN
iajs-3480	270	58	in	in	ADP
iajs-3480	270	59	community	community	NOUN
iajs-3480	270	60	-	-	PUNCT
iajs-3480	270	61	acquired	acquire	VERB
iajs-3480	270	62	pneumonia	pneumonia	NOUN
iajs-3480	270	63	.	.	PUNCT
iajs-3480	271	1	open	open	ADJ
iajs-3480	271	2	forum	forum	PROPN
iajs-3480	271	3	infectious	infectious	ADJ
iajs-3480	271	4	diseases	disease	NOUN
iajs-3480	271	5	2021	2021	NUM
iajs-3480	271	6	,	,	PUNCT
iajs-3480	271	7	8(4	8(4	NUM
iajs-3480	271	8	)	)	PUNCT
iajs-3480	271	9	,	,	PUNCT
iajs-3480	271	10	ofab082	ofab082	PROPN
iajs-3480	271	11	.	.	PUNCT
iajs-3480	271	12	https://doi.org/10.1093/ofid/ofab082	https://doi.org/10.1093/ofid/ofab082	PROPN
iajs-3480	271	13	.	.	PUNCT
iajs-3480	272	1	https://doi.org/10.4103%2fijem.ijem_265_17	https://doi.org/10.4103%2fijem.ijem_265_17	PUNCT
iajs-3480	273	1	https://doi.org/10.3390/diseases11010015	https://doi.org/10.3390/diseases11010015	PROPN
iajs-3480	273	2	https://doi.org/10.1200/jco.22.01217	https://doi.org/10.1200/jco.22.01217	PROPN
iajs-3480	273	3	https://doi.org/10.1146%2fannurev-med-043021-032816	https://doi.org/10.1146%2fannurev-med-043021-032816	PROPN
iajs-3480	273	4	https://doi.org/10.1038/s41598-019-52715-3	https://doi.org/10.1038/s41598-019-52715-3	PROPN
iajs-3480	273	5	https://doi.org/10.1182/blood-2006-06-027631	https://doi.org/10.1182/blood-2006-06-027631	NOUN
iajs-3480	273	6	https://doi.org/10.1016/j.cyto.2012.01.006	https://doi.org/10.1016/j.cyto.2012.01.006	X
iajs-3480	273	7	https://doi.org/10.1177/00045632231159529	https://doi.org/10.1177/00045632231159529	ADV
iajs-3480	273	8	https://doi.org/10.7860%2fjcdr%2f2015%2f14640.6806	https://doi.org/10.7860%2fjcdr%2f2015%2f14640.6806	NOUN
iajs-3480	273	9	https://doi.org/10.1210/jc.2006-1075	https://doi.org/10.1210/jc.2006-1075	NOUN
iajs-3480	273	10	https://doi.org/10.1186/s12902-015-0032-3	https://doi.org/10.1186/s12902-015-0032-3	NUM
iajs-3480	273	11	https://doi.org/10.1186/s12902-015-0032-3	https://doi.org/10.1186/s12902-015-0032-3	NUM
iajs-3480	273	12	https://doi.org/10.1146%2fannurev-med-043021-032816	https://doi.org/10.1146%2fannurev-med-043021-032816	PROPN
iajs-3480	273	13	https://doi.org/10.5772/20586	https://doi.org/10.5772/20586	PROPN
iajs-3480	273	14	https://doi.org/10.3390/ijms24054659	https://doi.org/10.3390/ijms24054659	PROPN
iajs-3480	273	15	https://doi.org/10.1093/ofid/ofab082	https://doi.org/10.1093/ofid/ofab082	PROPN
iajs-3480	273	16	ihjpas	ihjpas	PROPN
iajs-3480	273	17	.	.	PUNCT
iajs-3480	274	1	2024	2024	NUM
iajs-3480	274	2	,	,	PUNCT
iajs-3480	274	3	37(4	37(4	NOUN
iajs-3480	274	4	)	)	PUNCT
iajs-3480	274	5	108	108	NUM
iajs-3480	274	6	abstract	abstract	ADJ
iajs-3480	274	7	1	1	NUM
iajs-3480	274	8	.	.	PUNCT
iajs-3480	274	9	introduction	introduction	NOUN
iajs-3480	274	10	2	2	NUM
iajs-3480	274	11	.	.	PUNCT
iajs-3480	274	12	materials	material	NOUN
iajs-3480	274	13	and	and	CCONJ
iajs-3480	274	14	methods	method	NOUN
iajs-3480	274	15	3	3	NUM
iajs-3480	274	16	.	.	NOUN
iajs-3480	274	17	results	result	NOUN
iajs-3480	274	18	and	and	CCONJ
iajs-3480	274	19	discussion	discussion	NOUN
iajs-3480	274	20	4	4	NUM
iajs-3480	274	21	.	.	PUNCT
iajs-3480	275	1	conclusions	conclusion	NOUN
iajs-3480	275	2	references	reference	NOUN